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Introduction 
 
  
 
 
Both from a scientific and common sense point of view, there are many ideas about 
how patients adjust to a life-threatening disease such as cancer. However, the 
empirical evidence on this topic is still elusive, especially about the consequences 
that patients may experience in the long term. The present thesis addresses patients’ 
physical and psychosocial adjustment to cancer, in the first year after diagnosis 
onward to eight years after diagnosis. This introductory chapter starts with a 
description of the multiple consequences that cancer patients may experience as a 
result of the disease and its treatment. Next, the theoretical framework of the present 
study is presented, followed by the main research questions and the design of the 
present study. The chapter ends with a brief overview of the book.  
 
 
Cancer and its treatment 
 
In the Netherlands, approximately 57,000 persons are newly diagnosed with cancer 
each year (Visser et al., 1998). The chance of receiving a diagnosis of cancer is 
about equally high for men and women, with about one out of three persons 
developing cancer during his or her life. Among men, the most common cancer 
types are lung cancer (21%), prostate cancer (19%),  
and colorectal cancer (12%), whereas among women, breast cancer is the most 
common type (32%), followed by colorectal cancer (14%) and lung cancer (6%).  
Mainly as a result of the increase in the elderly population, changes in risk 
factors (e.g. smoking), and improvements in cancer screening and detection, there 
has been a gradual increase in the incidence of cancer in the last decades (Coebergh 
et al., 1995; Visser et al., 1998). At the same time, earlier cancer detection and/or 
more effective treatment have led to better five-year survival rates for most cancers. 
For instance, the five-year survival rate for breast cancer has increased from 52% to 
76% in the period from 1955 to 1992. The expected chance of survival depends, 
amongst others, on cancer type, disease stage, and patients’ age. For instance, certain 
types of cancer such as breast, cervix, and corpus cancer have a relatively good five-
year survival chance (i.e. more than 70%). Moreover, patients with an early disease 
stage and those younger than 60 years at the time of diagnosis generally have a 
better chance of survival. On the whole, the risk of dying from cancer has decreased                                                                                                                                             CHAPTER 1                                                                    2 
only slightly over time and with 36,500 patients dying of cancer each year, cancer 
remains to be the second leading cause of death in the Netherlands. 
Treatment for cancer depends, amongst others, on the cancer site, disease stage, 
and patients’ age, and may consist of surgery, radiotherapy, chemotherapy, 
hormonal therapy, or a combination of these treatment modalities. Improvements in 
the quality of cancer treatment have led to less mutilating surgeries, more precise 
techniques in radiotherapy resulting in less damage to healthy cells and tissues, and 
a better management of physical side-effects such as pain, nausea, and vomiting. All 
together, these progresses have significantly improved the quality of life of cancer 
patients. However, cancer patients may still experience severely disabling, 
disfiguring, and painful side-effects while receiving cancer treatment (Jacobsen et 
al., 1998). For instance, surgery can be impairing and disfiguring, radiotherapy can 
cause fatigue, nausea, and a reddening and irritation of the skin, and chemotherapy 
often induces nausea, vomiting, hair loss, fatigue, temporary low blood cells counts, 
and suppression of the immune system. Most of these side-effects disappear after 
treatment has finished, but some physical problems may persist until years after 
treatment. For instance, cancer patients may have to face permanent changes to their 
body image, fatigue, impaired bowel, bladder, and sexual functioning, and infertility 
(Passik et al., 1998). Cancer patients are also at an increased risk of a recurrence of 
the primary tumour or the development of a second tumour.  
In sum, as a result of better survival rates, many cancer patients are presently 
faced with a long period of uncertainty and the late consequences of cancer and its 
treatment. Therefore, cancer may be regarded as a chronic disease, which may bring 
along a series of stressful disease- and treatment-related situations and problems that 
vary in duration and severity. 
 
 
Psychosocial aspects of cancer 
 
Besides the multiple physical sequelae, cancer patients may also experience a wide 
variety of psychosocial problems as a result of the cancer experience. The sudden 
and unexpected confrontation with a life-threatening and still stigmatised disease 
and its treatment can disturb patients’ emotional balance. Patients may experience 
less confidence in their own body and feel uncertain, hopeless, and depressed (Moos 
& Schaefer, 1984). The disease may also affect patients’ self-image, sense of 
autonomy and competence, their social activities and their relationships with their 
partner, children, other family members, and friends (Hoekstra-Weebers, 2001; Katz 
et al., 1995; Wortman, 1984).  
With effective treatment and the support from members of the health care team 
and family and friends, the overwhelming impact of the diagnosis of cancer upon 
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patients’ functioning will become less salient over time. In the phase of remission 
and rehabilitation, life will become more and more dominated by more mundane 
concerns associated with daily living. Still, long-term cancer survivors may have 
recurrent thoughts about the cancer event and experience a greater sense of 
uncertainty about their health, about their future, and fears of a recurrence of the 
cancer (Kornblith, 1998; Tross & Holland, 1989). Some cancer survivors may also 
have to face problems regarding re-entry into prior normal responsibilities and roles 
or difficulties regarding job discrimination and insurance. 
Given the life-threatening nature of cancer and its chronic nature, it is not 
surprising that the focus of the literature in psycho-oncology has been on the 
negative consequences. However, recently, there is a growing realization that cancer 
may also have positive consequences. Being confronted with one’s mortality may 
call into question basic values, beliefs, and goals and produce a heightened sense of 
vulnerability (Janoff-Bulman & Frieze, 1983). In such a period of loss and 
uncertainty, patients search for meaning (e.g. ”Why me?”) and reconsider their 
priorities and values (Taylor, 1983; Ten Kroode, 1990). Eventually, this may lead to 
positive changes in patients’ life, prompted by and attributed to the cancer, such as a 
more positive self-image, more intimate and stronger relationships with family and 
friends, and a greater appreciation of life and its small pleasures (Andrykowski et 
al., 1996; David, 1999; Folkman & Greer, 2000; Justice, 1999; Petrie et al., 1999).  
 
 
Theoretical framework 
  
Clearly, the cancer and its treatment may have multiple physical and psychosocial 
consequences for the patient, both in the short and in the long term. In order to 
increase our knowledge about patients’ adjustment to the disease and its treatment, it 
is important to disentangle the various factors that are believed to play an important 
role herein, either as an outcome affected by the disease and/or as a predictor of 
(mal)adjustment.  
Moos and Schaefer have developed a model about how people adapt to a life crisis 
such as a serious physical disease (Moos & Schaefer, 1984; Moos & Schaefer, 
1993). Their model can be used to classify the multiple factors into an overall 
conceptual framework. The use of such a stress-coping model in cancer research 
may lead to a better understanding of patients’ adjustment to cancer and individual 
differences in the process of adjustment. Most patients cope relatively well with the 
cancer experience and seem to be able to control negative feelings and to retain a 
hopeful and meaningful outlook, a positive self-esteem, and satisfying relationships 
with others. Some cancer patients, however, suffer from severe psychosocial 
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sequelae. Why do cancer patients adjust so differently from one another? Which 
factors affect patients’ adjustment to cancer?  
According to Moos and Schaefer (1993), three sets of factors influence people’s 
appraisal and coping with a stressful event and ultimately their physical health and 
psychological well-being: (a) characteristics of the life crisis, (b) relatively stable 
personal factors (i.e. sociodemographic factors and personal resources), and (c) the 
environmental system (i.e. social resources, and other life events and chronic 
illnesses) (see Figure 1). The incorporation of cognitive appraisal and coping 
processes in the model emphasizes the importance of people’s subjective perception 
of the meaning of the crisis and their choice of coping responses in the process of 
adjustment (Lazarus & Folkman, 1984). 
In the case of cancer, objective disease characteristics, such as cancer site, 
disease stage, and type of treatment, are believed to affect patients’ adjustment 
(Holland, 1989; Lipowski, 1970). At a later stage, a recurrence of the cancer may 
interfere with patients’ functioning (Somerfield et al., 1999). Besides disease 
characteristics, patients’ sociodemographic characteristics and personal resources 
(e.g. self-esteem, optimism, mastery, neuroticism, prior coping experience, and 
important goals, tasks, and beliefs) play a crucial role in the adjustment to cancer. 
Finally, patients’ social resources (e.g. relationships with family, friends, and the 
medical team) as well as the presence of other life events and chronic diseases 
influence patients’ adjustment. The bi-directional paths in the model indicate that 
reciprocal feedback can occur. For instance, patients’ social resources can enhance 
their personal resources and vice versa. The model also incorporates the possibility 
that effectively coping with a stressor may lead to personal growth, in terms of 
enhanced personal and social resources and more effective coping skills (Schaefer & 
Moos, 1998). On the whole, the model  
emphasizes that cancer patients may simultaneously have to cope with the  
diagnosis and treatment of cancer, changes in personal and social resources  
Figure 1. Stress-coping model of Moos and Schaefer  
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as a result of cancer, and/or other stressful life events and chronic diseases. All these 
factors may affect the process of adjustment. 
The model of Moos and Schaefer does not explicitly make a distinction between 
short- and long-term adjustment. We believe, though, that the model is particularly 
useful to both forms of adjustment, since the model includes a wide variety of 
different components (also non-cancer related) and the possibility of personal 
growth. Such a meta-model of stress and coping can serve as a conceptual template 
for the development of more specific research questions and models, which define a 
less extensive and more manageable set of variables.  
In the present study, we have used the model to categorize the main variables of 
interest and the hypothesized relationships among these variables. This has led to the 
formulation of the two main research questions:  
 
(a)  what is the impact of a diagnosis of cancer and its treatment on patients’ 
physical and psychological functioning and on their personal and social 
resources during the course of the illness? 
(b)  what is the role of patients’ sociodemographic and disease characteristics 
and their personal and social resources in the  
process of adjustment?  
Numerous studies have examined these two issues among cancer patients, providing 
valuable information. However, when looking at the model, it becomes clear that an 
adequate methodological study design is needed to obtain a more comprehensive 
picture of the complex process of adjustment to cancer over time. Most importantly, 
the study should measure a wide variety of factors, should use a longitudinal design, 
and should incorporate a reference group of individuals without cancer from the 
general population. This is needed to distinguish the impact of cancer and its 
treatment from other factors that may influence patients’ functioning, such as rather 
stable personal and environmental variables. Unfortunately, most previous studies 
among cancer patients used a cross-sectional design, did not include a healthy 
reference group, and studied a limited range of variables, focussing mainly on the 
negative consequences. Furthermore, most studies concentrate on the first year after 
diagnosis. Studies that did examine the long-term consequences of cancer often 
assessed patients at a wide variable time after diagnosis. Consequently, the 
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information about long-term adjustment is still elusive. As can be read more 
extensively in the section below, the present study attempted to fill in these gaps, 
through the use of a longitudinal, case-control design and the assessment of a wide 
variety of factors, using both quantitative and qualitative measures. 
 
 
The current research project 
 
The data for the present study was collected as part of a longitudinal study that was 
initiated in 1990 on the role of social relationships in patients’ quality of life (De 
Ruiter, 1995). A large group of 475 cancer patients were recruited from 12 hospitals 
in the three northern provinces of the Netherlands. The following types of cancer 
were included: breast, colon, rectum, lung, testis, corpus uteri, cervix, and ovarian 
cancer, thus representing the most common types of cancer. Patients had to be aware 
of the diagnosis of cancer and they had to have a relatively good prognosis, that is, a 
life expectancy of at least twelve months. Patients were assessed at four fixed points 
in time since diagnosis, that is, at 3 months, 9 months, 15 months, and 8 years after 
diagnosis. These points in the course of the illness were chosen to capture the period 
of crisis (3 months), intermediate adjustment (9 months), relatively short-term 
adjustment (15 months),  
and clearly long-term adjustment (8 years). In the present thesis, we have focused on 
the assessments at 3 months (n = 475), 15 months (n = 403), and  
8 years after diagnosis (n = 206).  
Based on the gender and age distribution of the patient group, a  
reference group of 255 individuals without a history of cancer from the general 
population was selected from the register office of five townships in the same region 
as the patients. The reference group was also assessed at four points in time with 
similar intervals as the patient group. Again, we focused on the first assessment (n = 
255), the third (n = 225), and the last assessment (n = 120). 
In order to obtain a comprehensive account of patients’ adjustment to cancer, a 
wide range of variables were assessed by means of a self-report questionnaire and a 
semi-structured interview at the patient’s home. Based on the model of Moos and 
Schaefer, these variables can be divided into three main groups:  
(a)  physical functioning (i.e. physical symptoms and functional limitations in 
household and social activities);  
(b)  psychological functioning (i.e. depressive symptoms and anxiety); 
(c)  personal and social resources (i.e. neuroticism, extraversion, coping styles, 
satisfaction with life, self-esteem, meaning in life, social assertiveness, 
social comparison, social support, and marital satisfaction).  
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Information about the main sociodemographic characteristics (i.e. gender, age, 
education, and marital status) and the occurrence of other chronic illnesses and life 
events was collected during the semi-structured interview. Medical data (i.e. type, 
stage of disease, and treatment) were derived from the cancer registration from the 
Comprehensive Cancer Centre North Netherlands (CCCNN). 
At eight years after diagnosis, a uniquely designed interview collected 
information about issues of particular concern to cancer survivors. This interview 
was based on the literature on long-term adjustment to cancer and the transcription 
of six lengthy pilot-interviews with long-term cancer survivors. In the interview, 
survivors were prompted to talk about the following issues: current quality of life 
and changes herein over the past eight years; current physical functioning, 
limitations in daily and social activities, and late physical effects of cancer or 
treatment; current psychological functioning, thoughts about the cancer (e.g. fear of 
recurrence, cause of the cancer, ”Why me?”), and the experience of follow-up visits 
in the hospital; changes in activities and social relationships, current appreciation of 
activities and social relationships as well as changes herein in the past eight years; 
and finally, changes in the self as a person and life in general, current appreciation of 
the self and life in general, as well as changes herein in the past eight years. When 
cancer survivors reported a change, they were asked to indicate to what extent this 
change was due to cancer or due to other factors such as ageing. The interview 
ended with some general questions about the overall perception and impact of the 
cancer experience. The interview was also conducted in the reference group, with 
the exclusion of particular cancer-related issues. This has made it possible for us to 
draw comparisons between the group of cancer survivors and references. 
The interview was conducted after respondents had completed the semi-
structured interview. On average, the interviews lasted for about one hour in the 
reference group up till two hours in the survivor group (in addition to a semi-
structured interview of about half hour). During the interview, survivors and 
references were encouraged to talk openly and at their own pace about the 
aforementioned issues. The interviewers were free to decide in which order to 
address the issues of the interview and to (re)formulate the questions. The interviews 
were recorded on tape. At home, while listening again to the interview on tape, the 
interviewers coded the open-ended responses on one or more response categories. 
 
 
Overview of the book 
 
First part 
Depressive symptoms are the most frequently encountered psychological problem in 
the medically ill, including in cancer patients (Katon & Sullivan, 1990; McDaniel et 
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al., 1997). Therefore, the first part of the book focuses on the measurement and the 
presence and course of depressive symptoms in cancer patients in the year following 
diagnosis. Moreover, the factors associated with an increased risk of depressive 
symptoms are examined, using the model of Moos and Schaefer as a framework.  
 
In Chapter 2, the psychometric characteristics of the Center for Epidemiologic 
Studies Depression (CES-D) scale are reported. The CES-D is one of the most 
widely used self-report questionnaires to measure depressive symptoms, both in the 
general population and in cancer patients (Beeber et al., 1998; Pasacreta, 1997). The 
scale consists of 20 items, 16 being negatively formulated items (e.g. “I felt sad”) 
and four being positively formulated items (e.g. “I felt hopeful”). The total sumscore 
is based on the summation  
of all 20 items. Little is known, however, about the function and the content of the 
four positively formulated items in a mainly negatively formulated measure of 
depressive symptoms. Do they measure the presence (or absence) of positive affect? 
Furthermore, to what extent are they related to the negatively formulated items? 
Some researchers believe that negative (depressed) affect and positive affect are the 
opposite poles of a single continuum (Ross & Van Willigen, 1997), while others 
argue that these two types of affect are largely independent of each other and may 
co-occur simultaneously (Folkman, 1997). In order to address these issues and to 
validate the use of the total sum score, we tested the validity and the reliability of the 
CES-D scale, both in the group of cancer patients and in the reference group.  
 
Chapter 3 explores into further detail the presence and course of depressive 
symptoms in cancer patients in the first year after diagnosis. The chapter also reports 
the results regarding the associations of patients’ sociodemographic (i.e. gender, age, 
education, and marital status) and disease characteristics (i.e. site, stage, and 
treatment) with depressive symptoms. When examining the prevalence of depressive 
symptoms in cancer patients, it has to be taken into account that individuals without 
cancer from the general population may suffer also from depressive symptoms. Most 
previous studies among cancer patients, however, lack a reference group from the 
general population. Thus little is known about the extent to which depressive 
symptoms in cancer patients are the result of cancer or mainly reflect general 
psychological morbidity. Another important issue that has been overlooked by 
previous studies on the role of sociodemographic factors in depressive symptoms in 
cancer patients is that these factors have also been associated with depressive 
symptoms in the general population. If we want to know more specifically whether 
sociodemographic factors place cancer patients at a higher risk of developing 
depressive symptoms as a result of cancer or whether they primarily reflect general 
vulnerability, we need to compare the associations of sociodemographic factors with 
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depressive symptoms in cancer patients with those in references. In the present 
study, we compare the levels of depressive symptoms in cancer patients with those 
in a reference group of individuals without cancer from the general population, both 
at 3 months and 15 months after diagnosis. The study also examines the associations 
of sociodemographic factors with depressive symptoms, in cancer patients and 
references separately, and differences between the two groups in these associations. 
Finally, since patients’ sociodemographic and medical characteristics are likely to be 
related to each other, we explore the associations among patients’ sociodemographic 
and medical characteristics and examine whether both types of factors are 
independently of each other related to depressive symptoms.  
Besides sociodemographic and disease characteristics, the model of Moos and 
Schaefer postulates that personal and social resources play an important role in 
patients’ adjustment to cancer. Chapter 4 focuses on two particular resources, that is, 
self-esteem and social support. Social support is the most frequently studied 
resource in stress-coping studies and is believed to be of crucial importance for 
psychological functioning (Thoits, 1995). According to the model of Moos and 
Schaefer, social resources (i.e. social support) are likely to be related to a person’s 
personal resources. In the context of social support, self-esteem is considered to be 
an important personal resource, since one of the major functions of social support is 
to bolster or maintain self-esteem (Curbow & Somerfield, 1991). Therefore, we 
examine the interrelationships between self-esteem and social support and whether 
both resources, as measured at 3 months after diagnosis, are independently related to 
depressive symptoms at 3 months and 15 months after diagnosis. To investigate 
whether these resources are related to psychological functioning in all 
circumstances, or particularly in the face of adversity, the associations of social 
support and self-esteem with depressive symptoms in cancer patients are compared 
to those in references.  
 
Second part 
In the second part of the book, we focus on the impact of cancer upon patients’ 
functioning in the long term. Since the empirical evidence concerning the long-term 
adjustment to cancer is still limited, we broaden our scope of interest and examine, 
besides depressive symptoms, a wide variety of measures of physical functioning 
and personal and social resources.  
 
Chapter 5 presents the first results regarding survivors’ long-term functioning at 
eight years after diagnosis. A major problem in the assessment of long-term 
adjustment to cancer is distinguishing the effects due to cancer from those due to 
ageing and comorbidities (Gotay & Muraoka, 1998). Many cancer patients are in the 
age of 60 years or older when they receive a diagnosis of cancer. Therefore, they are 
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likely to suffer from other physical problems (e.g. less energy and limitations in 
daily activities) and chronic diseases, which may affect their functioning and 
resources. In order to differentiate the impact of cancer and its treatment from 
ageing, the present study compares cancer survivors and references on a wide 
variety of aspects of physical functioning (i.e. physical symptoms and functional 
limitations), psychological functioning (i.e. depressive symptoms and anxiety), and 
personal and social resources (i.e. self-esteem, global sense of meaning in life, life 
satisfaction, marital satisfaction and emotional support). Since functioning may 
fluctuate over time, comparisons between survivors and references are made at 3 
months, 15 months, and 8 years after diagnosis. We also examine differences 
between the two groups in changes (i.e. difference scores) in these outcomes 
measures over time. These longitudinal quantitative data were supplemented with 
the data from a qualitative interview at eight years after diagnosis. Additional 
analyses were performed to examine to what extent a cancer recurrence or a new 
primary tumour affects survivors’ long-term functioning.  
 
In Chapter 6, we zoom in on the role of age in long-term adjustment to cancer. 
There are several indications that patients’ age at the time of diagnosis affects their 
adjustment to cancer, both in the short and in the long term. As mentioned in the 
previous paragraph, older cancer patients are more likely to suffer from other 
physical problems that may impair their functioning. Age is also believed to 
influence the psychological impact of the cancer experience, by its effect on 
patients’ appraisal of the meaning of the cancer experience. That is, younger cancer 
patients may be less anticipated, have less prior coping experience, and may 
perceive a greater sense of loss as a result of the illness. In Chapter 3, we started off 
with the examination of the role of age in the course of depressive symptoms in the 
first year after diagnosis. In Chapter 6, we continue our research by examining age 
differences in various aspects of survivors’ physical and psychological functioning 
at 3 months, 15 months, and 8 years after diagnosis. At the latter point in time, we 
also look at age differences in a global sense of meaningfulness in life, positive 
consequences of illness, and more qualitative aspects of adjustment to cancer. In 
addition, to take the role of ageing into account, we compare levels of functioning in 
cancer survivors with those in similar-aged references.  
 
A summary and general discussion of the meaning and implications of the results is 
presented in Chapter 7. This is followed by a Dutch summary. 
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The evaluation of the Center for  
Epidemiologic Studies Depression (CES-D) Scale: 
Depressed and Positive Affect in cancer patients 
and healthy reference subjects 
 
 
 
Abstract 
 
This study examined the reliability and validity of a two-factor structure of the 
Center for Epidemiologic Studies Depression (CES-D) scale. The study was 
conducted in a large group of cancer patients (n = 475) and a matched reference 
group (n = 255). Factor analysis confirmed our hypothesis that the 16 negatively and 
four positively formulated items measure two relatively independent factors, i.e. 
Depressed Affect and Positive Affect. Therefore, these items should not be 
combined into an overall sumscore. In both groups, Depressed Affect proved to be a 
reliable and valid measure of depressive symptomatology, as indicated by its good 
internal consistency, its strong correlations with other measures of psychological 
distress and neuroticism, and its effectiveness in discriminating patients from the 
reference group on depressive symptomatology. In contrast, the validity of the 
Positive Affect factor could not be confirmed, since it was only weakly related to 
other measures of psychological distress and extraversion. Depressed and Positive 
Affect were about equally related to self-esteem, life satisfaction, and quality of life. 
These findings support the use of a sumscore based on the 16 negatively formulated 
CES-D items as a more valid measure of depressive symptomatology, in cancer 
patients and in healthy individuals from the general population.   
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Introduction 
 
There is a high prevalence of depressive symptoms among the medically ill (Katon 
& Sullivan, 1990). Among cancer patients, a recent review reported that an average 
of 24% (range 1.5% to 50%) of all patients experience depressive symptoms in the 
initial period after diagnosis (McDaniel et al., 1995). With regard to the course of 
depressive symptoms over time, most studies indicated an improvement in 
psychological functioning in the year after diagnosis (Ganz et al., 1996). Some 
studies, however, found no change in depressive symptoms (Vinokur et al., 1990) or 
a worsening of depressive symptoms over time (Omne-Ponten et al., 1992). 
Interpreting these differences in rates of depression is difficult because the studies 
vary by  
(a) definition of depression, (b) diagnostic method, (c) study cohort, and  
(d) time since diagnosis (DeFlorio & Massie, 1995; McDaniel & Nemeroff, 1993; 
McDaniel et al., 1995). Nonetheless, they provide important clinical information. 
The recognition and treatment of depressive symptoms in cancer patients is crucial, 
because depressive symptoms may adversely affect survival, the length of hospital 
stay, compliance with treatment, the ability to care for oneself, and the quality of life 
(McDaniel et al., 1995). 
With regard to the definition of depression, four different concepts are frequently 
used, i.e. mood (i.e. predominant emotion), symptom, syndrome (i.e. group of 
symptoms), and psychiatric illness (Ensel, 1986). For instance, according to the 
DSM-IV diagnostic criteria, the central feature of a major depression is the presence 
of a “depressed mood” and/or “a loss of interest or pleasure” (Kaplan et al., 1994). 
Other symptoms include a significant weight loss or gain, changes in appetite, 
sleeping problems, changes in motor and cognitive activity, fatigue or loss of 
energy, feelings of worthlessness or guilt, recurrent thoughts of death or suicide, and 
difficulty concentrating or thinking. This definition of depression emphasizes the 
presence of negative affect.    
Differences in the definition of depression are reflected in the variety of 
diagnostic methods used to assess depressive symptomatology. As opposed to 
diagnostic interviews such as the Structured Interview for the DSM-IV (SCID) 
(Spitzer et al., 1989), which measure psychiatric disorders, self-report symptom 
scales such as the CES-D (Radloff, 1977) measure depression as a group of 
symptoms. 
The Center for Epidemiologic Studies Depression (CES-D) scale is one of the 
most widely used self-report instruments to measure current depressive 
symptomatology and to identify possible cases of depressive disorders, both in the 
general population (Hertzog et al., 1990; Kessler et al., 1992; Radloff, 1977; Vera et 
al., 1991) and in patients with cancer (Kurtz et al., 1994; Given et al., 1994; 
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Pasacreta, 1997). The scale was derived from five other depression scales: the Beck 
Depression Inventory (Beck et al., 1961), the Zung Depression Scale (Zung, 1965), 
parts of the Minnosota Multiphasic Personality Inventory (Dahlstrom & Welsh, 
1960), the Raskin Self-report Depression Scale (Raskin et al., 1970), and the 
Gardner Symptom Checklist (Gardner, 1968). The selected items are assumed to 
measure the most important components of depressive symptomatology, including 
depressed mood, feelings of guilt and worthlessness, feelings of helplessness and 
hopelessness, loss of appetite, sleep disturbances, and psychomotor retardation 
(Radloff, 1977). Using factor analysis, Radloff (1997) found that the 20 items 
clustered in four dimensions: (1) Depressed Affect, (2) Positive Affect, (3) Somatic-
Retarded Activity, and (4) Interpersonal Relations. However, because they are all 
dimensions of depression, Radloff (1977) recommends the use of the total scale 
score. 
The psychometric properties of the CES-D scale have been tested in several 
populations varying in sociodemographic factors and health status (Barlow & 
Wright, 1998; Beeber et al., 1998; Callahan & Wolinsky, 1994; Edman et al., 1999; 
Hann et al., 1999; Pasacreta, 1997; Radloff, 1977; Santor & Coyne, 1997; Stommel 
et al., 1993). In general, these studies have supported the reliability and validity of 
the CES-D scale in identifying individuals with depressive symptomatology. With 
regard to the internal structure of the CES-D, the results have yielded the four 
underlying factors, which were similar to the components of depression that the 
scale was intended to measure (Beeber et al., 1998; Ensel, 1986; Hertzog et al., 
1990; Radloff, 1977). However, a closer look at the findings of the studies that 
examined the factorial structure of the CES-D (Barlow & Wright, 1998; Beeber et 
al., 1998; Edman et al., 1999) showed that the original four-factor solution was not 
always replicable, as indicated by the crossover of items from one factor to another, 
especially between Depressed Affect and Somatic-Retarded Activity. Depressed 
Affect was also found to be highly correlated (r = .87) to Somatic-Retarded Activity 
(Stommel et al., 1993). Only Positive Affect was consistently found to be composed 
of the four positively formulated items. These findings raise doubts about the 
usefulness and interpretation of the four original CES-D factors and suggest a two-
factor structure, differentiating between Positive Affect and the other three factors, 
thus combining Depressive Affect, Somatic-Retarded Activity, and Interpersonal 
Relations. One study on the internal structure of the CES-D found this two-factor 
structure, differentiating between Positive Affect on one hand and Depressive 
Affect, Somatic-Retarded Activity, and Interpersonal Relations on the other hand 
(Edman et al., 1999). 
Two issues raise with regard to the inclusion of the Positive Affect items in the 
CES-D scale. First, what is the function of positive affect in a measure of depressive 
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symptomatology? Second, do the four positively formulated CES-D items measure 
depressive symptomatology or a different concept, e.g. positive affect? 
First, with regard to the function of positive affect in a measure of depressive 
symptomatology, some theories assume independent unipolar dimensions of 
positive and negative affect (Watson & Clark, 1997), whereas other theories assume 
a bipolar positive-negative dimension (Russell & Carroll, 1999). Watson et al. 
(1988) found that high negative affect as well as low positive affect were related to 
depression, and concluded that the inclusion of positive affect in measures of 
depression might enhance their sensitivity. They look upon positive and negative 
affect as being largely independent across a wide range of conditions (Watson & 
Clark, 1997). The degree of their independence, often described in terms of the 
strength of the correlation, may be influenced by two conditions: (a) the greater the 
importance of the goal, the more intense will be the positive or negative affective 
reaction to the goal-related circumstances in the encounter (Stein et al., 1993), and 
(b) the greater the intensity of the affective reaction, the stronger will be the inverse 
relationship between positive and negative affect (Diener & Emmons, 1984; Diener 
et al., 1991). In contrast, Ross and Van Willigen (1997) viewed well-being and 
distress as the opposite poles on a single continuum. They included positive affect in 
their measure of depression and defined depression as “the balance of depressed 
affect minus positive affect”. In sum, positive affect in a measure of depression 
might enhance its sensitivity but its function and interpretation depends on the 
hypothesized relationship between both concepts, i.e. two unipolar of one bipolar 
dimension.   
Second, when looking at the content and formulation of the Positive Affect 
items, it is ambiguous whether these items, after scored in reverse, relate to the 
concept of depression (i.e. content validity). The reason for formulating the four 
items positively was to avoid the possibility of patterned responses (Ensel, 1986). 
However, to what extent can depressive symptomatology be measured by means of 
positively formulated items (after scored in reverse)? As mentioned earlier, essential 
components of depression are a depressed mood, a loss of interest and pleasure, and 
feelings of worthlessness and hopelessness (Kaplan et al., 1994), in short the 
presence of symptoms of negative affect. When looking at the content of the four 
Positive Affect items, it is doubtful whether these positively formulated items 
(scored in reverse) measure depressive symptomatology. For example, to what 
extent is item 4 “felt as good as others” related to feelings of worthlessness, item 12 
“happy” and item 16 “enjoyed life” related to a loss of interest and pleasure, and 
item 8 “hopeful future” to feelings of hopelessness? Iwata et al. (1998) found that 
the four positively formulated items of Positive Affect could not be used to 
adequately assess depressive symptomatology, but the corresponding negatively 
revised items (e.g. happy into unhappy, hopeful into not hopeful) were able to 
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discriminate depressed patients from controls. Thus, it seems more reasonable that 
the four positively formulated items do not measure depressive symptomatology but 
a different concept, e.g. positive affect.  
An additional problem with the use of the four positively formulated items in a 
mainly negatively formulated symptom scale is the question whether respondents 
notice the difference in the formulation of these items. The reason for formulating 
the four items positively was to avoid the possibility of patterned responses. 
However, it seems questionable whether the inclusion of these items can actually 
reduce the effect of patterned responses.  
In conclusion, only limited information is available about the internal structure 
of the CES-D and the use of a total scale score as an indicator of depressive 
symptomatology. Further research on the reliability and validity of the subscales is 
necessary to clarify the use of the CES-D as a measure of psychological functioning 
in populations varying in sociodemographic factors and health status. Specifically, 
little is known about the function of the four positively formulated items of Positive 
Affect in a scale purported to measure depressive symptomatology.  
The aim of the present study was to investigate the psychometric properties of 
the CES-D scale. Since the CES-D is one of the most widely used self-report 
instruments to measure current depressive symptomatology in the general population 
as well as in patients with a medical illness, we examined its psychometric 
properties in a large group of cancer patients and in a reference group of healthy 
individuals from the general population. In addition, since the CES-D is often used 
in longitudinal studies, we examined its psychometric properties at two points in 
time, thus taking into account possible fluctuations in the representation of 
depressive symptomatology over time. We hypothesized that the CES-D scale 
measures two relatively independent and weakly correlated factors, differentiating 
between the negatively and positively formulated CES-D items, subsequently 
labelled as Depressed Affect and Positive Affect. Second, we expected differences in 
the endorsement of the 16 negatively formulated items of Depressed Affect and the 
four positively formulated items of Positive Affect. Third, we expected Depressed 
Affect to be strongly related to other measures of psychological distress, 
neuroticism, and physical symptom distress, whereas we expected Positive Affect to 
be more strongly related to measures of well-being and extraversion (DeNeve & 
Cooper, 1998; Diener, 1998; Given et al., 1994; Greer & Burgess, 1987; Hobfoll & 
Walfisch, 1984; Meyer & Shack, 1989; Pasacreta, 1997). Finally, we expected 
Depressed Affect to be able to discriminate cancer patients from the reference group 
on depressive symptomatology, especially in the initial period after diagnosis. 
Because it is doubtful that Positive Affect measures depressive symptomatology, we 
expected no significant differences between the patient and reference group on 
Positive Affect.  
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Methods 
 
Subjects and Procedures 
The data presented in this article were obtained as part of a longitudinal study on the 
psychosocial adjustment to cancer (De Ruiter et al., 1993; Van der Zee et al., 1996). 
The sample consists of a heterogeneous group of 475 patients with cancer and a 
group of 255 reference subjects. This latter group was matched at group level on age 
and gender-ratio with the patient group. All patients filled out questionnaires and 
were interviewed at three points in time, i.e. 3, 9, and 15 months after diagnosis; the 
reference group was interviewed at three occasions with similar intervals.  
For the present study we used the data collected at the first and third assessment 
(here labelled as T1 and T2). Only respondents who filled in all 20 CES-D items 
were included in the analyses. At T1, eight percent of the respondents failed to 
respond to all items, resulting in a sample of 434 patients and 236 reference subjects. 
At T2, 403 patients and 224 reference subjects participated in the study. Seven 
percent of these respondents failed to respond to all items, resulting in a sample of 
376 patients and 209 reference subjects at T2.  
 
Measures 
For the present study we used the Dutch version of the Center for Epidemiologic 
Studies Depression (CES-D) scale to measure depressive symptomatology (Bouma 
et al., 1995). The CES-D scale consists of 20 items. Sixteen items are negatively 
formulated, e.g. “felt depressed” (item 6), whereas the remaining four items are 
positively formulated, i.e. “felt as good as others” (item 4), “hopeful future” (item 
8), “happy” (item 12), and “enjoyed life” (item 16). The scale is purported to 
measure the presence of depressive mood by asking respondents to rate how often 
they have experienced each of the 20 symptoms during the past week. Each item is 
scored on a 4-point scale: (0) “rarely or none of the time” (less than once a week), 
(1) “some or a little of the time” (1-2 days a week), (2) “occasionally or a moderate 
amount of time” (3-4 days a week), or (3) “most or all of the time” (5-7 days a 
week). The responses to the four positively formulated items (item 4, 8, 12, and 16) 
are subsequently scored in reverse, thus score 0 becomes score 3, score 1 becomes 
score 2, etc. In the present article, the reported scores on the positively formulated 
items are scored in reverse, with higher scores indicating less positive affect. The 
total score for a respondent consists of a sum score of the responses to all 20 items, 
ranging from 0 to 60. Radloff (1977) recommended that respondents with a total 
CES-D score of 16 or higher should be screened for a diagnosis of major depression. 
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Situational or current anxiety was measured by the State-Anxiety subscale of the 
State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1970). Respondents rate 
each of the 20 items on a Likert type 4-point scale, ranging from 1 “hardly ever” to 4 
“almost always”. Several studies used the STAI as a measure of anxiety in patients 
with cancer (Kreitler et al., 1997; Spiegel et al., 1994; Weitzner et al., 1997). In the 
present study, Cronbach’s alpha for this subscale was .74 in both the patient and 
reference group. 
Psychological distress was assessed with the 28-item version of the General 
Health Questionnaire (GHQ-28) (Goldberg & Williams, 1988; Goldberg & Hillier, 
1979). The scale consists of four subscales: Anxiety, Depression, Social, and 
Somatic Distress. In the present study, Cronbach’s alpha for the total scale was in 
both groups .92.  
Physical symptom distress and psychological distress were assessed with the 
Rotterdam Symptom Checklist (RSCL) (De Haes et al., 1990). For the present study, 
a 27-item version of the RSCL was used. The Physical Distress subscale consisted 
of 17 items and the Psychological Distress subscale of 10 items. Cronbach’s alpha 
for Physical Distress was in the patient and reference group .79 and .84, 
respectively. The alpha for Psychological Distress was .87 in both groups. 
Neuroticism and extraversion were assessed using the Eysenck Personality 
Questionnaire (Eysenck & Eysenck, 1991; Sanderman et al., 1995). Both subscales 
consist of 12 items and respondents are asked to indicate whether or not they agree 
with a statement. The sumscores of both subscales range from 0 to 12. Cronbach’s 
alpha for Neuroticism was in the patient and reference group .83 and .86, 
respectively, and the alpha for Extraversion  
was .81 and .82, respectively.  
Self-esteem was measured by the Rosenberg Self-esteem scale (RSE) 
(Rosenberg, 1965; Van der Linden et al., 1983). The alpha for the total scale was in 
the patient and reference group .82 and .85, respectively. 
Overall quality of life was assessed by the LASA. With one question on a Visual 
Analogue Scale, the degree to which an individual evaluated his or her quality of life 
was assessed.  
Finally, satisfaction with life was measured by the Satisfaction With Life Scale 
(SWLS) (Arrindell et al., 1991). The scale consists of five items. Alpha in both 
groups was high: .89 in the patient group and .87 in the reference group.  
In a semi-structured interview data was collected regarding subjects’ 
sociodemographic characteristics, i.e. gender, age, educational level, and marital 
status.  
Medical data was available from the cancer registration, and included cancer site, 
stage, and initial treatment, i.e. surgery, radiotherapy, and/or chemotherapy.   
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Statistical analyses 
The validity of the scale, in terms of internal structure, was examined by an 
explorative Principal Component Analysis (PCA) with Varimax Rotation and by a 
confirmative Simultaneous Component Analysis (SCA) (Kiers, 1990). The first 
factor was expected to load high on the 16 negatively formulated items, i.e. 
Depressed Affect, and a second factor was expected to load high on the four 
positively formulated items, i.e. Positive Affect. The SCA was performed to test 
whether a two-factor structure explains enough variance of the possible maximal 
explained variance. Differences between the results of the PCA and SCA in the 
amount of explained variance demonstrate the fit of the factor structure of the 
model. In addition, item-level analysis determined how the patient and reference 
group endorsed the individual items of the CES-D. 
The reliability of the Depressed Affect and Positive Affect factors, in terms of 
internal consistency, was analysed by using Cronbach’s alpha. Item-level analysis 
was performed by examining the item-total correlations and the total alpha with each 
item removed.  
Validity was further examined by the correlations between Depressed and 
Positive Affect. In order to examine the correlation between the negatively and 
positively formulated items, we calculated the mean of the 120 possible pairwise 
correlations among the 16 negatively formulated items, the mean of the 6 possible 
pairwise correlations among the four positively formulated items, and the mean of 
64 possible pairwise correlations between the 16 negatively formulated and four 
positively formulated items. If the latter mean is significantly lower than the mean of 
possible pairwise correlations among the negatively and positively formulated items 
separately, the correlation between the negatively and positively formulated items is 
relatively low. Pearson correlation coefficients were calculated to examine the 
relationship between Depressed Affect and Positive Affect, as well as to examine the 
relationships among Depressed Affect, Positive Affect, and other psychosocial 
measures expected to vary with depressive symptoms.   
Finally, in order to test whether the two factors are able to discriminate patients 
from the reference group on depressive symptoms, we performed  
t-tests for independent samples to evaluate differences between both groups on 
Depressed Affect and Positive Affect. 
 
 
Results 
 
Sample characteristics 
The sociodemographic and medical characteristics of the patient group and the 
reference group at the first assessment are presented in Table 1. Both groups were 
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similar to each other with regard to their sociodemographic characteristics, with the 
majority being female, married, and lower educated. The mean age of the patient 
group was 58.1 years (SD = 14.28), ranging from 23 years to 88 years old. The mean 
age of the reference group was 56.8 years (SD = 14.80), ranging from 19 years to 88 
years old. Using Pearson Chi-square analysis, we found no significant differences 
between both groups on gender, age, and marital status. The patient group was 
slightly lower educated, compared to the reference group (p < .05). 
 
Principal Component Analysis 
In order to assess the internal structure of the CES-D, we performed a four-factor 
PCA with varimax rotation on all 20 items of the CES-D. Four factors had an 
Eigenvalue greater than one, explaining after rotation respectively 18.3%, 14.4%, 
11.6%, and 8.2% of the variance (total 52.5%) in the patient group and 17.4%, 
16.9%, 12.3%, and 8.0% of the variance (total 54.6%) in the reference group. 
However, some items were factorial complex, i.e. had high loadings on more than 
one factor or did not load on their conceptually  
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Table 1. Sociodemographic and medical characteristics of the patient and reference group 
 
 Patient  group 
(n = 434) 
Reference group 
(n = 236) 
 
p 
 n  %  n  %   
Gender         .18 
Female 312  72  158  67   
Male 122  28  78  33   
Age (yrs)          .41 
< 65  275  63  157  67   
 ≥  65  159  37  79  33   
Educational status          .03 
Elementary schooling  171  41  80  35   
Low secondary schooling  158  37  79  34   
High secondary schooling  92  22  72  31   
Marital status          .84 
Married/cohabitant 334  77  186  79   
Widow/widower 61  14  31  13   
Divorced/separated 16  4  6  3   
Single 22  5  13  5   
Cancer site       
Breast 191  44   
Colorectal 123  29   
Gynaecological 62  14   
Lung 43  10   
Other 11  3   
Stage      
I 161  41   
II 234  59   
Initial treatment       
Surgery 217  50   
Surgery and radiotherapy  120  28   
Surgery and 
chemotherapy,  
with/without radiotherapy 
64 15   
Other 32  7   
 
coherent factor. Especially, we found a crossover of several items from the original 
Depressed Affect factor to the Somatic-Retarded Activity factor and from the 
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original Somatic-Retarded Activity factor to the Depressed Affect factor. Only the 
Positive Affect factor was consistently found in both groups. 
Next, we conducted a two-factor PCA (see Table 2). We found two uncorrelated 
components, explaining after rotation respectively 28.2% and 12.4% of the variance 
(total 40.6%) in the patient group and 29.3% and 12.9% of the variance (total 
42.2%) in the reference group. As expected, the first factor loaded high on the 16 
negatively formulated items, subsequently labelled as Depressed Affect, and the 
second component loaded high on the four positively formulated items, herein after 
labelled as Positive Affect. Only item 2 “poor appetite” in the patient group and item 
15 “people unfriendly” in both groups had relatively low factor loadings (i.e. < .40). 
However, taking the large sample sizes into account, these factor loadings were still 
significant and therefore not excluded. Another reason for the inclusion of item 2 
“poor appetite” was that a loss of appetite is part of the definition of depression and, 
that in the reference group, this item did have a relatively high factor loading on 
Depressed Affect. 
The results of the PCA showed that the two subscales are sufficiently recognized 
by the data. This notion of sufficient structure was supported by the results of a 
SCA. In the patient group, the SCA indicated that a two-factor model explained 
40.3% of the variance (40.6% explained variance possible). In the reference group, a 
two-factor model explained 42.0% of the variance (42.2% explained variance 
possible). The small reductions in variance explained by the model (SCA) in 
comparison with the variance explained by the data (PCA), prove the fit of the two-
factor structure of the model.  
In order to test the replicability of the two-factor structure, we repeated the 
analyses at T2. The PCA yielded the same two-factor structure, explaining after 
rotation respectively 34.3% and 14.0% of the variance (total 48.3%) in the patient 
group and 27.1% and 13.1% of the variance (total 40.2%) in the reference group. 
Again, the results of the SCA supported the notion of sufficient structure, with a 
two-factor model explaining in the patient group 48.1% of the variance (48.3% 
explained variance possible) and in the reference group 39.7% of the variance 
(40.2% explained variance possible).      
In summary, the results of the explorative and confirmative factor-analyses 
proved our hypothesis that the CES-D measures two factors, differentiating between 
the negatively and positively formulated items. These two factors are subsequently 
labelled as Depressed Affect and Positive Affect. 
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Table 2. CES-D items and Factor loadings (Principal Component Analysis, Varimax rotation)   
 
Item  Patient group   Reference group 
 Factor  1 
before 
rotation 
Factor 1 
Depresse
d Affect 
Factor 2 
Positive 
Affect 
Factor 1 
before 
rotation 
Factor 1 
Depresse
d Affect 
Factor 2 
Positive 
Affect 
1  Bothered  .609 .592 .153 .494 .517 .022 
2  Poor appetite  .320  .363     -.063  .536  .513  .157 
3  Blues  .686 .670 .162 .766 .763 .142 
5  Concentrating  .625 .634 .086 .653 .661 .094 
6  Felt  depressed .791 .782 .165 .784 .719 .318 
7  Effort  .537 .555 .045 .701 .667 .217 
9  Life  a  failure  .580 .542 .207 .571 .552 .154 
10  Felt  tearful  .682 .709 .046 .647 .626 .173 
11  Sleep  restless  .467 .484 .034 .558 .557 .101 
13  Talked  less  .503 .509 .071 .503 .533 .006 
14  Lonely  .682 .634 .252 .644 .608 .213 
15  People unfriendly  .328  .319  .080  .346  .390     -.063 
17  Crying  spells  .629 .640 .078 .515 .543 .013 
18  Felt  sad  .743 .743 .130 .671 .696 .045 
19 Other  disliked 
you 
.467 .443 .147 .574 .615        -.015 
20  Not  get  going  .584 .606 .041 .576 .580 .091 
4  As good as 
others 
.233     -.023  .750  .253  .005  .734 
8  Hopeful  future  .365 .174 .592 .347 .134 .651 
12  Happy  .408 .142 .809 .364 .101 .796 
16  Enjoyed  life  .395 .130 .803 .395 .127 .814 
 
 
Item-analysis 
As mentioned earlier, the essential characteristics of depression are the presence of a 
depressed mood, a loss of interest or pleasure, a significant weight loss or gain, 
sleeping problems, changes in motor and cognitive activity, fatigue or loss of 
energy, feelings of worthlessness or guilt, recurrent thoughts of death or suicide, and 
difficulty concentrating or thinking. The content of the 16 negatively formulated 
items of Depressed Affect seems to reflect the definition of depression, whereas the 
content of the four positively formulated items of Positive Affect is less clear. 
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When examining the endorsement of the individual CES-D items, an interesting 
pattern was found. In response to the 16 negatively formulated items, 85 to 100% of 
the patient and reference group reported no or few depressive symptoms (i.e. score 0 
“rarely” or 1 “sometimes”). Thus, only 15% or less had a higher score on the 
negatively formulated items (i.e. score 2 “occasionally” or 3 “most of the time”). In 
contrast, in response to the four positively formulated items (scored in reverse), 20 
to 30% of both groups reported little or no positive affect (i.e. score 2 “sometimes” 
or 3 “rarely”).  
If we want to add the negatively and positively formulated items together into an 
overall sumscore, we would expect a stronger correspondence between the 
endorsement of both types of items. That is, we would expect that the majority of 
both groups, in addition to low scores on the 16 negatively formulated items, also 
had low scores on the positively formulated items (scored in reverse). However, this 
was not found.  
These differences in the endorsement of the negatively and positively formulated 
items were reflected in the relatively high mean item scores for Positive Affect, 
compared to those for Depressed Affect (see Table 3). In the patient group, the mean 
item score for Depressed Affect was .39 (SD = .19), compared to .98 (SD = .10) for 
Positive Affect. Similarly, in the reference group, the mean item score for Depressed 
Affect was .27 (SD = .13), compared to .87 (SD = .08) for Positive Affect. 
We also found that in response to the positively formulated items 4, 8, and 16, 
score 3 “rarely” was endorsed more frequently than score 2 “some of the time”, 
whereas in response to all negatively formulated items, there was a gradual decrease 
in item-endorsement (i.e. score 0 was endorsed most frequently and 3 least of all). 
The non-gradual decrease in item-endorsement of the positively formulated items 
might indicate that, due to patterned responses, some respondents incorrectly 
answered one or more positively formulated items. 
The analyses at T2 yielded similar results as above, indicating that in both 
groups, the mean item scores for Positive Affect were significantly higher, compared 
to those for Depressed Affect. In the patient group, the mean item score for 
Depressed Affect was .32 (SD = .15), compared to 1.04 (SD = .14) for Positive 
Affect. Similarly, in the reference group, the mean item score for Depressed Affect 
was .23 (SD = .15), compared to 1.08  
(SD = .18) for Positive Affect. 
In sum, there was a weak correspondence between the endorsement of the 
negatively and positively formulated items, which was reflected in the relatively 
high mean scores for Positive Affect. Thus, when combining the negatively and 
positively formulated items into an overall sumscore, the positively formulated 
items have a relatively high impact on the total score. 
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Table 3. Mean item scores in the patient and reference group  
 
CES-D items       Patient group            Reference group 
  Mean SD  Mean SD 
1 Felt  bothered  .36  .64  .24  .48 
2 Poor  appetite  .31  .67  .11  .36 
3 Blues  .17  .47  .14  .39 
4  As good as others  1.06  1.22  .91  1.14 
5 Difficulty  concentrating  .60  .78  .39  .58 
6 Felt  depressed  .38  .63  .33  .56 
7  Everything was an effort  .71  .81  .43  .66 
8 Hopeful  future  .83  1.07  .75  1.04 
9  Life a failure  .14  .44  .11  .38 
10 Felt  tearful  .33  .58  .19  .47 
11 Sleep  restless  .67  .84  .50  .72 
12 Happy  .99  1.08  .94  1.04 
13 Talked  less  .45  .71  .33  .63 
14 Felt  lonely  .38  .67  .33  .67 
15 People  unfriendly  .16  .51  .19  .41 
16 Enjoyed  life  1.03  1.10  .87  1.05 
17 Crying  spells  .30  .58  .13  .46 
18 Felt  sad  .40  .63  .27  .51 
19  Other disliked you  .18  .49  .17  .42 
20  Not get going  .68  .78  .46  .67 
 
 
Reliability analysis 
Cronbach’s alpha for Depressed Affect was high, in the patient and reference group 
.87 and .88, respectively (see Table 4). These values were slightly higher than the 
alpha for the total 20-item CES-D scale, i.e. .85 in both groups, and suggest high 
internal consistency. Cronbach’s alpha for Positive Affect was in the patient and 
reference group .75 and .76, respectively. Since alpha is a function of the number of 
items, a possible reason for the slightly lower alpha for Positive Affect may be that 
this scale consists of only four items. To further insure that no single item within the 
scale was significantly reducing the reliability of the total scale, alpha coefficients 
were recalculated with each item removed. The result was that no single item 
significantly reduced the internal consistency of both subscales. In the patient group, 
alpha for Depressed Affect ranged from .85 to .87 and for Positive Affect from .64 
to .75. In the reference group, alpha for Depressed Affect ranged from .86 to .88 and 
for Positive Affect from .65 to .76. 
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 Item-total correlations for Depressed Affect ranged in the patient group from .27 
(item 15 “people unfriendly”) to .72 (item 6 “felt depressed”), with 13 of the 16 
items strongly to moderately correlated with the total subscale score (i.e. > .40). This 
indicated that each item contributed some common and some unique variance in the 
total subscale score. In the reference group, item-total correlations for Depressed 
Affect ranged from .31 (item 15 “people unfriendly”) to .71 (item 6 “felt 
depressed”), with 15 of the 16 items strongly to moderately correlated with the total 
subscale score.  
For Positive Affect, item-total correlations ranged in the patient group from .41 
(item 8 “hopeful future”) to .62 (item 12 “happy” and item 16 “enjoyed life”) and in 
the reference group from .45 (item 8 “hopeful future”) to .64 (item 16 “enjoyed 
life”), with in both groups all four items strongly to moderately correlated with the 
total subscale score.  
The replication of the reliability analyses at T2 showed the same picture. The 
alpha for Depressed Affect was in the patient and reference group  
.91 and .86, respectively, again slightly higher than the alpha for the  
total 20-item CES-D scale (in the patient and reference group .88 and .81, 
respectively). The alpha for Positive Affect was in the patient and reference group 
.82 and .78, respectively.  
The item-total correlations for Depressed Affect and Positive Affect were also 
similar to those at T1. For Depressed Affect, item-total correlations ranged in the 
patient group from .31 (item 2 “poor appetite” and item 15 “people unfriendly”) to 
.78 (item 6 “felt depressed”), with 13 of the 16 items strongly to moderately 
correlated with the total subscale score. In the reference group, item-total 
correlations for Depressed Affect ranged from 
.17 (item 15 “people unfriendly”) to .70 (item 6 “felt depressed”), with 10 of the 16 
strongly to moderately correlated with the total subscale score. Item-total 
correlations for Positive Affect ranged in the patient group from .52 (item 4 “as good 
as others”) to .69 (item 12 “happy”) and in the reference group from .48 (item 4 “as 
good as others”) to .67 (item 8 “hopeful”), with  
in both groups all four items strongly to moderately correlated with the total 
subscale score.  
In sum, Depressed Affect and Positive Affect demonstrated good reliability in 
both groups, as indicated by high Cronbach’s alpha. Most items for Depressed 
Affect and all four items for Positive Affect were moderately to strongly correlated 
with the total subscale score.  
Correlations between Depressed and Positive Affect 
In both the patient and reference group, the individual items of Positive Affect and 
Depressed Affect were weakly correlated with each other. The mean of the possible 
pairwise correlations among the items of Depressed Affect and Positive Affect (in 
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the patient and reference group .14 and .13, respectively) were lower than the mean 
of the possible pairwise correlations among the items of Depressed Affect (in the 
patient and reference group  
.30 and .33, respectively) and among the items of Positive Affect separately 
(in the patient and reference group .43 and .44, respectively).  
Using Pearson correlation coefficients, we found a significant but only 
moderately strong correlation between Depressed Affect and Positive Affect, in the 
patient and reference group .30 and .29, respectively (p < .001)  
(see Table 4). This finding was validated at T2, as indicated by a correlation 
between Depressed and Positive affect in the patient group of .34 (p < .001) and in 
the reference group of .22 (p < .01).   
 
 
Table 4. Intercorrelations and Cronbach’s alpha for Depressed Affect and Positive Affect in 
the patient and reference group 
 
   Depressed 
Affect 
Positive 
Affect 
      
Patient group  Depressed Affect  .87a  
 Positive  Affectb .30  .75a 
      
Reference group  Depressed Affect  .88a  
 Positive  Affect  .29  .76a 
 
aDiagonal values indicate Cronbach’s alpha for the subscale. 
bThe Positive Affect items are scored in reverse, with higher scores indicating less positive 
affect. 
 
 
Correlations among Depressed Affect, Positive Affect, and related 
psychosocial measures 
Further validity for the hypothesis that Depressed Affect and Positive Affect are 
relatively independent factors was supported by their correlations with related 
psychosocial measures. As can be seen in Table 5, Depressed Affect was strongly 
related to other measures of psychological distress, physical symptom distress, and 
neuroticism. In contrast, Positive Affect was only  
Table 5. Relationships among Depressed Affect, Positive Affect, and related psychosocial 
measures 
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  Patient group  Reference group 
 
 
Depressed 
Affect 
Positive 
Affect 
Depressed 
Affect 
Positive 
Affect 
STAI        
     State anxiety  .64 ***  .39 ***  .59 **      .50 ** 
GHQ        
  Anxiety  .74 ***  .25 ***  .65 **  .28 ** 
  Depression  .67 ***  .36 ***  .60 **  .31 ** 
  Social distress  .60 ***  .22 ***  .47 **  .15 ** 
  Somatic distress  .66 ***  .19 ***  .59 **  .19 ** 
RSCL        
  Psychological distress  .77 ***  .26 ***  .74 **  .36 ** 
  Physical symptom distress  .54 ***  .22 ***  .58 **  .23 ** 
LASA        
     Quality of life     -.44 ***    -.33 ***       -.43 **     -.24 ** 
SWLS        
  Satisfaction with life  -.50 ***    -.40 ***  -.45 **     -.32 ** 
EPQ        
  Neuroticism  .62 ***  .32 ***  .61 **      .34 ** 
  Extraversion    -.12 *    -.13 **       -.22 **     -.07 
RSE        
  Self-esteem    -.41 ***    -.37 ***  -.45 **     -.33 ** 
 
* p < .05; ** p < .01; *** p < .001.   
 
 
weakly related to other measures of psychological distress as well as to extraversion. 
Depressed and Positive Affect were both moderately strong related to self-esteem, 
life satisfaction, and quality of life. 
The findings at T2 were similar, showing that in both groups, Depressed Affect 
was strongly related to other measures of psychological distress, physical symptom 
distress, and neuroticism, whereas Positive Affect was weakly related to other 
measures of psychological distress and to extraversion.  
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Depressive symptoms in the patient and reference group 
Finally, we examined whether Depressed Affect and Positive Affect were able to 
discriminate patients from the reference group on depressive symptomatology. At 
T1 (3 months after diagnosis), the patient group scored significantly higher on 
Depressed Affect, compared to the reference group; 6.24 (SD = 6.04) in the patient 
group compared to 4.33 (SD = 5.12) in the reference group (t = 4.310, p < .001). As 
expected, we found no significant differences between the patient and reference 
group on Positive Affect;  
3.91 (SD = 3.37) in the patient group, compared to 3.47 (SD = 3.25) in the reference 
group (t = 1.618, p = .106).   
The same picture was found at T2 (15 months after diagnosis), with the patient 
group scoring significantly higher on Depressed Affect than the reference group; 
5.14 (SD = 6.30) in the patient group compared to 3.75  
(SD = 4.58) in the reference group (t = 3.071, p < .01). Again, we found no 
significant differences between both groups on Positive Affect (t = .496,  
p = .663). 
 
 
Discussion 
 
In the present study, the Center for Epidemiologic Studies Depression 
(CES-D) scale was evaluated for its reliability and validity as a measure of current 
depressive symptomatology in cancer patients and in a matched reference group of 
healthy individuals from the general population. Specifically, we were interested in 
the reliability and the validity of a  
two-factor structure, differentiating between the negatively and the positively 
formulated items. The results confirmed our hypothesis that the CES-D measures 
two relatively independent and weakly correlated factors, subsequently labelled as 
Depressed Affect and Positive Affect. Both factors demonstrated good reliability in 
terms of internal consistency. However, apart from good reliability, the validity of a 
measure has to be demonstrated. Item-analyses showed a weak correspondence 
between the endorsement of the negatively and positively formulated items. In both 
groups, only a minority had high scores on Depressed Affect, indicating the 
presence of depressive symptoms, whereas about a quarter had high scores on 
Positive Affect, indicating little positive affect. These differences were reflected in 
the relatively high mean item scores for Positive Affect (scored in reverse), 
compared to the mean item scores for Depressed Affect. Hence, the four positively 
formulated items have a relatively high impact on the total 20-item CES-D 
sumscore, compared to the 16 negatively formulated items. This is an important 
finding, since it emphasizes the importance of examining the validity of the four 
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positively formulated items. It should be clear which concept they measure, 
otherwise the use of the total 20-item sumscore may not accurately reflect 
depressive symptomatology.  
The content of the negatively formulated items of Depressed Affect seem to 
reflect the definition of depression, but the content of the positively formulated items 
is less clear. The validity of Depressed Affect was also demonstrated by moderate to 
high correlations with other measures of psychological distress, physical symptom 
distress, and neuroticism. In contrast, the validity of Positive Affect was not 
confirmed, since Positive Affect was only weakly related to measures of 
psychological distress and to extraversion. The validity of Depressed Affect was 
also supported by the finding that the patient group scored significantly higher on 
Depressed Affect, thus reporting more depressive symptoms, than the reference 
group. As expected, we found no significant differences between both groups on 
Positive Affect.  
The original four-factor structure of the CES-D was not found in the present 
study. More specifically, there appeared to be a crossover of items between the 
original Depressed Affect factor and the Somatic-Retarded Activity factor. A major 
problem in the study of depression in patients with a medical illness such as cancer 
has been the difficulty distinguishing the symptoms that are associated with 
depression from the symptoms that are caused by the patients’ medical illness and/or 
its treatment (Kathol et al., 1990a; Kathol et al., 1990b; McDaniel et al., 1995). 
Although symptoms such as weight loss, loss of appetite, lack of energy, and 
sleeping difficulties may reflect depression in physically healthy populations, they 
may be confounded by cancer and its treatment. In the present study, we combined 
the original Depressed Affect and Somatic-Retarded Activity factor. Thus, the 16-
item Depressed Affect factor still includes a few somatic items that may represent 
symptoms of depression and/or symptoms of cancer and its treatment. This may 
partly explain the strong relationship between Depressed Affect and physical 
symptoms distress found in the present study, but previous research has indicated 
that the presence of severe physical symptoms is an important risk factor of 
depression in cancer patients (Kathol et al., 1990b). Nevertheless, the fact that the 
CES-D scale includes a few somatic items should be taken into account when using 
the scale for diagnosing depressive symptomatology in patients with a medical 
illness. 
With regard to Positive Affect, patients did not differ markedly from the 
reference group. Since previous research has indicated that cancer patients are 
significantly depressed, especially in the initial period after diagnosis, this finding 
suggest that Positive Affect does not measure depressive symptomatology. Another 
explanation for the finding that both groups had similar scores on Positive Affect 
may be that cancer patients do experience positive affect in the period after 
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diagnosis. Coping theory has traditionally focused on coping processes that help 
manage or reduce aversive states (Lazarus & Folkman, 1984). A recent study of 
Folkman (1997), however, showed that in the context of intense distress both 
negative and positive psychological states are experienced. Since the present study 
was not able to validate the construct validity of the Positive Affect factor, it remains 
unclear whether this factor measures a concept related to positive psychological 
states. 
In conclusion, the present study strongly suggests that the use of a sumscore 
based on the 16 negatively formulated items of the CES-D, instead of a sumscore 
based on all 20 items, is a more valid measure of depressive symptomatology, both 
in cancer patients and in a matched reference group of healthy individuals from the 
general population. Future research should examine more closely the validity of the 
Positive Affect factor. In addition, more research should be conducted to examine 
the effect of patterned responses on answering positively formulated items in a scale 
that consists mainly of negatively formulated items and the reverse scoring of 
positively formulated items in order to calculate an overall sumscore based on 
negatively and positively formulated items. Finally, although the validity of the 
Positive Affect factor could not be validated in the present study, the relatively weak 
relationship between Positive Affect and Depressed Affect is an interesting finding. 
The co-occurrence of depressed and positive affect in the context of stressful 
circumstances should receive further attention in future studies on the psychosocial 
adjustment to stressful life events such as a diagnosis of cancer.  
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Appendix 
 
Endorsement of CES-D items in the patient and reference group 
 
Item Item  description 
 
Patient 
group 
% 
Reference 
group 
% 
Item 1       
0 
1 
2 
3 
72 
21 
 6 
 1 
78 
19 
 3 
 
I was bothered by things that usually don’t bother 
me 
Item 2       
0 
1 
2 
3 
78 
15 
 5 
 2 
90 
 9 
 1 
I did not feel like eating, my appetite was poor  
Item 3       
0 
1 
2 
3 
86 
11 
 2  
 1 
88 
10 
 2 
 
I felt that I could not shake off the blues even with 
the help from my family or friends 
Item 4      
0 
1 
2 
3 
50 
16 
13 
21 
53 
18 
13 
16 
I felt that I was just as good as other people 
Item 5       
0 
1 
2 
3 
55 
34 
 8 
 3 
66 
30  
 4 
 
I had trouble keeping my mind on what I was 
doing 
Item 6       
0 
1 
2 
3 
69 
26 
 4 
 1 
70 
27 
 2 
 1 
I felt depressed 
Item 7       
0 
1 
2 
3 
47 
38 
11 
 4 
66 
27 
 6 
 1 
I felt that everything I did was an effort 
Item 8      
0 
1 
2 
3 
54 
23 
10 
13 
58 
20 
11 
11 
I felt hopeful about the future 
Item 9       
0 
1 
2 
3 
88 
10 
 1 
 1 
91 
 7 
 2 
 
I thought my life had been a failure 
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Item Patient 
group 
Reference 
group 
Item description 
Item 10       
0 
1 
2 
3 
72 
24 
 3 
 1 
84 
13 
 2 
 1 
I felt tearful 
Item 11       
0 
1 
2 
3 
53 
32 
11 
 4 
61 
30 
 7 
 2 
My sleep was restless 
Item 12      
0 
1 
2 
3 
44 
26 
16 
14 
45 
28 
15 
12 
I was happy 
Item 13       
0 
1 
2 
3 
66 
27 
 5 
 2 
74 
20 
 5 
 1 
I talked less than usual 
Item 14       
0 
1 
2 
3 
71 
22 
 5 
 2 
76 
17 
 5 
 2 
I felt lonely 
Item 15       
0 
1 
2 
3 
89 
 8 
 2 
 1 
82 
17 
 1 
People were unfriendly 
Item 16      
0 
1 
2 
3 
43 
26 
15 
16 
50 
26 
11 
13 
I enjoyed life 
Item 17       
0 
1 
2 
3 
75 
20 
 5 
 
90 
8 
 1 
 1 
I had crying spells 
Item 18       
0 
1 
2 
3 
67 
27 
 5 
 1 
75 
23 
 2 
 
I felt sad 
Item 19       
0 
1 
2 
3 
85 
12 
 2 
 1 
84 
15 
 1 
I felt people disliked me 
Item 20       
0 
1 
2 
3 
49 
37 
11 
 3 
62 
32 
 4 
 2 
I could not get going  
 
 
 
Depressive symptoms in cancer 
patients compared to individuals from  
the general population: the role of 
sociodemographic and medical factors 
 
 
 
 
Abstract 
 
This study examined: (1) depressive symptoms in cancer patients  
(n = 475) and a reference group of individuals without cancer from the general 
population (n = 255), and (2) their associations with sociodemographic and medical 
factors. Depressive symptoms were measured at 3 months (T1) and 15 months (T2) 
after diagnosis. Patients reported more depressive symptoms than references at T1 
and T2.  
Especially a younger age was related to the onset of depressive symptoms after a 
diagnosis of cancer. Higher educated patients and those with a lower stage of disease 
reported a greater decrease in depressive symptoms over time. Possible problems 
and solutions regarding the recognition and treatment of depressive symptoms in 
cancer patients are discussed. 
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Introduction 
 
A diagnosis of cancer, its prolonged treatment and physical side-effects can have a 
profound impact on the patient’s life. The sudden confrontation with such a life-
threatening disease may disrupt patients’ emotional balance and induce feelings of 
uncertainty, a diminished self-image, and changes in the relationships with family 
and friends (Moos & Schaefer, 1984). Not surprisingly, depressive symptoms are the 
most frequently encountered psychological problem in the medically ill, including 
cancer patients  
(Grassi et al., 2000; Katon & Sullivan, 1990).  
The recognition and treatment of depressive symptoms in cancer patients is of 
crucial importance, since these symptoms may adversely affect patients’ quality of 
life, compliance with treatment, the length of hospital stay, the ability to care for 
oneself, and perhaps even disease progression (McDaniel et al., 1995). Among 
cancer patients, however, the recognition of depressive symptoms is often hampered 
for several reasons (Kathol et al., 1990a; Kathol et al., 1990b). First, depressive 
symptoms are often an appropriate and normal reaction to a life-threatening event 
such as a diagnosis of cancer. In addition, somatic symptoms of depression, such as 
fatigue, weight loss, and sleep problems, may resemble symptoms of cancer or side-
effects of its treatment. Patients may also find it difficult to disclose emotional 
problems with their doctor or nurses and, on the other hand, doctors and nurses may 
be reluctant and lack time and communication skills to probe into psychological 
problems (Maguire et al., 1980). Information about the risk factors related to an 
increased vulnerability to depressive symptoms may facilitate the early recognition, 
monitoring and treatment of high-risk patients (Sheard & Maguire, 1999). Important 
predictors of depressive symptoms in cancer patients include sociodemographic 
factors (such as gender, age, education, and marital status) and medical factors (such 
as cancer site, stage, and type of treatment) (Breitbart, 1995; Jacobsen et al., 1998; 
Moos & Schaefer, 1984; Van 't Spijker et al., 1997). Since these factors are known 
at diagnosis and unlikely to be modifiable, they may be particular useful markers for 
the identification of patients at high-risk for depressive symptoms.  
In the initial period after diagnosis, about a quarter (24%) of cancer patients 
report depressive symptoms, although there exists a wide variability in the rates of 
these symptoms among studies that have examined the prevalence of depressive 
symptoms in cancer patients, ranging from 1% to 50% (McDaniel et al., 1995). Over 
time, many studies found a decrease in depressive symptoms in the year after 
diagnosis (Chaturvedi & Maguire, 1998; Fallowfield et al., 1990; Goldberg et al., 
1992; Nordin & Glimelius, 1999). Some studies, however, found no significant 
decrease in depressive symptoms over time (Omne-Ponten et al., 1992; Vinokur et 
al., 1990). Furthermore, a significant minority of cancer patients, ranging from 15 to 
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30%, seems to continue to experience depressive symptoms up to one year after 
diagnosis (Fallowfield et al., 1990; Goldberg et al., 1992; Grassi et al., 1997). 
Interpreting the variability in the results about the presence and course of depressive 
symptoms is difficult, because the studies vary by medical factors (e.g. site, stage, 
treatment, hospitalisation status, time since diagnosis), study cohort (e.g. gender, 
age), definition of depression (syndrome versus symptom), and diagnostic method 
(self-report versus interview) (DeFlorio & Massie, 1995; McDaniel & Nemeroff, 
1993). Nevertheless, they clearly demonstrate that depressive symptoms are 
common in recently diagnosed cancer patients.  
A limitation of most previous studies on depressive symptoms in cancer patients 
is the lack of a reference group of individuals without cancer from the general 
population. The inclusion of such a reference group is needed to examine the 
magnitude of depressive symptoms in cancer patients, hereby taking into account 
that depressive symptoms are also prevalent in the general population (Blazer et al., 
1994). A few empirical studies among cancer patients included a reference group of 
individuals from the general population, but the results of these studies are 
inconsistent (Dean, 1987; Groenvold et al., 1999). Dean (1987) found that cancer 
patients were significantly more depressed than controls, whereas Groenvold et al. 
(1999) found that the proportion of cases of depression in patients and controls was 
not significantly different. A recent meta-analysis of 58 studies among cancer 
patients on psychological problems found that patients were significantly more 
depressed in the first months after diagnosis, in comparison with the general 
population (Van 't Spijker et al., 1997). In sum, the conflicting results of these 
studies provide only limited information about the magnitude of depressive 
symptoms as a response to a diagnosis of cancer. Still, little is known about to what 
extent depressive symptoms in cancer patients are the result of the diagnosis or 
reflect premorbid (general) psychological dysfunction. Furthermore, if cancer 
patients develop depressive symptoms as a response to the diagnosis, what happens 
in the year after diagnosis, when they have finished treatment and returned home? 
Do they continue to experience elevated levels of depressive symptoms? Clearly, 
these issues need further investigation. Therefore, the first purpose of the present 
study is to examine the presence and course of depressive symptoms in cancer 
patients, in comparison with a gender- and age-matched reference group of 
individuals from the general population at 3 and 15 months after diagnosis.  
The inclusion of such a reference group is also useful when examining the role 
of sociodemographic factors in the onset and course of depressive symptoms after a 
diagnosis of cancer. That is, sociodemographic factors have also been related to 
depressive symptoms in the general population.  
In general, women, persons in the age of 20 and 50, persons with a lower education, 
and those without a partner (separated, widowed, or divorced) are more at risk of 
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developing depressive symptoms, compared to their counterparts (Adler et al., 1994; 
Bebbington et al., 1998; Blazer et al., 1994; Kaplan et al., 1994). It is not surprising, 
therefore, that sociodemographic factors have also been associated with depressive 
symptoms in cancer patients. For instance, it has been found that female patients 
reported similar (DeFlorio & Massie, 1995; Greimel et al., 1998; Rodrigue, 1994) or 
higher levels of depressive symptoms than male patients (Baider et al., 1989; Liang 
et al., 1990). Furthermore, younger cancer patients seem to experience more 
depressive symptoms and psychological problems than older patients (Compas et al., 
1999; Ganz et al., 1992; Pasacreta, 1997; Vinokur et al., 1990; Wenzel et al., 1999). 
A few studies, however, failed to find this relationship between age and depressive 
symptoms (Derogatis et al., 1983; Maunsell et al., 1992; Rodrigue, 1994). 
Interestingly, in contrast to findings in the general population, education and marital 
status seem to be weakly related to depressive symptoms in cancer patients, both in 
the initial period after diagnosis and one year thereafter (Maunsell et al., 1992; 
Omne-Ponten et al., 1992). Thus a higher education and having a partner does not 
seem to buffer cancer patients against the negative consequences of a diagnosis of 
cancer.  
In sum, since most previous studies among cancer patients lack of reference group 
from the general population, little is known about whether certain sociodemographic 
factors place people at a higher risk of developing depressive symptoms after a 
diagnosis of cancer or whether they primarily reflect morbidity in the general 
population. Therefore, the second purpose of the present study was to examine 
differences between the patient and reference group in the relationships between 
sociodemographic factors and the presence and course of depressive symptoms.  
Medical factors such as cancer site, stage, and treatment have also been 
frequently examined in relationship with depressive symptoms (Loge et al., 1997; 
Van 't Spijker et al., 1997). For instance, patients with certain cancer sites such as 
pancreatic cancer have been found to report elevated levels of depressive symptoms, 
compared to patients with breast, colon, and gynaecological cancer (McDaniel et al., 
1995; Newport & Nemeroff, 1998). However, Given, Given & Stommel (1994) 
found no significant differences in depressive symptoms between patients with 
breast, colon, gynaecologic, prostate, lung, and lymphoma cancer. Regarding stage, 
most studies did not find elevated levels of psychological distress in patients with a 
advanced stage in the first year after diagnosis, compared to those with a low stage  
(Ell et al., 1989; Hoskins, 1997; Maunsell et al., 1992). Regarding treatment,  
it has been found that patients treated with chemotherapy reported elevated levels of 
depressive symptoms in the first months after diagnosis (Hoskins, 1997; Maguire et 
al., 1980). Pasacreta (1997), however, found no significant difference in depressive 
symptoms between patients treated with or without chemotherapy.  
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The forementioned medical characteristics of patients are likely to be strongly 
related to their sociodemographic characteristics (Coebergh et al., 1995; Schaapveld 
& Otter, 1998). For instance, breast cancer is primarily found in female patients and 
often diagnosed at an earlier age (i.e. 45 to  
75 years old) than, for instance, colorectal cancer (i.e. 60 years or older). These 
strong interrelationships may cause problems in the interpretation of the associations 
of sociodemographic and medical factors with depressive symptoms. For instance, 
when a relationship is found between gender and depressive symptoms, this 
relationship may be confounded by age and site. Most studies among cancer patients 
have not systematically examined both sociodemographic and medical factors in 
relationship to depressive symptoms (Ford et al., 1995). Therefore, the third purpose 
of the present study was to examine, within the patient group, the relationships 
among  
the sociodemographic and medical factors and the independent effects of 
sociodemographic and medical factors on the presence and course of depressive 
symptoms. 
In conclusion, in order to provide more insight in the onset of depressive 
symptoms after a diagnosis of cancer, we conducted a longitudinal study in a large 
group of newly diagnosed cancer patients and an age- and gender-matched reference 
group of individuals without cancer from the general population. The first purpose 
of the study was to examine to what extent cancer patients report more depressive 
symptoms at 3 and 15 months after diagnosis than references. A second purpose was 
to explore the relationships between the sociodemographic factors and the presence 
and course of depressive symptoms in patients and references and differences in 
these associations between the two groups. A third purpose was to explore the 
relationships between the medical factors and the presence and course of depressive 
symptoms in cancer patients. Fourth, we examined the interrelationships among the 
medical and sociodemographic factors and whether sociodemographic and medical 
factors were independently related to the presence and course of depressive 
symptoms in cancer patients. 
 
 
Methods 
 
Subjects and procedures 
The data for the present study were collected as part of a longitudinal study on the 
quality of life of cancer patients in the year after diagnosis (De Ruiter, 1995). Cancer 
patients were recruited from 12 hospitals in the northern part of the Netherlands, 
with the assistance of the Dutch Cancer Registration of the Comprehensive Cancer 
Centre North Netherlands (CCCNN). Based on the cancer registration of the 
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CCCNN, patients were selected on the basis of cancer site and disease stage. The 
inclusion criteria for study participation were: (a) age 18 years or older, (b) newly 
diagnosed with cancer, (c) no distant metastases, (d) a life expectancy of at least one 
year, and (e) informed on the diagnosis of cancer. A letter containing information 
about the project and a participation form was attached to the patients’ medical 
status and patients were approached for participation in the study by their doctor. 
Patients were interviewed and filled in a questionnaire at three points in time: at 3 
months, at 9 months, and at 15 months after diagnosis. The references were selected 
from the register office of five townships in the same region as the patients. These 
individuals without cancer from the general population were matched at group level 
on age and gender with the patient group. These references were also interviewed 
and filled in a questionnaire at three points in time with the same intervals as 
patients. In the present study, we focused on the interview at 3 and 15 months after 
diagnosis, hereafter labelled as T1 and T2. These two points in the course of the 
illness are believed to capture the period of crisis (3 months) and short-term 
adjustment to cancer (15 months). 
Over a period of two years, 516 patients returned the participation form. It has 
not been registered consistently how many cancer patients actually received a 
participation form by their medical specialist. Therefore, information on the exact 
response rate is not available. At three months after diagnosis (T1), 475 (92% of the 
516) entered the study and 403 patients (85% of 475) also participated at 15 months 
after diagnosis (T2). The main reasons for drop out were serious illness and death. 
Based on the gender and age distribution of the patient group, 559 references were 
selected and sent a participation form. At T1, 255 (46% of 559) entered the study 
and 225 references (88% of 255) participated also at T2. The main reasons for drop 
out were unwillingness to participate, the impossibility to locate references, or 
incomplete questionnaire data.  
In the analyses of the present study, we included those cancer patients and 
references who participated both at 3 months and at 15 months after diagnosis (T1 
and T2, respectively). Comparisons between the patients who were included and 
those who dropped out after T1 showed that patients with lung or colorectal cancer, 
those with stage III or IV, those treated with chemotherapy (with or without surgery) 
or radiotherapy (p < .01), and male, older, and lower educated patients (p < .05) 
were more likely to have dropped out of the study. Obviously, patients with a worse 
prognosis had dropped out of the study relatively more often. However, we found no 
significant differences in the level of depressive symptoms between patients who 
were included and those who dropped out. Comparisons between the references in 
the present study and those who dropped out revealed no significant differences on 
the sociodemographic factors, neither on depressive symptoms. 
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Measures 
The Center for Epidemiologic Studies Depression (CES-D) scale is a 20-item self-
report instrument of depressive symptoms (Radloff, 1977; Weissman et al., 1977). In 
the present study, we used a sumscore based on the 16 negatively formulated CES-D 
items. In a previous study, we found that a sumscore based on the 16 negatively 
formulated CES-D items, excluding the four positively formulated items, was a 
more valid measure of depressive symptoms, both in cancer patients and healthy 
individuals (Schroevers et al., 2000). A score of 10 or higher was defined as an 
indicator of possible caseness of depression (i.e. more than one S.D. above the mean 
score in the reference group). In the present study, Cronbach’s alpha was .86 and .84 
in the patient and reference group, respectively.   
Sociodemographic factors (gender, age, education, and marital status) were 
collected in a semi-structured interview. For the analyses in the present study, we 
classified age into three groups: 18-44 years, 45-64 years, and  
65 years or older, thus making a distinction between mature adults, older adults, and 
ageing adults, respectively (Rowland, 1989a). Education was classified into four 
groups: primary, lower vocational/secondary, middle vocational/secondary, and 
higher vocational/university. Marital status was dichotomised into two groups: 
having a partner (i.e. married or cohabited) or not having a partner (i.e. widowed, 
divorced, or single). 
Medical data (site, stage, and treatment) were derived from the cancer 
registration from the Comprehensive Cancer Centre North Netherlands. According 
to the Tumour Node Metastasis (TNM) classification of malignant tumour, the stage 
is based on the tumour size and the presence of local or distant metastases and may 
range from I to IV (Hermanek & Sobin, 1992). Since only a few patients in the 
present study were diagnosed with stage IV, we combined patients with stage III and 
IV into one group. Treatment was classified into the following categories: only 
surgery, surgery and radiotherapy, surgery and chemotherapy, surgery and radio- 
and chemotherapy, surgery and hormonal therapy, surgery and radio- and hormonal 
therapy, and other (e.g. only radiotherapy). 
 
 
Results 
 
Descriptives 
The characteristics of the present sample are described in Table 1. The majority of 
the patient and reference group were female, lower educated, and having a partner. 
The average age of the patient group was 58.0 years (SD = 14.3 years) and that of 
the reference group 57.4 years (SD = 15.2 years). Using t-tests, we found no 
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significant differences between the two groups in age and Pearson Chi-square 
analyses revealed no significant differences in gender, education, and marital status.  
Regarding the medical factors, the two most important cancer sites were breast 
cancer (47%) and colorectal cancer (27%). The majority of the patients (89%) were 
diagnosed with a stage I or II, indicating a relatively good prognosis. Most patients 
were treated with surgery only (48%) or surgery and radiotherapy (22%).   
 
The presence and course of depressive symptoms 
To investigate our first research question, Student’s t-tests were used to examine 
mean differences in depressive symptoms at T1 and T2 between the patient and 
reference group. We used paired t-tests to examine the course of depressive 
symptoms over time within the patient and reference group.  
Repeated measures analysis, with group (i.e. patient or reference) as a between-
subjects variable and time (i.e. depressive symptoms at T1 and T2) as a within-
subjects variable were performed to examine differences between the patient and 
reference group in the course of depressive symptoms. Mean scores of depressive 
symptoms in the reference group were similar to those identified by other studies in 
the general population (Bouma et al., 1995; Hann et al., 1999).  
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Table 1. Sample characteristics 
 
  Patient group 
(n = 403) 
Reference group 
(n = 225) 
 n  %  n  % 
Gender        
 Female  295  73  157  70 
  Male  108  27    68  30 
Age          
  18-44    84  21    50  22 
  45-64  168  42    97  43 
  ≥ 65  151  37    78  35 
Marital status         
 Partner  310  77  172  76 
  No partner    92  23    53  24 
Education        
  Primary  153  39    79  36 
  Lower vocational/secondary  155  39    77  35 
  Middle vocational/secondary    46  12    36  16 
  Higher vocational/university    39  10    29  13 
Cancer site         
 Breast  189  47     
 Colorectal    107  27     
  Gynaecological    62  16     
  Lung     29    7     
  Other     11    3     
Stage        
 I  165  45     
 II  161  44     
  III-IV    40  11     
Initial treatment         
  Only surgery   195  48     
  Surgery and radiotherapy    88  22     
  Surgery and chemotherapy     29    7     
  Surgery, radio- and chemotherapy    25    6     
  Surgery and hormonal therapy    15    4     
  Surgery, radio- and hormonal 
therapy  
  29    7     
  Other    22    6     
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Note. Comparisons between the patient and reference group were not significant (p > .05). 
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Table 2. Mean scores of depressive symptoms   
 
                T1  
         Mean (SD) 
              T2  
         Mean (SD) 
 
Patient group 
 
6.09 (6.00) *** 
 
5.17 (6.36) ** 
Reference group           4.13 (4.81)           3.86 (4.66) 
 
 Note. Independent t-test between the patient and reference group.  *** p < .001; ** p < .01.  
 
 
As can be seen in Table 2, cancer patients reported significantly more depressive 
symptoms at 3 months (T1) and 15 months (T2) after diagnosis than references (T1, 
t = 4.44, p < .001; T2, t = 2.93, p < .01)
1. Over time, patients showed a significant 
decrease in depressive symptoms in the year after diagnosis (t = 4.19, p < .001). 
However, the results from the repeated measures analysis showed only a small, 
nearly significant difference between patients and references in the course of 
depressive symptoms over time (time by group, F (1, 619) = 3.52, p = .06). In other 
words, there were no significant differences between the two groups in the course of 
depressive symptoms over time. 
We found strong correlations between depressive symptoms at T1 and T2, in 
patients (r = .68) and in references (r = .55) (p < .001). This indicates that, at an 
intra-individual level, the amount of depressive symptoms was rather stable over 
time in the year after diagnosis, especially in patients. 
The examination of the percentage of possible cases of depression, using 
Pearson Chi-square 
 analysis, revealed a similar picture as above. Compared to the 
reference group, a significantly greater percentage of the patients was classified as a 
possible case of depression, at T1 (23% in patients versus 12% in references; χ2 = 
10.43, p < .01) and at T2 (18% in patients versus 10% in references; χ2 = 7.65, p < 
.01). In order to examine the course of possible cases of depression over time, we 
determined four groups of persons:  
(1) non-cases both at T1 and T2, (2) possible cases both at T1 and T2,  
(3) possible cases at T1 only, and (4) possible cases at T2 only. The majority of the 
patients (71%) and references (83%) were non-cases at both points in time. 
However, the percentage of possible cases at both points in time was twice as high 
in patients (11%) as in references (5%). In addition, the percentage of possible cases 
at T1 only (thus these persons improved over time) was higher in patients (11%) 
than in references (7%). This is in line with the findings above, which showed a 
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smaller number of possible cases in patients at T2, compared to T1. Finally, a 
number of patients (7%) and references (5%) were classified as a possible case at T2 
only (thus these persons worsened over time). 
 
Sociodemographic factors and depressive symptoms in patients and 
references 
 
The presence of depressive symptoms 
To investigate our second research question, we used analyses of variance to 
examine the relationships between sociodemographic factors and the presence of 
depressive symptoms, in the patient and reference group separately. In order to 
examine differences between the two groups in these relationships, additional 
analyses of variance were performed in the total sample, using group (i.e. patient or 
reference), one of the sociodemographic factors, and the interaction of group by the 
sociodemographic factor as the independent factors. A significant interaction 
indicates that the relationship between the sociodemographic factor and depressive 
symptoms differs significantly for patients and references.  
Gender was in both groups significantly related to depressive symptoms, 
indicating that women reported significantly more depressive symptoms than men 
(patients, at T1, F (1, 398) = 21.18; at T2, F (1, 399) = 11.07,  
p < .001; references, at T1, F (1, 223) = 5.10; at T2, F (1, 221) = 4.60, p < .05). 
Comparisons between the patient and reference group revealed no significant 
differences in this relationship between gender and depressive symptoms (see Figure 
1a). That is, a cancer diagnosis did not change the likelihood that women would 
report either more or less depressive symptoms, compared to men. 
Age was only in the patient group significantly related to depressive symptoms at 
T1 (F (2, 397) = 8.49, p < .001) and nearly significant at T2  
(F (2, 398) = 2.88, p = .06). Pairwise comparisons showed that patients younger than 
65 years reported significantly more depressive symptoms than those of 65 years or 
older (p < .001). The finding that a younger age was only in the patient group related 
to higher levels of depressive symptoms was confirmed by a significant group by 
age interaction in the total group, both at T1 (group by age, F (2, 619) = 8.08, p < 
.001) and at T2 (group by age, F (2, 618) = 3.31, p < .05). Younger patients reported 
more depressive symptoms than younger references (see Figure 1b). Older patients 
and references reported similar levels of depressive symptoms.  
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Figure 1a. Mean scores of depressive symptoms in female and male patients and references   
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Figure 1b. Mean scores of depressive symptoms in patients and references in the following 
age-groups: younger than 45 years, 45 to 64 years, and 65 years or older, respectively 
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Figure 1c. Mean scores of depressive symptoms in patients and references with primary 
education (level 1), lower vocational/secondary education (level 2), middle 
vocational/secondary education (level 3), and higher vocational education/university (level 4), 
respectively.  
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Figure 1d. Mean scores of depressive symptoms in patients and references with or without a 
partner. 
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Education was not significantly related to depressive symptoms, neither  
in the patient nor in the reference group. We also found no significant differences 
between the two groups in this relationship between education and depressive 
symptoms (see Figure 1c). 
Marital status was only in the reference group significantly related to depressive 
symptoms, showing that references without a partner reported significantly more 
depressive symptoms than those with a partner (at T1,  
F (1, 223) = 15.28, p < .001; at T2, F (1, 221) = 5.96, p < .05). In contrast, cancer 
patients with or without a partner reported similar levels of depressive symptoms. 
This difference between the patient and reference group in the relationship between 
marital status and depressive symptoms was significant at T1 (group by marital 
status, F (1, 620) = 4.90, p < .05). As can  
be seen in Figure 1d, patients with a partner reported more depressive symptoms 
than reference subjects with a partner, whereas patients and reference subjects 
without a partner reported similar levels of depressive symptoms.  
Multivariate analyses including all four sociodemographic factors were 
performed to examine whether the sociodemographic factors were independently 
related to depressive symptoms. Besides a significant main effect of gender (F (1, 
594) = 10.94, p < .01) and marital status (F (1, 594) = 7.02, p < .01), we found a 
significant group by age interaction on depressive symptoms at T1 (F (2, 594) = 
3.08, p < .05). At T2, only gender had a main effect on depressive symptoms (F (1, 
593) = 6.05, p < .05).  
 
The course of depressive symptoms 
Repeated measures analyses were performed to examine the associations of the each 
of the sociodemographic factors with the course of depressive symptoms. None of 
the sociodemographic factors was significantly related to the course of depressive 
symptoms, neither in the patient nor in the reference group.  
In cancer patients, we found a nearly significant relationship between education 
and the course of depressive symptoms (F (3, 384) = 2.56, p = .05), indicating that 
higher educated patients reported a greater decrease in depressive symptoms than 
lower educated patients. However, comparisons of patients and references showed 
no significant differences between the two groups in the relationships between the 
sociodemographic factors and the course of depressive symptoms.  
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Medical factors and depressive symptoms in patients 
 
The presence of depressive symptoms 
To investigate our third research question, we focused on the patient group and used 
analyses of variance to examine the relationship between medical factors and the 
presence of depressive symptoms (see Table 3).  
Cancer site was significantly related to depressive symptoms, at T1 
(F (4, 390) = 5.77, p < .001) and at T2 (F (4, 391) = 3.65, p < .01). Pairwise 
comparisons showed that, at T1, patients with breast or gynaecological cancer 
reported more depressive symptoms than patients with colorectal or lung cancer (p < 
.01). At T2, women with breast or gynaecological cancer still reported significantly 
more depressive symptoms than patients with colorectal cancer (p < .05).  
Stage and treatment were not significantly related to depressive symptoms, 
neither at T1 nor at T2. As can be seen in Table 3, there was a  
 
 
Table 3. Mean scores of depressive symptoms in the patient group, according to cancer site, 
stage, and treatment 
 
 T1 
Mean (SD) 
T2 
Mean (SD) 
Cancer site    
  Breast  7.12 (6.44)  6.15 (6.40) 
  Colorectal   4.40 (4.62)  3.30 (5.12) 
  Gynaecological  7.10 (6.93)  5.42 (7.50) 
  Lung  3.68 (3.33)  5.10 (6.77) 
  Other  3.73 (4.00)  3.55 (5.97) 
Stage    
  Stage I  5.88 (6.02)  4.44 (6.16) 
  Stage II  6.31 (6.00)  5.70 (6.51) 
  Stage III-IV  4.95 (4.03)  4.95 (5.52) 
Treatment    
  Only surgery  5.46 (6.58)  4.71 (6.70) 
  Surgery and radiotherapy  6.66 (5.04)  4.76 (5.42) 
  Surgery and chemotherapy  5.59 (4.72)  5.07 (6.72) 
  Surgery, radio- and chemotherapy  7.16 (5.42)  5.92 (6.21) 
  Surgery and hormonal therapy  5.47 (4.60)  5.67 (6.59) 
  Surgery, radio- and hormonal therapy  8.61 (7.04)  7.00 (5.64) 
  Other  5.95 (4.95)  7.36 (7.06) 
tendency showing that certain types of treatment (e.g. the combination  
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of radiotherapy and chemo- or hormonal therapy) were associated with relatively 
higher levels of depressive symptoms.  
When using multivariate analyses including all three medical factors,  
cancer site was the only medical factor that was significantly related  
to depressive symptoms, at T1 (F (4, 350) = 2.92, p < .05) and T2  
(F (4, 352) = 2.40, p = .05). 
 
The course of depressive symptoms 
Repeated measures analyses were performed to examine the associations of each of 
the medical factors with the course of depressive symptoms. However, none of the 
medical factors was significantly related to the course of depressive symptoms. 
There were some trends, indicating a small increase in depressive symptoms in lung 
cancer patients, compared to a small decrease in these symptoms in patients with 
other sites. In addition, patients with stage I and those treated with radiotherapy 
(with or without chemo- or hormonal therapy) reported a slightly greater decrease in 
depressive symptoms than their counterparts. 
 
Medical and sociodemographic factors and depressive symptoms  
in patients 
As mentioned in the introduction, patients’ medical characteristics are likely to be 
related to their sociodemographic characteristics. In this section, we examine these 
relationships, using Chi-square analysis. As expected, we found significant 
relationships among site, stage, treatment, gender, and age  
(p < .001). Patients with breast and gynaecological cancer (all female) had a mean 
age of 55 years, whereas patients with colorectal and lung cancer (the majority being 
male) had a mean age of 65 years. In addition, 83% of patients with gynaecological 
cancer were mostly diagnosed with a stage I, whereas 63% of breast cancer patients, 
64% of colorectal cancer patients, and 34% of lung cancer patients were diagnosed 
with stage II or higher. Moreover, 83% of colorectal cancer patients were treated 
with only surgery, whereas 44% of breast cancer patients and 53% of gynaecological 
cancer patients also received radio- and/or chemotherapy.  
Next, we examined whether medical and sociodemographic factors were 
independently associated with the presence of depressive symptoms in patients. 
Multivariate analyses of variance including all sociodemographic and medical 
factors showed that only age was significantly related to depressive symptoms at T1 
(F (2, 333), p < .01) and nearly significant at T2  
(F (2, 335), p = .06). These results are in line with the earlier analyses, which 
indicated that age was significantly related to depressive symptoms in the patient 
group only. 
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Repeated measures analysis showed that both stage and education were 
independently significantly related to the course of depressive symptoms over time 
(stage, F (2, 332); education, F (3, 332), p < .05). Pairwise comparisons showed a 
greater decrease in depressive symptoms in patients with stage I, compared to stage 
II or higher (p < .05). Moreover, higher educated patients reported a greater decrease 
than those with a lower education (p < .01). 
 
 
Discussion 
 
The results of the present study broaden our understanding of the magnitude of 
depressive symptoms in cancer patients and the role of sociodemographic (gender, 
age, education, and marital status) and medical factors (site, stage, and treatment) 
herein in several ways. First, the findings showed that, as a group, cancer patients 
reported significantly more depressive symptoms at three months after diagnosis 
than age-matched references without cancer from the general population. Despite a 
small decrease in patients’ depressive symptoms over time, patients continued to 
report significantly more depressive symptoms at 15 months after diagnosis than the 
reference group. Second, multivariate analyses revealed that, at three months after 
diagnosis, age was the only sociodemographic factor that was differently related to 
the presence of depressive symptoms in the patient and reference group. This 
suggests that, in the present sample, especially younger patients experience 
depressive symptoms in response to a diagnosis of cancer. Third, medical factors 
were not independently related to the presence of depressive symptoms, when 
examined simultaneously with the sociodemographic factors. Fourth, regarding the 
course of depressive symptoms over time, we found that higher educated patients 
and those with a low stage reported a greater decrease in depressive symptoms over 
time. 
The findings regarding the presence and course of depressive symptoms in 
cancer patients are in line with those of previous studies and suggest that a 
significant minority of cancer patients (approximately 20%) experience depressive 
symptoms that may persist until one year after diagnosis and initial treatment 
(McDaniel et al., 1995; Pasacreta, 1997). The findings clearly demonstrate that a 
diagnosis of cancer may be regarded as a life crisis, which may shatter persons’ 
basic assumptions about their life and future (Janoff-Bulman & Frieze, 1983). The 
confrontation with the multiple physical and psychosocial strains may lead to 
feelings of loss, for instance, of a good physical health and independency, valued 
social roles, and, more fundamental, of identity and the meaning of one’s life. As a 
result, patients may feel depressed and a lack of joy and interest in daily activities. 
The results also indicated that, at an intra-individual level, the amount of depressive 
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symptoms was rather stable over time in the year after diagnosis, especially in 
cancer patients. These findings are in line with those of other studies and 
demonstrate the importance of the early identification of patients at increased risk of 
depressive symptoms as a response to cancer. 
Therefore, of particular interest was the finding that not all cancer patients, but 
especially younger patients reported more depressive symptoms in the initial period 
after diagnosis, compared to the reference group. Other studies have also stressed 
the importance of patient’s age for the adjustment to cancer (Northouse, 1994; 
Pasacreta, 1997; Wenzel et al., 1999). Younger patients seem to perceive the cancer 
to be a greater threat to their lives (Vinokur et al., 1990) and experience more 
intrusive thoughts about the cancer, compared to older patients (Epping-Jordan et 
al., 1999; Wenzel et al., 1999). A possible explanation for these findings may be 
that, since cancer is usually a disease of the elderly, younger patients may be less 
anticipated and therefore, a diagnosis of cancer may be more disruptive and 
distressing at a younger age. Health care providers should carefully monitor possible 
signs of depression in younger cancer patients in the initial period after diagnosis. If 
treatment of depression is indicated, information about what tasks and future life 
goals are threatened or interrupted as a result of the diagnosis of cancer may provide 
insight into the psychological problems likely to result from the disease. That is, 
younger patients may be particularly confronted with the following issues: (a) 
uncertainty in  
planning the future and interruption of certain life goals and expectations, (b) 
infertility or sterility, diminished attractiveness, and problems in establishing or 
maintaining a sexual relationship, (c) feeling different and isolated, confrontation 
with unsatisfying social relationships, and concerns about the impact of the disease 
on the partner and children, (d) a sense of physical vulnerability, increased 
dependency on others, and role reversals, normally associated with ageing, and (e) a 
heightened introspection and reflection, which may lead to despair about the 
meaningfulness of life (Rowland, 1989a; Siegel et al., 1999).  
Regarding the other sociodemographic factors, multivariate comparisons 
revealed no significant differences between the patient and the reference group in 
the associations of gender, education, and marital status with depressive symptoms. 
For instance, similar to other studies, we found that female patients reported more 
depressive symptoms than male patients (Baider et al., 1989), but this relationship 
between gender and depressive symptoms was about equally strong in the reference 
group. These findings suggest that certain sociodemographic factors (such as 
gender) may primarily reflect pre-morbid psychological dysfunction rather than risk 
factors of developing depressive symptoms in response to a diagnosis of cancer. 
This finding has certain practical implications. Apart from the possibility of 
identifying patients at increased risk of depressive symptoms, this finding also 
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suggest that higher levels of depressive symptoms in some cancer patients are not so 
much cancer-specific but rather reflect, at least to some extent, general dysfunction. 
Thus for certain cancer patients, general psychosocial care rather than cancer-
specific psychosocial interventions may be more suitable. 
Apart from these multivariate analyses, bivariate analyses showed a significant 
difference between the patient and reference group in the relationship between 
marital status and depressive symptoms, indicating that marital status (i.e. having a 
partner) was only in the reference group related to lower levels of depressive 
symptoms. The weak relationship between marital status and depressive symptoms 
in cancer patients has also been reported by other studies (Maunsell et al., 1992; 
Omne-Ponten et al., 1992). A possible explanation for this finding may be that a 
diagnosis of a life-threatening disease such as cancer may present a challenge to the 
emotional stability of an intimate relationship. Having a partner may not always or 
merely have beneficial effects on patients’ psychological well-being (Manne, 1998; 
Penninx et al., 1998). It is likely that differences in marital quality play an important 
role, with worse relationships conveying the same or a greater risk as not being 
married (Coyne & Anderson, 1999; Pistrang & Barker, 1995; Rodrigue & Park, 
1996). However, when controlling for gender, age, and education, the significant 
difference between the two groups in the relationship between marital status and 
depressive symptoms disappeared. Possibly, this relationship was confounded by 
age. 
Interestingly, education was not significantly related to depressive symptoms, 
neither in the patient nor in the reference group. However, patients with a higher 
education reported a greater decrease in depressive symptoms over time than lower 
educated patients. In other words, cancer patients, regardless education, showed a 
similar initial reaction to the diagnosis of cancer, but higher-educated patients seem 
to adjust better over time. Possibly, higher educated patients have a more adequate 
access to social and personal resources (such as social support and feelings of 
control, optimism, and self-esteem) to cope with the cancer and its treatment (Thoits, 
1995). The findings suggest that education may play an important role in the 
recovery of depressive symptoms in cancer patients. 
Regarding the role of medical factors in depressive symptoms, we found that 
only cancer site was related to the presence of depressive symptoms, with women 
with breast and gynaecological cancer reporting relatively more depressive 
symptoms. However, this relationship between site and depressive symptoms 
disappeared, when examined simultaneously with the sociodemographic factors. 
Interestingly, although a higher stage was not significantly related to higher levels of 
depressive symptoms, we found that, when examined simultaneously with 
sociodemographic factors, patients with a low stage reported a greater decrease in 
depressive symptoms over time than those with a higher stage.  
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The overall weak relationship between medical factors and depressive symptoms 
has also been demonstrated by other studies (Ell et al., 1989; Given et al., 1994; 
Hoskins, 1997; Pasacreta, 1997). There are several possible explanations for this 
weak relationship. First, the subjective appraisal of the stressfulness of the situation 
may be more important than objective medical factors regarding the prognosis 
(Dunkel-Schetter et al., 1992). Secondly, we do not know for sure to what extent 
patients receive and understand medical information about the severity of the 
situation and their prognosis. Thirdly, the presence of severe physical impairment 
may have a stronger impact on patients’ functioning than medical characteristics 
such as treatment (Given et al., 1994). A large number of physical problems may 
lead to more concerns about a recurrence and loss of confidence in own body, which 
may consequently lead to higher levels of depressive symptoms. Finally, since most 
studies, including the present study, focused on patients with a relatively good 
prognosis, it may be difficult to detect a significant effect of certain medical factors 
(e.g. advanced stage or treatment with chemotherapy).  
Several limitations should be kept in mind when interpreting the results of the 
present study. First, it needs to be mentioned that no information was available 
about how many patients did not return the participation form. Furthermore, the 
majority of the patients were female, lower educated, and living with a partner, and 
diagnosed with a relatively good prognosis. This may affect the validity of the 
findings. Second, the moderate number of references that returned the participation 
form may also cause concern regarding the validity of the findings. Still, the finding 
that the levels of depressive symptoms in references were comparable with those in 
other samples of references from the general population underpins the representation 
of the reference group. Furthermore, the present study is the first study to compare 
the level of depressive symptoms and its associations with sociodemographic factors 
in cancer patients with an age- and gender-matched reference group. Third, we have 
made an effort to take into account the strong interrelationships among the 
sociodemographic and medical characteristics. Still, the existence of these strong 
interrelationships (e.g. the overlap between gender and site) precludes drawing 
definite conclusions regarding their associations with depressive symptoms.  
In conclusion, this study demonstrates that, especially in younger cancer patients, 
a diagnosis of cancer may induce depressive symptoms. Additional research is 
needed to identify other risk factors of depressive symptoms in response to a 
diagnosis of cancer, such as a lack of psychosocial resources (e.g. low perceptions of 
social support, self-esteem, optimism, and control),  
a past history of depression, and other coexisting stressful life-events and chronic 
illnesses. This information may facilitate the early identification and monitoring of 
cancer patients at increased risk of developing depressive symptoms after a 
diagnosis of cancer. Furthermore, psychosocial interventions targeted at those 
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patients at risk may prove to be more effective and able to prevent the development 
of severe depressive symptoms.  
 
 
Notes 
1 Using the 20-item version of the CES-D, we found the following mean scores in the patient  
and reference group, respectively: at T1, 9.82 and 7.79 (p < .001) and at T2, 9.35 and 8.26  
(p = .07). Using the original cut-off point of 16 as an indicator of possible caseness, we found  
the following percentage of possible cases in the patient and reference group, respectively:  
at T1, 18% and 10% (p < .01) and at T2, 18% and 12% (p = .06). 
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The role of social support and self-esteem 
in the presence and course of depressive 
symptoms: a comparison of cancer patients  
and individuals from the general population 
 
 
Abstract 
The aim of the present study was to examine the role of social support  
(i.e. perceived emotional support, lack of problem-focused emotional support, and 
negative social interactions) and self-esteem in depressive symptoms in 475 cancer 
patients and 255 individuals without cancer from the general population. 
Specifically, we examined: (a) the relationship between social support and self-
esteem, (b) whether social support and self-esteem have independent effects on the 
presence and course of depressive symptoms, and (c) differences between patients 
and references in the associations of social support and self-esteem with depressive 
symptoms. Patients and references were interviewed and filled in a questionnaire at 
two points in time: at 3 months (T1) and 15 months (T2) after diagnosis. Social 
support and self-esteem were only weakly to moderately related to each other. Both 
social support and self-esteem were independently related to depressive symptoms 
(concurrently), with lower levels of social support and self-esteem related to higher 
levels of depressive symptoms. The longitudinal analyses showed that only social 
support significantly predicted future levels of depressive symptoms. The data 
provided clear evidence that, in general, social support and self-esteem were 
strongly related to depressive symptoms, regardless the presence of a stressful 
situation (i.e. a recent diagnosis of cancer). The only exception was found for 
problem-focused emotional support at T1. At three months after diagnosis, a lack of 
this type of support was in patients significantly stronger related to higher levels of 
depressive symptoms than in references.  
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Introduction 
 
Cancer patients may have to face multiple stressful situations during the course of 
the illness, such as disabling physical symptoms, limitations in daily activities, 
disfigurement, feelings of uncertainty, and diminished feelings of self-esteem. Not 
surprisingly, about a quarter of the cancer patients experience depressive symptoms 
in the initial period after diagnosis (McDaniel et al., 1995; Schroevers et al., 2001a). 
Over time, most longitudinal studies show a gradual decrease in depressive 
symptoms in cancer patients in the first year after diagnosis (Fallowfield et al., 1990; 
Goldberg et al., 1992; Grassi et al., 1997).  
According to Moos and Schaefer (1984), social and personal resources play a 
crucial role in the process of adjustment to a life crisis such as a diagnosis of cancer. 
Especially social support has been frequently studied as a psychosocial resource 
(Hobfoll & Vaux, 1993; Thoits, 1995). Furthermore, social and personal resources 
are likely to be strongly interrelated (Hobfoll et al., 1990; Hobfoll & Vaux, 1993; 
Moos & Schaefer, 1993; Thoits, 1995). In the context of social support, self-esteem 
may be regarded as an important personal resource, since one of the major functions 
of social support is to bolster or maintain feelings of self-esteem (Curbow & 
Somerfield, 1991; Rowland, 1989b). Therefore, the goal of the present study was to 
examine the associations of social support and self-esteem with the presence and 
course of depressive symptoms and to determine whether these associations are 
stronger in recently diagnosed cancer patients than in references from the general 
population.  
The support from family and friends is a valuable resource long believed to be 
associated with psychological well-being (Thoits, 1995). There are several 
explanations for this relationship. Social support (especially emotional support) may 
bolster or maintain feelings of social identity and self-evaluations (Cooley, 1902; 
Mead, 1934; Wills, 1981) and social integration (Durkheim, 1951), thus 
counteracting feelings of loneliness (Lepore, 1997). In cancer patients, the physical 
and psychosocial sequelae are likely to result in a greater need for social support 
(Wortman, 1984). Paradoxically, because of the fears and the stigma associated with 
the disease, cancer patients may experience problems in obtaining adequate support. 
Still, most cancer patients seem to experience an increase in social support in the 
initial period after diagnosis and are satisfied with the support they receive (De 
Ruiter, 1995; Tempelaar et al., 1989). The support from others may buffer the 
negative consequences of a diagnosis of cancer and is therefore of great importance 
for patients’ adjustment to cancer (Helgeson & Cohen, 1996).  
An important issue in the investigation of beneficial effects of social support on 
well-being is the lack of consensus about how social support should be defined. 
There exists a great variability in the operationalization of social support, regarding: 
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(a) the type of support (e.g. emotional, instrumental, or informational), (b) perceived 
availability (i.e. expectancies) versus actual received support, and (c) amount versus 
satisfaction with actual received support. This latter distinction incorporates the idea 
that social support should fit the needs of the person in order to be beneficial for 
well-being (Thoits, 1982).  
These differences in the definition of social support make it difficult to interpret 
and compare the results of previous studies on social support among cancer patients. 
In general, a negative relationship has been found between the perceived availability 
or satisfaction with received (emotional) support and psychological distress (Alferi 
et al., 2001; Courtens et al., 1996; Grassi et al., 1997; Sollner et al., 1999). In 
contrast, a positive relationship has been found between received emotional support 
and psychological distress (De Leeuw et al., 2000). A possible reason for this latter 
finding may be that distressed persons have a higher need for support and thus seek 
and/or receive more social support, or alternatively, that an excess of support may 
lead to psychological distress (Lepore, 1997), possibly through undermining the 
persons’ own coping capacities (Schreurs & De Ridder, 1997). Regarding the type 
of social support, the literature generally suggests that emotional support 
(characterised by love, respect, sympathy, understanding, listening, reassuring, and 
comforting) is particularly important for cancer patients and a lack of emotional 
support may be detrimental for patients’ adjustment (Helgeson & Cohen, 1996; 
Wortman, 1984). Overall, these findings suggest that the perceived availability and 
the satisfaction with emotional support are most consistently associated with 
psychological well-being. 
Previous studies on social support have mainly focused on the positive aspects of 
social relationships. Recently, there is a growing body of literature indicating that 
negative aspects of social relationships (characterised by conflict, criticism, and 
interference) are independent of positive aspects of support (Rook, 1984) and 
strongly related to psychological functioning (Coyne & DeLongis, 1986; Helgeson, 
1993; Schreurs & De Ridder, 1997; Thoits, 1995). Among cancer patients, the few 
studies that have examined the associations of negative aspects of social 
relationships show that the amount of negative interactions is strongly related to 
psychological distress, even stronger than the positive interactions with others 
(Kuijer et al., 2000; Manne et al., 1997; Manne et al., 1999; Pistrang & Barker, 
1995). 
Self-esteem is an important personal resource, which may reduce psychological 
distress and buffer the consequences of stressful events (Katz et al., 1995; Thoits, 
1995). A possible explanation for this finding may be the universal need to like 
oneself (Maslow, 1970) and to hold positive self-evaluations (Taylor & Armor, 
1996). Among cancer patients, most studies have studied self-esteem as an outcome 
variable. A diagnosis of cancer and its treatment may diminish self-esteem as a 
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result of, for instance, changes in body image, disruption of life goals, or a loss of 
intimate relationships. Still, studies that have compared self-esteem in cancer 
patients with healthy individuals generally report no differences between the two 
groups in self-esteem (Curbow & Somerfield, 1991; Katz et al., 1995). 
Comparatively less attention has been paid to the role of self-esteem as a predictor 
of patients’ psychological functioning. The few studies that have examined the 
association of self-esteem with psychological functioning show that a higher self-
esteem is related to lower levels of depressive symptoms and higher well-being in 
cancer patients (Carpenter, 1997; Dirksen, 1989; Hobfoll & Walfisch, 1984).  
As mentioned earlier, social and personal resources are strongly interrelated and 
generally, resources tend to enrich other resources.  
For instance, the support from others may strengthen a person’s self-esteem 
(Rowland, 1989b; Wills, 1985) and persons with a high self-esteem seem more 
likely to receive or perceive social support (Winnubst et al., 1988).  
In line with this reasoning, most studies among cancer patients found a positive 
relationship between the perceived availability or satisfaction with social support 
and self-esteem (Carpenter, 1997; Dirksen, 1989; Douglass, 1997). It has been 
suggested that social support may counterbalance threats to self-esteem that occur 
during stressful periods, and therefore, social support may be especially important 
for feelings of self-esteem in the face  
of a stressful situation such as a diagnosis of cancer (Hobfoll et al., 1990). Clearly, 
the interrelationship between social support and self-esteem is important and should 
be taken into account when examining the role of these resources in psychological 
well-being. In order to examine whether both resources are independently associated 
with well-being, they need to be studied simultaneously.  
Another important issue that needs to be mentioned is the question whether 
resources are related to psychological well-being in all circumstances or particularly 
in the face of a stressful situation, such as  
a serious illness (Cassel, 1976; Cobb, 1976; Cohen & Wills, 1985). Since social 
support and self-esteem fulfil basic human needs, it can be hypothesised that they 
have a main effect on well-being, regardless the presence of a stressful situation 
(Vilhjalmsson, 1993). However, it can also be hypothesised that these resources are 
more important for well-being in people who are confronted with a stressful life-
event, since the presence of resources may buffer the negative impact of such a 
situation (Hobfoll et al., 1990; Katz et al., 1995; Thoits, 1995). For instance, the 
availability of someone with whom a cancer patient can discuss illness-related 
concerns may help the patient to cope with the situation and to gain control over the 
overwhelming situation and his or her emotions (Aymanns et al., 1995; McColl et 
al., 1995; Sollner et al., 1999; Thoits, 1986). The few studies that have examined 
whether resources are more important for patients with a serious illness focused on 
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patients with a chronic illness (i.e. cancer or arthritis) (Druley & Townsend, 1998; 
Penninx et al., 1998). These studies found no differences between patients and 
healthy references (i.e. no chronic illness) in the associations of social support and 
self-esteem with depressive symptoms. In the present study, we focused on patients 
facing an acute life-threatening illness, that is, a recent diagnosis of cancer. It has 
been consistently found that the initial period after a diagnosis of cancer is most 
stressful for patients (see Spencer et al., 1998). We compared these patients with a 
reference group that consisted of individuals without cancer from the general 
population. As in daily life, both cancer patients and references could suffer from 
other chronic illnesses. The only difference between the two groups was the 
presence of an acute stressor (i.e. cancer).  
The aim of the present study was three-fold: (a) to examine the relationship 
between social support and self-esteem, (b) to determine whether social support and 
self-esteem are independently related to the presence and course of depressive 
symptoms, and (c) to examine differences between recently diagnosed cancer 
patients and individuals without cancer from the general population in these 
associations among social support, self-esteem, and depressive symptoms.  
We examined these associations at two points in time, that is, at 3 and 15 months 
after diagnosis. As mentioned in the previous paragraph, the initial period after 
diagnosis is particularly stressful for patients and may be regarded as a period of 
crisis. Eventually, however, the period of intense uncertainty and preoccupation with 
the illness will resolve and it can be expected that, at 15 months after diagnosis, the 
disease will be less prominent in daily life of most patients.  
Methods 
 
Sample 
The data for the present study were collected as part of a longitudinal study on the 
quality of life of cancer patients in the year after diagnosis (De Ruiter, 1995; 
Schroevers et al., 2001a; Van der Zee et al., 1996). Cancer patients were recruited 
from 12 hospitals in the northern part of the Netherlands, with the assistance of the 
Dutch Cancer Registration of the Comprehensive Cancer Centre North Netherlands 
(CCCNN). Based on the cancer registration of the CCCNN, patients were selected 
on the basis of cancer site and disease stage. The inclusion criteria for study 
participation were: (a) age 18 years or older, (b) newly diagnosed with cancer, (c) no 
distant metastases, (d) a life expectancy of at least one year, and (e) informed on the 
diagnosis of cancer. A letter containing information about the project and a 
participation form was attached to the patients’ medical status and patients were 
approached for participation in the study by their doctor. Patients were interviewed 
and filled in a questionnaire at three points in time: at 3 months, at 9 months, and at 
15 months after diagnosis. The references were selected from the register office of 
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five townships in the same region as patients. These individuals without cancer from 
the general populations were matched at group level on age and gender with the 
patient group. These references were also interviewed and filled in a questionnaire at 
three points in time with the same intervals as patients. In the present study, we 
focused on the interview at 3 and 15 months after diagnosis, hereafter labelled as T1 
and T2. These two points in the course of the illness are believed to capture the 
period of crisis (3 months) and short-term adjustment to cancer (15 months).  
Over a period of two years, 516 patients returned the participation form. It has 
not been registered consistently how many cancer patients actually received a 
participation form by their medical specialist. Therefore, information on the exact 
response rate is not available. At T1, 475 (92% of the 516) entered the study and 403 
patients (85% of 475) also participated at T2. The main reasons for drop out were 
serious illness and death. Based on the gender and age distribution of patients, 559 
references were selected and sent a participation form. At T1, 255 (46% of 559) 
entered the study and  
225 references (88% of 255) also participated at T2. The main reasons for drop out 
were unwillingness to participate, the impossibility to locate, and incomplete 
questionnaire data. Thus the final sample for the present study included 403 patients 
and 225 references who participated at both points in time. 
In the analyses of the present study, we included those cancer patients and 
references who participated both at 3 months and at 15 months after diagnosis (T1 
and T2, respectively). Patients (n = 403) and references  
(n = 225) who were included in the present study were compared with respectively 
patients (n = 72) and references (n = 30) who dropped out of the study after T1, on 
the main sociodemographic and medical characteristics. Compared to patients 
included in the present study, patients who dropped out were significantly more 
often diagnosed with lung or colorectal cancer, stage III or IV, treated with 
radiotherapy or chemotherapy (with or without surgery) (p < .01), and were more 
often male, older, and lower educated  
(p < .05). Furthermore, the patients who dropped out reported a greater lack of 
problem-focused support (p < .05). Comparisons between the references in the 
present study and references who dropped out revealed no significant differences on 
the sociodemographic factors, neither on the measures of social support, self-esteem, 
and depressive symptoms. 
 
Measures 
The Center for Epidemiologic Studies Depression (CES-D) scale is a 20-item self-
report questionnaire of depressive symptoms (Radloff, 1977; Weissman et al., 1977). 
Each item is scored on a 4-point scale: (0) “rarely or none of the time” (less than 
once a week), (1) “some or a little of the time” (1-2 days a week), (2) “occasionally 
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or a moderate amount of time” (3-4 days a week), and (3) “most or all of the time” 
(5-7 days a week). In the present study, we used a sumscore based on the 16 
negatively formulated CES-D items, with higher scores indicating more depressive 
symptoms. In a previous study, we found that a sumscore based on the 16 negatively 
formulated CES-D items, excluding the four positively formulated items, was a 
more valid measure of depressive symptoms, both in cancer patients and healthy 
individuals (Schroevers et al., 2000). Cronbach’s alpha of the scale in the present 
study was in the patient and reference group .86 and .84, respectively.   
We used the Social Support List (SSL) to measure social support (Van 
Sonderen, 1991; Van Sonderen, 1993). Psychometric research has shown that this 
self-report questionnaire has good construct validity and high reliability (Van 
Sonderen, 1993). Based on the literature, we examined three different types of social 
support. First, we used the subscale “Perceived Availability of Daily Emotional 
Support” (9 items) (e.g. feelings of respect, trust, listening, and the ability to have a 
good conversion). Respondents are asked to indicate the extent to which they 
perceived social support on a 4-point scale, ranging from (1) “not at all” to (4) “very 
much”, thus higher scores indicate higher perceived availability of social support. 
Cronbach’s alpha for the scale was in the patient and reference group .87 and .85, 
respectively. Second, we used the subscale “Lack of Problem-Focused Emotional 
Support Interactions” (8 items) (e.g. reassuring, comforting, problem-solving, and 
advice). Respondents are asked to indicate the extent to which the amount of 
supportive interactions with others differs from their preferred amount of supportive 
interactions (thus taking into account the individual’s need for social support). Items 
can be scored on a 3-point scale: (1) “just right, this is as I would like to have it”, (2) 
“I do not really miss it, but it would be pleasant if it happened somewhat more 
often”, and (3) “I really miss it, I would like it to happen more often”. Thus higher 
scores indicate a greater lack of received problem-focused emotional support. 
Cronbach’s alpha was in the patient and reference group .90 and .85, respectively. 
Finally, we used the subscale ”Negative Interactions” (7 items) (e.g. criticising, 
interfering, reproaching). The items were scored on a 4-point scale, ranging from 
(1) “seldom or never” to (4) “often”. Thus higher scores indicate more negative 
interactions. Cronbach’s alpha for the scale was in the patient and reference group 
.83 and .77, respectively. 
Self-esteem was measured by the Rosenberg Self-Esteem scale (Rosenberg, 
1965). A factor-analysis on the 10 items of the scale yielded two independent 
factors, based on the five negatively formulated items (e.g. “I think I’m no good at 
all”, “I feel useless”, and “I feel like a failure”) and the five positively formulated 
items (e.g. “I feel satisfied with myself” and “I feel positive about myself”) 
(Andrews, 1998; Ranchor et al., 1996). In the present study, we focused on the 
positively formulated self-esteem scale, since we were interested in the role of self-
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esteem as a resource. Previous research has suggested that especially positively 
formulated self-esteem is strongly related to the recovery of depressive symptoms 
(Brown et al., 1990c). Compared to the negatively formulated items, positively 
formulated self-esteem may also be less likely to overlap with depressive symptoms 
(characterised by, amongst others, feelings of worthlessness). Items are scored on a 
4-point scale: (1) “totally disagree”, (2) “disagree”, (3) “agree”, and (4) “totally 
agree”, thus higher scores indicate a higher self-esteem. Cronbach’s alpha in the 
patient and reference group was .76 and .73, respectively.  
The sociodemographic factors (gender, age, marital status, and education) were 
collected in a semi-structured face-to-face interview. Medical data (site, stage, and 
treatment) were derived from the cancer registration from the Comprehensive 
Cancer Centre North Netherlands. 
 
 
Table 1. Sample characteristics  
 
  Patient group  
(n = 403) 
% 
Reference group 
(n = 225) 
% 
Gender (% female)  73  70 
Age (mean ± SD in years)  58 ± 14  57 ± 15 
Marital status (% partner)  77  76 
Education      
 Primary  39  36 
 Lower  vocational/secondary  39  35 
 Middle  vocational/secondary  12  16 
 Higher  vocational/university  10  13 
Cancer site     
 Breast  47   
 Colorectal    27   
 Gynaecological  16   
  Lung     7   
  Other    3   
Stage    
 I  45   
 II  44   
 III-IV  11   
Initial treatment     
  Only surgery   48   
  Surgery and radiotherapy  22   
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  Surgery and chemotherapy     7   
  Surgery, radio- and chemotherapy    6   
  Surgery and hormonal therapy    4   
  Surgery, radio- and hormonal therapy     7   
  Other    6   
 
 
Results 
 
The sociodemographic and medical characteristics of the patient and reference group 
are described in Table 1. As can be seen, the majority of both groups were female, 
lower educated, and living with a partner. Using t-tests, we found no significant 
differences between the two groups in age and Chi-square analyses revealed no 
significant differences in gender, education, and marital status.   
Next, we examined mean differences between the patient and reference group in 
social support, self-esteem, and depressive symptoms at T1 and T2. No significant 
differences between the two groups were found on self-esteem. At T1, however, 
patients reported significant more social support than the reference group, as 
indicated by higher levels of perceived emotional support (t = -2.96, p < .01), a 
smaller lack of problem-focused support (t = 2.55, p < .05), and less negative 
interactions (t = 2.26, p < .05). Moreover, cancer patients reported significantly 
more depressive symptoms than references, at T1 (t = -4.45, p < .001) and at T2 (t = 
-2.94, p < .01). 
 
Intercorrelations among the study variables 
Pearson’s correlation coefficients were computed to examine the associations among 
the sociodemographic factors, social support, self-esteem at T1, and depressive 
symptoms at T1 and T2, in the patient and reference group separately (see Table 2).  
Sociodemographic factors were weakly but significantly related to social support 
and self-esteem. For instance, younger persons reported more negative interactions 
than older persons, both in patients (r = -.11, p < .05) and in references (r = -.28, p < 
.001). Moreover, lower educated persons reported a lower self-esteem than those 
higher educated, both in patients  
(r = .16) and in references (r = .22) (p < .01). The interrelationships among the three 
types of social support were moderately (r < .40, p < .01), suggesting that they 
measure distinct aspects of social support. Self-esteem was moderately related to 
perceived emotional support, in patients (r = .27) and in references (r = .33) (p < 
.001), but only weakly to the other two types of social support (r < .20, p < .05). 
In the patient group, depressive symptoms at T1 were significantly related to 
gender (r = .23) and age (r = -.18) (p < .001), indicating that female and younger 
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patients reported relatively more depressive symptoms. At T2, both gender (r = .16, 
p < .01) and education (r = -.11, p < .05) were related to patients’ depressive 
symptoms, indicating that female patients and those with a lower education reported 
more depressive symptoms. In the reference group, depressive symptoms at T1 were 
significantly related to gender (r = .15, p < .05), marital status (r = .25, p < .001), 
and education  
(r = -.14, p < .05), showing that female references, those without a partner, and with 
a lower education reported more depressive symptoms. These relationships were 
also found at T2 (p < .05).
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Table 2. Interrelations among the variables under study 
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Depressive symptoms were also significantly related to social support and self-
esteem in both groups, indicating that persons with lower levels of social support 
and a low self-esteem reported more depressive symptoms, both at T1 and at T2. 
Both in patients and references, perceived emotional support was less strongly 
related to depressive symptoms at T1 (r = -.23 and r = -.27, respectively) than a lack 
of problem-focused support (r = .51 and  
r = .45, respectively) and negative interactions (r = .42 and r = .48, respectively) (p < 
.001). Finally, we found a strong correlation between depressive symptoms at T1 
and T2, both in patients (r = .68) and in references (r = .55), respectively (p < .001). 
 
Social support and self-esteem as predictors of depressive symptoms  
We performed multiple regression analyses to test the associations of social support 
and self-esteem at T1 with depressive symptoms at T1. Since sociodemographic 
factors were significantly related to depressive symptoms and to social support or 
self-esteem, all analyses were controlled for gender, age, education, and marital 
status. Separate analyses were performed for each type of social support (i.e. 
perceived emotional support, lack of problem-focused support, and negative 
interactions). In each analysis, group (i.e. reference group = 0 and patient group = 
1), social support, and self-esteem were first entered as predictors. Next, the two-
way interactions of group by social support and group by self-esteem were entered. 
These interactions tested differences between the patient and reference group in the 
associations of social support and self-esteem with depressive symptoms. 
Standardised scores were used to compute the interaction terms. Only one 
interaction was significant. Therefore, we repeated the other analyses without the 
interactions terms.  
As can be seen in Table 3, social support (each type) and self-esteem were 
independently related to depressive symptoms at T1, indicating that persons with 
low levels of social support and a low self-esteem experienced higher levels of 
depressive symptoms. Perceived emotional support was less strongly related to 
depressive symptoms than a lack of problem-focused support and negative 
interactions. When we performed an overall analysis (including group, all three 
types of social support, self-esteem, and all two-way interactions simultaneously), 
we found the same results as above. Only perceived emotional support failed to 
reach significance.   
Comparisons of the patient and the reference group generally revealed no 
significant differences between the two groups in the associations of social support 
and self-esteem with depressive symptoms at T1. The only exception was found for 
problem-focused support. Following the method  
Table 3. Multiple regression of depressive symptoms at T1 and T2 on social support and self-
esteem at T1 in the total sample (n = 628) 
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 Depressive  symptoms 
 T1  T2 
  ∆R2 Beta ∆R2 Beta 
Perceived emotional support          
  Sociodemographic factors  .06 ***    .05 ***   
  Depressive symptoms T1  -  -  .36 ***  .59 *** 
  Group (patient or reference)  .02 ***  .18 ***  .001  -.001 
  Perceived emotional support  .06 ***  -.18 ***  .001       -.04 
  Self-esteem  .05 ***  -.24 ***  .001       -.06 
      
Lack of problem-focused support         
  Sociodemographic factors  .06 ***    .05 ***   
  Depressive symptoms T1  -  -  .39 ***  .59 *** 
  Group   .03 ***  .23 ***   .001       -.01 
  Lack of problem-focused 
support 
.20 ***  .30 ***       .01 **      .11 ** 
  Self-esteem  .06 ***  -.23 ***   .001       -.05 
  Group X support      .01 **     .15 **  -  - 
  Group X self-esteem       .001      -.02  -  - 
      
Negative  interactions      
  Sociodemographic factors  .06 ***    .05 ***   
  Depressive symptoms T1  -  -  .37 ***  .58 *** 
  Group  .03 ***  .21 ***  .001       -.01 
  Negative interactions  .16 ***  .37 ***  .01 *    .09 * 
  Self-esteem  .05 ***  -.24 ***  .001       -.04 
 
Note. Dashes indicate that regression was not calculated. *** p<.001; ** p<.01; * p<.05. 
 
 
recommended by Aiken and West (1991), analyses of this interaction showed that a 
lack of this type of support was especially in patients strongly related to higher 
levels of depressive symptoms.   
 
Longitudinal analyses 
The same multiple regression analyses were performed to examine whether social 
support and self-esteem at T1 could predict depressive symptoms at T2, controlling 
for depressive symptoms at T1. First, we tested the two-way interactions, but none 
of the interactions reached significance. Therefore, these were removed from the 
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analyses. As can be seen in Table 3, a lack of problem-focused support and negative 
interactions at T1 significantly predicted depressive symptoms at T2. In contrast, 
perceived emotional support and self-esteem at T1 were not significant predictors of 
depressive symptoms at T2. 
 
 
Discussion 
 
The aim of the present study was to examine the role of social support and self-
esteem in depressive symptoms in recently diagnosed cancer patients and a reference 
group of individuals without cancer from the general population. The results 
indicated that social support and self-esteem were only weakly to moderately related 
to each other. Both social support and self-esteem were independently related to 
depressive symptoms (concurrently), showing that lower levels of social support and 
self-esteem were related to higher levels of depressive symptoms. Social support 
also significantly predicted depressive symptoms one year later (longitudinally). 
Overall, the findings clearly showed that, in general, social support and self-esteem 
were strongly related to depressive symptoms, regardless the presence of a stressful 
situation (i.e. a recent diagnosis of cancer).  
Similar to other studies (Druley & Townsend, 1998), we found a rather weak 
relationship between social support and self-esteem, both in patients and in 
references. Only the perceived availability of emotional support was in both groups 
moderately strong related to self-esteem. A possible explanation for the weak 
relationship between social support and self-esteem may be the relatively older age 
of the participants (on average approximately 60 years). It has been suggested that 
social relationships are particular important for self-esteem in younger persons 
(Andrews, 1998). Furthermore, positive self-evaluations may be a natural state of 
mind and people are able to protect themselves against threats to their self-esteem 
through self-enhancing cognitions (Taylor & Armor, 1996).  
An important finding of the present study is that social support and self-esteem 
were independently related to the presence of depressive symptoms. Thus these 
resources seem to supplement each other, each fulfilling different basic human 
needs. Consistent with previous studies, our findings emphasise the strong effect of 
negative social interactions on depressive symptoms (Manne et al., 1997; Rook, 
1984). It has been suggested that social and personal resources augment (rather than 
supplement) each other in relation to well-being (Thoits, 1995). Few studies have 
examined possible interactions between social and personal resources. The findings 
of these studies are difficult to compare due to differences in the definition of social 
support and the choice of personal resource, but overall, they provide weak evidence 
for strong interaction effects (Dalgard et al., 1995; Grassi et al., 1997; Riley & 
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Eckenrode, 1986). In the present study, we focused for theoretical reasons on the 
independent (main) effects of social support and self-esteem. Nevertheless, when we 
had a closer look at interactions, we found no significant interactions between social 
support and self-esteem.  
All together, the findings favour the idea that social and personal resources 
supplement each other. 
Consistent with other studies (Druley & Townsend, 1998; Penninx et al., 1998), 
we generally found no significant differences between patients and references in the 
associations of social support and self-esteem and the presence of depressive 
symptoms. These findings conform the notion of Thoits (1982, 1995) that 
psychosocial resources are likely to affect psychological well-being, regardless the 
presence of a threatening life-event. The only resource that was clearly more 
important for cancer patients’ well-being was problem-focused emotional support. 
At three months after diagnosis, a lack of this type of support, characterized by 
reassuring, comforting, problem-solving, and advise was especially in cancer 
patients strongly related to higher levels of depressive symptoms. In the initial 
period after diagnosis, the availability of someone with whom the cancer patient can 
talk about his or her illness-related concerns seems to be of great importance for 
patients’ adjustment (Classen et al., 1996; Helgeson & Cohen, 1996; Stanton et al., 
2000). Others may reinforce the patient’s efforts to cope with the situation and to 
reinterpret the situation so it seems less threatening (Thoits, 1986). In contrast, a 
lack of support may lead to the rumination of pessimistic thoughts, preoccupation 
with the disease, self-pity and, subsequently, to psychological distress (Aymanns et 
al., 1995; Sollner et al., 1999). Future research is needed to examine whether a lack 
of problem-focused support is detrimental for all cancer patients or mostly for 
certain subgroups of cancer patients, for instance, those at increased risk for cancer-
related concerns and psychological distress such as younger cancer patients.    
Cross-sectional relations of social support and self-esteem with depressive 
symptoms do not give us information about a possible causal direction between 
predictors and outcome. Our longitudinal analyses showed that persons who 
reported lower levels of social support (i.e. a greater lack of problem-focused 
emotional support and more negative interactions) experienced higher levels of 
depressive symptoms one year later, after adjusting for their initial level of 
depressive symptoms. This finding is consistent with other studies among cancer 
patients and demonstrates the importance of social support for the course of 
psychological functioning over time (Alferi et al., 2001; Grassi & Rosti, 1996). It 
has been suggested that, on the other hand, depressed people have a greater need and 
search for support, which may, ironically, turn others away and lead to an erosion of 
social support over time (Alferi et al., 2001; Moyer & Salovey, 1999). Thus, a lack 
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of social support may lead to a worsening of depressive symptoms and these 
symptoms may decrease one’s social support resources.  
An important issue in the context of social support is that social support may be a 
personality characteristic rather than a feature of the social environment (McColl et 
al., 1995; Winnubst et al., 1988). The degree of social support that a person has 
available is likely to be partly determined by personality factors, especially 
neuroticism. Neuroticism denotes the tendency to be emotionally unstable, to 
experience negative emotions, and to worry about things that could go wrong 
(Eysenck & Eysenck, 1991). Furthermore, persons scoring high on neuroticism 
seem to be less successful in the building, maintenance, and mobilisation of 
supportive relationships and perceive less support from others than emotional stable 
persons (Tempelaar et al., 1989; Winnubst et al., 1988). In the present study, we 
have not paid attention to the influence of neuroticism on social support. However, 
studies that have taken into account the effect of neuroticism found that a lack of 
emotional support still contributed independently to depressive symptoms, even 
when controlling for neuroticism (Krol, 1996). Thus it seems that personality 
characteristics such as neuroticism cannot fully explain the relationship between 
social support and depressive symptoms. 
The self-esteem measure in the present study was positively formulated (e.g. “I 
feel positive about myself”). The discussion regarding the conceptual differences 
between positively and negatively formulated self-esteem (Brown et al., 1990a) is 
analogous to the discussion regarding differences between the positive and negative 
aspects of social relationships (Manne et al., 1997; Rook, 1984) and psychological 
well-being (Folkman, 1997; Russell & Carroll, 1999; Schroevers et al., 2000). As 
several researchers have recently urged, it is time to recognise that many 
psychosocial concepts may not be one-dimensional but rather multi-dimensional, 
measuring distinct concepts that may occur simultaneously (Andrews, 1998; 
Folkman, 1997; Manne et al., 1997; Manne et al., 1999). In order to better 
understand the conceptual differences between the positively and negatively 
formulated self-esteem, we repeated our regression analyses, this time using the 
negatively formulated self-esteem items (e.g. “I feel useless”). In general, the results 
of the regression analyses were similar to those using the positively formulated self-
esteem. However, in contrast to positively formulated self-esteem, negatively 
formulated self-esteem appeared to be a significant predictor of depressive 
symptoms one year later, when controlling for the initial level of depressive 
symptoms. Perhaps, negative cognitions are more salient than positive cognitions in 
determining the level of depressive symptoms. According to Beck, especially 
negative self-perceptions makes a person more vulnerable to depressive symptoms 
(Beck, 1983). The examination of the correlations between negatively formulated 
self-esteem and social support revealed that, compared to positively formulated self-
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esteem, negatively formulated self-esteem was stronger related to all three types of 
social support. All together, these findings demonstrate the importance of 
distinguishing positive and negative aspects of psychosocial concepts in future 
research.  
It should be kept in mind that the majority of the patients and references were 
female, lower educated, and living with a partner. Moreover, the majority of the 
cancer patients were diagnosed with stage of 1 or 2, indicating a relatively good 
prognosis. Over time, patients with a worse prognosis and those with lower levels of 
social support were more likely to drop out. This might limit the generalizibility of 
the present results. For instance, among patients with a poor prognosis, other 
processes could be at hand.  
The present study has important methodological strengths and extends prior 
research among cancer patients in several ways. First, the associations among social 
support, self-esteem, and depressive symptoms were examined in a large group of 
cancer patients and references, both cross-sectional and longitudinal, at two fixed 
points in time after diagnosis. Second, the inclusion of both social support and self-
esteem made it possible to examine their interrelationships and to take these 
interrelationships into account when examining their association with depressive 
symptoms. Third, both positive and negative aspects of social support were taken 
into account.  
Overall, the results demonstrate that the supportive relationships and self-esteem 
play a crucial role in psychological well-being. The results also suggest that, at 
group level, a diagnosis of cancer does not deteriorate these psychosocial resources. 
Nevertheless, at an individual level, a diagnosis of cancer may have a great impact 
on the availability of psychosocial resources. Health care-providers may carefully 
monitor patients’ psychosocial resources and changes herein in the weeks and 
months after diagnosis. By means of education or group discussions with other 
patients, patients and their partners may be given information about the benefits of 
sharing illness-related concerns and how to be more available and supportive. 
Patients may also be stimulated to focus on the positive aspects of themselves and 
their lives.  
The enhancement of patients’ own resources may help them to manage the 
physical and psychosocial consequences of the illness. Future research may 
investigate the role of other personal resources (e.g. coping styles, mastery, 
optimism, and meaning in life) in patients’ adjustment to the cancer (Debats, 1996; 
Peterson, 2000; Stanton & Snider, 1993; Thompson & Collins, 1995; Vilhjalmsson, 
1998). In addition, it has been hypothesised that unequal distributions of 
psychosocial resources by demographic factors may account for the observed 
demographic differences in psychological adjustment to cancer (Ridder, 1995; 
Schroevers et al., 2001a; Thoits, 1995). Although we generally found weak 
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correlations between the sociodemographic factors and the presence of resources, 
more research is needed to explore whether deficiencies in psychosocial resources 
can explain sociodemographic differences in psychological well-being and 
adjustment to cancer. 
 
 
 
 
   
 
Do cancer survivors differ from the  
general population at eight years after diagnosis: a 
longitudinal study of their physical and 
psychosocial adjustment over time 
 
 
 
 
Abstract 
 
In the present study, we examined to what extent cancer survivors (n = 206) 
experience long-term physical and psychosocial consequences of the illness and its 
treatment. Using a longitudinal, case-control design, we compared survivors’ 
physical and psychological functioning and their psychosocial resources at 3 months 
(T1), 15 months (T2), and 8 years (T3) after diagnosis with a reference group of 
similar-aged individuals without cancer from the general population (n = 120). The 
findings indicated that, at T3, survivors reported levels of psychological functioning 
and psychosocial resources similar to those in references. However, levels of 
physical problems were significantly higher in survivors than in references. During 
the first year after diagnosis, survivors showed significant improvements in their 
physical and psychological functioning. However, in the seven years thereafter, both 
survivors and references showed a decrease in physical functioning, demonstrating 
the effect of ageing on patients’ long-term adjustment. Levels of psychosocial 
resources were stable over time, both in survivors and in references. During the 
interview at T3, however, both survivors and references reported (retrospectively) 
positive changes in their resources. Overall, the findings of the study not only 
demonstrate the persistence of physical symptoms and somatic distress but also shed 
light on the role of positive beliefs and a search for meaning in the adjustment 
process. 
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Introduction 
 
A diagnosis of cancer is a major stressful life event, that affects nearly one of every 
three individuals in the Netherlands (Visser et al., 1998). As a result of medical 
advances in the field of cancer screening, detection, and multimodal treatment, the 
survival rate in cancer patients has increased within the past thirty years (Coebergh 
et al., 1995; Levi et al., 2000). For instance, among women with breast cancer, the 5-
year survival rate has increased from 52% to 76%. Consequently, many cancer 
patients are presently faced with a long period of uncertainty and the late 
consequences of cancer and its treatment. Information about the long-term 
adjustment of cancer survivors may identify areas in which cancer treatment can be 
improved and patient services that should be maintained or developed (Dorval et al., 
1998). Furthermore, knowledge about the specific late physical and psychosocial 
sequelae of cancer survivors may help health-care providers to target problems that 
need special attention during follow-up visits. The purpose of this article was to 
explore the long-term adjustment to cancer in patients who have survived cancer for 
eight years beyond the initial diagnosis. In the first five years after diagnosis, 
patients are monitored more regularly and the likelihood of a recurrence is greater, 
and therefore, cancer patients who have survived for five years or longer are 
considered as truly long-term survivors of cancer.  
The initial period after a diagnosis of cancer may be regarded as a life crisis and 
patients may have to face manifold distressing physical and psychosocial problems 
(e.g. feelings of uncertainty, a diminished self-esteem, changes in relations, and 
depressive symptoms) as a result of cancer and its treatment (Courtens et al., 1996; 
Moos & Schaefer, 1984). As time passes, the traumatic impact of the event will 
eventually become less salient and most studies showed significant improvements in 
patients’ overall quality of life in the first year following diagnosis (Ganz et al., 
1996). Nevertheless, particular problems, such as certain physical symptoms and 
uncertainty about the future, may persist till years after diagnosis (Kornblith, 1998; 
Tross & Holland, 1989). Moreover, cancer survivors are at increased risk of 
developing a recurrence or new primary tumour, which may have a devastating 
effect on their long-term adjustment (Leigh, 1998).  
Recently, there is a growing realization and interest that a life-crisis may also 
have positive consequences (Folkman & Greer, 2000; Schaefer & Moos, 1998; 
Taylor et al., 2000; Tedeschi et al., 1998). The confrontation with a life-threatening 
disease may challenge patients’ fundamental assumptions about their personal 
invulnerability, their self-worth, and the meaningfulness of life, and may therefore 
be regarded as a period of “existential crisis”  
(Janoff-Bulman & Frieze, 1983). In such periods of uncertainty and confusion, 
patients often actively search for meaning, in an attempt to understand why the 
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unexpected and stressful event happened and its significance for one self and one’s 
future (Taylor, 1983). In the aftermath  
of a life crisis, people often show resilience and eventually personal growth in terms 
of a more positive self-image, better social relationships, more empathy for others, 
altered priorities, and a greater appreciation of life (Schaefer & Moos, 1998; 
Tedeschi et al., 1998).  
Since previous studies among cancer patients have focused primarily on the 
short-term effects of a diagnosis of cancer and its treatment (i.e. less than 1-2 years 
after diagnosis), comparatively little is known about the long-term adjustment of 
cancer survivors. Furthermore, the studies among long-term survivors showed 
considerable diversity in design (e.g. cross-sectional, case-control, or longitudinal), 
methods (e.g. quantitative or qualitative), and sample characteristics (e.g. type of 
cancer, prognosis, and time since diagnosis), which makes it difficult to draw 
definite conclusions about the late consequences of cancer. In the following 
paragraphs, we critically review the results of previous studies among cancer 
survivors. 
According to a recent review of studies on the psychosocial adjustment of cancer 
survivors (2 to 15 years after diagnosis), the majority of the survivors seem to adjust 
remarkably well to the cancer experience (Kornblith, 1998). However, several 
studies indicated that cancer survivors still experience physical problems (Bush et 
al., 1995; Dow et al., 1999; Ferrell et al., 1998b; Greaves-Otte et al., 1991; Schag et 
al., 1994). For instance, in a quantitative study in a mixed sample of 278 short- and 
long-term survivors, Schag et al. (1994) found that survivors still reported difficulty 
in doing physical activities, reduced energy, sexual problems, and disfigurement. 
Physical symptoms may remind survivors of the cancer experience and may be a 
barrier to achieve normalcy (Dow et al., 1999).  
Regarding survivors’ psychological functioning, qualitative studies consistently 
showed that cancer survivors are still concerned about a recurrence of the cancer 
(Ferrans, 1994; Ferrell et al., 1998a; Fromm et al., 1996; Pelusi, 1997). For instance, 
in a phenomenological study among eight breast cancer survivors 2 to 15 years 
(mean 8 years) after completing treatment, Pelusi (1997) found that each woman 
experienced uncertainty about the future and a fear of cancer recurrence. However, 
the results of quantitative studies on psychological functioning were mixed (Bush et 
al., 1995; Ferrell et al., 1998b; Kurtz et al., 1995; Schag et al., 1994; Wyatt & 
Friedman, 1996). Among 125 cancer survivors 6 to 18 years after bone marrow 
transplantation, Bush et al. (1995) found low levels of general psychological 
distress. However, Ferrell et al. (1998) found that breast cancer survivors, on 
average nine years after diagnosis, were still worried about a fear of a recurrence of 
the cancer. Collectively, these studies suggest that survivors’ psychological 
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functioning is not globally impaired but rather specifically, in terms of a fear of 
cancer recurrence and uncertainty about the future.   
Despite the physical and psychological sequelae, cancer survivors also reported 
positive consequences of the cancer experience, in terms of enriched personal and 
social resources. For instance, among 14 breast cancer survivors 8 to 30 years after 
diagnosis, Fredette (1995) found that survivors reported altered priorities, more 
assertiveness, and more concern for others. Other studies have shown that survivors 
experience a greater sense of purpose and appreciation of life (Dow et al., 1999; 
Ferrans, 1994; Ferrell et al., 1998a; Ferrell et al., 1998b; Pelusi, 1997; Wyatt & 
Friedman, 1996). In contrast to these mainly positive findings, a qualitative study of 
Fromm et al. (1996) among 90 cancer survivors 1 to 10 years after bone marrow 
transplantation showed that, although half of the survivors reported a greater 
appreciation of life (47%) and improved family relationships (52%), about a quarter 
reported worsened family relationships (23%) and a lack of empathy from others 
(28%). 
Unfortunately, the aforementioned studies among cancer survivors had a cross-
sectional design, thus examining patients at one point in time, often with a wide 
variable time after diagnosis. Consequently, little is known about the course of 
survivors’ physical and psychological functioning and resources over time. It can be 
expected that certain aspects of functioning (e.g. physical symptoms) are likely to be 
most prominent in the period following diagnosis and during treatment, whereas 
other aspects (e.g. a greater appreciation of life) may not be evident until years after 
diagnosis. In order to understand the process of long-term adjustment, longitudinal 
studies are needed. The few longitudinal studies that have been conducted among 
long-term survivors suggest an improvement in survivors’ psychological functioning 
and overall psychosocial adjustment over time (Grassi & Rosti, 1996; Omne-Ponten 
et al., 1994). For instance, among 66 breast cancer survivors, Omne-Ponten et al. 
(1994) found that overall psychosocial maladjustment decreased over time in the six 
years after diagnosis. As far as we know, there are no longitudinal studies among 
cancer survivors that have examined other aspects of long-term adjustment.   
Another issue that is overlooked by most studies is the impact of a recurrence or 
new primary tumour on survivors’ long-term adjustment. Studies that examined how 
survivors’ functioning is affected by such an event demonstrate that a recurrence or 
new primary tumour may have a devastating effect on survivors’ functioning (Bull 
et al., 1999; Dorval et al., 1998; Frost et al., 2000; Okamura et al., 2000). For 
instance, in a prospective, longitudinal study among 69 women with recurrent breast 
cancer, Bull et al. (1999) found an increase in physical symptoms, emotional and 
social distress immediately following the diagnosis of a recurrence. In the six 
months following recurrence, they found no significant improvement in the amount 
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of physical symptoms. They did find significant improvements in emotional and 
social distress in this period.  
A major problem in the assessment of long-term adjustment is distinguishing 
effects due to cancer from those due to ageing and/or other comorbidities (Gotay & 
Muraoka, 1998). Most cancer patients are in the age of 60 years or older when they 
receive a diagnosis of cancer. Therefore, they are likely to suffer from other physical 
problems (e.g. less energy and decreased physical activity), chronic diseases, and 
stressful life events (e.g. the care and concerns for a seriously ill partner or the death 
of their spouse) (Coebergh et al., 1995; Mor, 1992; Penninx et al., 1999; Rowland, 
1989a). Inherent in such life events are losses (e.g. of good health or loved ones) 
which may affect feelings of depression and anxiety and which may diminish one’s 
resources (Ormel et al., 1998; Stuck et al., 1999). On the other hand, greater 
maturity and more extensive coping experience with previous life events may 
provide ageing persons with richer resources (e.g. greater appreciation of life) 
(Debats et al., 1995; Schaefer & Moos, 1998).  
In order to distinguish the late consequences of a diagnosis of cancer from those 
of ageing, the inclusion of a reference group of similar-aged individuals without 
cancer from the general population is needed. Only a few studies among long-term 
survivors included such a reference group (Bjordal et al., 1995; Dorval et al., 1998; 
Van Tulder et al., 1994; Weitzner et al., 1997). These studies generally showed that, 
compared to healthy references, survivors report more physical restrictions, lower 
perceived overall health, less satisfaction with their sexual life, and more worries 
about their health (Dorval et al., 1998; Van Tulder et al., 1994). The findings 
regarding psychological functioning, however, were inconsistent. In a study among 
long-term breast cancer survivors, at least five years after diagnosis, Weitzner et al. 
(1997) found that cancer survivors were significantly more depressed and anxious 
than women attending breast cancer screening. In contrast, in a relatively younger 
group of long-term survivors of Hodgkin’s disease, on average 14 years after 
diagnosis, Van Tulder et al. (1994) found that survivors reported similar levels of 
psychological distress as a healthy group of hospital visitors who were 
accompanying patients for a medical check-up or radiotherapy. Finally, regarding 
patients’ personal and social resources, most studies focused on the first years after 
diagnosis (Andrykowski et al., 1996; Carpenter, 1997; Zemore & Shepel, 1989). The 
only available information on the resources of long-term cancer survivors showed 
that cancer survivors experienced similar levels of available emotional support and 
satisfaction with the partner relationship as references (Dorval et al., 1998; Van 
Tulder et al., 1994). All together, these studies provide important information on 
survivors’ long-term adjustment. However, conclusions based on these data are 
limited, due to their cross-sectional design, the variable or long time after diagnosis, 
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the use of screening patients or individuals accompanying patients to the clinic as 
references, the limited range of outcome variables, and the lack of qualitative data.  
Therefore, the aim of the present study was to examine the long-term adjustment 
of 206 cancer survivors, in comparison with a reference group of 120 individuals 
without cancer from the general population. Both groups were interviewed and filled 
out a questionnaire at three fixed points in time since diagnosis: 3 months (T1), 15 
months (T2), and 8 years (T3). A wide variety of aspects of long-term adjustment 
were measured: physical functioning (i.e. physical symptoms and limitations in 
household and social activities), psychological functioning (i.e. depressive 
symptoms and feelings of anxiety), and personal and social resources (i.e. overall 
satisfaction with life, meaning in life, self-esteem, emotional support, and marital 
satisfaction). These quantitative data were supplemented with the data from a more 
in-depth, qualitative interview at eight years after diagnosis. Additional analyses 
were performed to examine the impact of a recurrence or new primary tumour on 
survivors’ long-term adjustment.  
As far as we know, this is the first longitudinal study that examined such a large 
group of cancer survivors and similar-aged references without cancer on a wide 
variety of outcome measures (both quantitative and qualitative), hereby taking into 
account the impact of a cancer recurrence or a new primary tumour. We expected 
differences between cancer survivors and references in physical and psychological 
functioning to be most prominent in the first year after diagnosis. Regarding 
personal and social resources, it might be expected that positive changes herein are 
more likely to occur somewhat later in the process of adjustment. On the other hand, 
when acknowledging the impact of a diagnosis of cancer on one’s resources and the 
importance of these resources for patients’ adjustment, we might also expect 
changes in these resources in the first year after diagnosis. 
 
 
Methods 
 
Subjects and Procedures 
The study was conducted among cancer survivors of a cohort of 475 newly 
diagnosed patients who have previously participated in a study on the social network 
of cancer patients and their adjustment to cancer in the first 15 months after 
diagnosis (De Ruiter, 1995; Van der Zee et al., 1996). This study also included a 
cohort of 255 references without a history of cancer from the general population. 
 
Initial study 
Cancer patients were recruited from 12 hospitals in the northern part of the 
Netherlands, with the assistance of the Dutch Cancer Registration of the 
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Comprehensive Cancer Centre North Netherlands (CCCNN). The inclusion criteria 
for study participation were: (a) age 18 years or older, (b) newly diagnosed with 
cancer, (c) no distant metastases, (d) a life expectancy of at least one year, and (e) 
informed on the diagnosis of cancer. A letter containing information about the 
project and a participation form was attached to the patients’ medical status and 
patients were approached for participation in the study by their physician.  
In the period from 1990 to 1992, 516 patients returned a participation form. At 
approximately three months after diagnosis, 475 of the 516 (92%) eligible patients 
entered the study. Patients were also interviewed and filled out a questionnaire at 9 
and 15 months after diagnosis. In total, 403 patients (85% of 475) participated at 15 
months after diagnosis. The main reasons for drop out during the first year were 
serious illness and death.  
Based on the gender and age distribution of the patient group, 559 references 
were selected from the register office of five townships in the same region as 
patients and sent a participation form. Of the 559 eligible references, 255 references 
(46%) participated in the first interview. Similar to the patient group, references 
were also interviewed and filled out a questionnaire twice with time intervals of 6 
months. In total, 225 references (88% of 255) participated at 15 months after 
diagnosis. The main reasons for drop out during the first year were unwillingness to 
participate, the impossibility to locate, or incomplete questionnaire data.  
 
Follow-up study 
At 15 months after diagnosis, 358 (of the 403) patients and 194 (of the 225) 
references gave informed consent to be approached for a follow-up study. Of these 
persons, 102 patients and 27 references died in the following seven years. For the 
present study, the 256 patients and 167 references who were still alive were sent a 
participation form, accompanied with a letter informing them of the follow-up study. 
A research assistant then telephoned participants when participants had not returned 
the participation form within 14 days of sending the letter.  
In total, 206 patients participated in the study at eight years after diagnosis. The 
main reasons of non-response of the 50 patients who dropped out were ill health, 
unwillingness to participate, and reluctance to talk about the cancer experience. 
Compared to cancer survivors who participated at eight years after diagnosis, cancer 
survivors who dropped out since the first interview were significantly more often 
diagnosed with colorectal cancer or lung cancer, stage III or IV, and treated with 
radiotherapy or chemotherapy (p < .01). Patients who were older, male, and lower 
educated were also more likely to drop out (p < .01). 
In addition, 128 references participated in the follow-up study. The main reasons 
of non-response of the 39 references who dropped out were unwillingness to 
participate and ill health. For the analyses in the present study, we excluded eight 
                                                                                                                                             CHAPTER 5                                                                    82 
references who were diagnosed with cancer in the past eight years, leading to a final 
sample of 120 references. Compared to the references who participated at eight 
years after diagnosis, references who dropped out of the study since the first 
interview were significantly older, lower educated, and less often had a partner (p < 
.05). 
 
Measures 
For the present study, we used the data collected at 3 months (T1),  
15 months (T2), and 8 years after diagnosis (T3). At all three points in time, 
survivors and references were interviewed at home, using a semi-structured 
interview. During the interview, information was collected about limitations in 
activities, social network, life events, chronic illnesses, and sociodemographic 
characteristics. Both groups also filled out a self-report questionnaire at all three 
points in time. At T3, the semi-structured interview was followed by a more 
qualitative interview. During this interview, persons were asked in a more open way 
about their current functioning and possible changes herein over time in the past 
eight years. 
 
Physical symptoms were measured with the 17-item subscale Physical Symptom 
Distress from the Rotterdam Symptom Checklist (RSCL) (De Haes et al., 1990; De 
Haes et al., 1996). Persons were asked to indicate the degree to which they had been 
bothered by the indicated symptoms (e.g. fatigue, low back pain, dizziness, stomach 
ache, shortness of breath, and decreased sexual interest) during the last week on a 4-
point scale (ranging from 1 to 4). Cronbach’s alpha was .85 in survivors and .80 in 
references.  
Limitations in household activities were measured with the Groningen Activities 
Restrictions Scale (GARS) (Kempen et al., 1993). The subscale consists of seven 
items. Examples of household activities include: doing light or heavy household jobs 
and preparing meals. In order to measure limitations in social activities, four 
additional items were developed. Examples of social activities include: paying a 
visit to someone, participating in outdoor activities, and doing strenuous hobbies. On 
both scales, persons were asked to indicate the degree to which they are able to do 
certain activities on their own on a 5-point scale (ranging from 1 to 5). For the 
Limitations in Household Activities subscale, Cronbach’s alpha was .90 in survivors 
and .93 in references. For the Limitations in Social Activities subscale, Cronbach’s 
alpha was .83 in survivors and .88 in references.  
Depressive symptoms were assessed with the Dutch version of the Center for 
Epidemiologic Studies Depression (CES-D) scale (Bouma et al., 1995; Radloff, 
1977; Weissman et al., 1977). Persons were asked to indicate how often they felt 
each of the symptoms during the last week on a 4-point scale (ranging from 0 to 3). 
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In the present study, we used a sumscore based on the 16 negatively formulated 
CES-D items. In a previous study, we found that a sumscore based on the 16 
negatively formulated CES-D items, excluding the four positively formulated items, 
was a more valid measure of depressive symptoms, both in cancer patients and 
healthy individuals (Schroevers et al., 2000). Cronbach’s alpha was .90 in survivors 
and .89 in references.  
Situational or current anxiety was measured by the 20-item State-Anxiety 
subscale from the State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1970). 
Persons were asked to indicate to what extent they currently experience each of the 
symptoms on a 4-point scale (ranging from 1 to 4). Cronbach’s alpha was .93 in 
survivors and .94 in references. 
Overall satisfaction with life was measured by the Satisfaction With Life Scale 
(SWLS) (Arrindell et al., 1991). This self-report questionnaire consists of five items 
(e.g. I am satisfied with my life). On a 7-point scale (ranging from 1 to 7), 
participants were asked to indicate whether they agree or not with each of the five 
statements. Cronbach’s alpha was .88 in survivors and .89 in references. It has been 
found that such global measures of subjective well-being are rather stable over time 
and strongly influenced by personality traits (DeNeve & Cooper, 1998). Therefore, 
we used overall life satisfaction as a personal resource.  
The Life Regard Index (LRI), a 23-item self-report questionnaire, was used to 
measure meaning in life (Battista & Almond, 1973; Debats, 1990; Debats, 1998). 
This questionnaire was assessed at T3 only. The scale consists of two subscales: 
“Framework” (10 items) and “Fulfilment” (13 items).  
The Framework scale measures the degree to which individuals can envision their 
lives within some meaningful perspective or have derived a set of life goals, whereas 
the Fulfilment scale measures the degree to which people see themselves as having 
fulfilled or being in the process of fulfilling their life goals. On a 3-point scale 
(ranging from 1 to 3), persons were asked to indicate whether they agree or not (or 
no opinion) with each of the statements. For the Framework subscale, Cronbach’s 
alpha was .75 in survivors and .82 in references and for the Fulfilment subscale .87 
and .90, respectively.  
Self-esteem was measured by the Rosenberg Self-Esteem (RSE) scale 
(Rosenberg, 1965). A factor-analysis on the 10 items of this self-report questionnaire 
yielded two independent factors, differentiating the five negatively formulated items 
(e.g. “I think I’m no good at all”, “I feel useless”, “I feel like a failure”) and the five 
positively formulated items (e.g. “I feel satisfied with myself”, “I feel positive about 
myself”) (Andrews, 1998; Ranchor et al., 1996). Since previous studies have 
demonstrated conceptual differences between positively and negatively formulated 
self-esteem (Brown et al., 1990a; Brown et al., 1990b), we used both subscales. 
Persons were asked to indicate whether they agreed with each of the statements on a 
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4-point scale (ranging from 1 to 4). Cronbach’s alpha was .73 in survivors and .78 in 
references for the positively formulated self-esteem scale and .81 and .82, 
respectively for the negatively formulated self-esteem scale. 
Social support was measured by the 8-item subscale Lack of Problem-Focused 
Emotional Support Interactions from the Social Support List (SSL) (Van Sonderen, 
1991; Van Sonderen, 1993). This scale measures a lack of emotional support 
characterized by reassuring, comforting, problem-solving, and advice. Items can be 
scored on a 3-point scale: (1) “just right, this is as I would like to have it”, (2) “I do 
not really miss it, but it would be pleasant if it happened somewhat more often”, and 
(3) “I really miss it, I would like it to happen more often”. Cronbach’s alpha was .88 
in survivors and .86 in references.  
Marital satisfaction was measured with the Maudsley Marital Questionnaire 
(MMQ) (Arrindell et al., 1983). This 10-item scale focuses on the communication 
with the partner, feelings of warmth and understanding, and satisfaction with the 
time spent together. Persons were asked to consider these aspects of the relationship 
on a 9-point scale (ranging from 0 to 8). Cronbach’s alpha was .92 in survivors and 
.94 in references.  
 
During a more qualitative interview at T3, both survivors and references were asked 
about their current physical and psychological functioning and the appreciation of 
their activities, relationships with others, themselves, and life in general as well as 
about possible changes herein in the past eight years since diagnosis. Thus the 
interview covered partly the same dimensions of functioning as the self-report 
questionnaires. In addition, survivors were asked more specific questions about the 
cancer experience, for instance, about their thoughts about a recurrence, possible 
causes of the cancer, and the question “Why me?”.  
Based on pilot interviews and the literature on long-term adjustment, categories 
of response were developed to code these open-ended responses. During the 
interview, survivors and references were encouraged to talk freely at their own past, 
but carefully prompted to talk about the aforementioned aspects of functioning. The 
trained interviewer then scored the answer to the questions on one or more response 
categories. 
When cancer survivors reported a change, they were asked to indicate to what 
extent cancer had influence this change. Thus, rather than asking cancer survivors 
directly about the consequences of cancer, they were first asked to indicate changes 
in general, and subsequently, the influence of cancer upon these changes. By 
formulating the questions in such a neutral way, we wanted to avoid influencing 
patients’ response about the consequences of cancer. It also enabled us to ask the 
reference group the same questions.  
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Information about the sociodemographic characteristics (gender, age, education, 
and marital status) and the number of chronic illnesses was collected during the 
semi-structured interview. Regarding the latter, we used a standardized list including 
21 chronic illnesses (such as asthma, hypertension, diabetes, disease of the joints, 
chronic headache, and heart disease). Medical data (site, stage, and treatment) were 
derived from the cancer registration from the Comprehensive Cancer Centre North 
Netherlands. During the interview, we asked patients whether they still went to 
follow-up visits in the hospital for the cancer and whether they had experienced a 
recurrence of the cancer or a new primary tumour in the past eight years. Of 13 
survivors no medical information about a recurrence or a new primary tumour was 
available).  
Statistical analyses 
T-tests for independent samples were conducted to examine differences between 
survivors and references in physical and psychological functioning and their 
resources at T1 to T3. Changes in physical and psychological functioning and 
resources within the group of survivors and references were examined with paired t-
tests.  
In order to examine differences between survivors and references in these 
changes over time, difference scores were calculated by subtracting T3 – T2 scores 
and T2 - T1 scores. T-tests for independent samples were used to examine 
differences between survivors and references in these difference scores. The 
interview data was analysed with cross-tabs and differences between survivors and 
references were tested with Chi-square analyses.  
 
 
Results 
 
Sample characteristics 
The characteristics of the present sample at eight years after diagnosis are shown in 
Table 1. As can be seen, the mean age of survivors and references was 62 years and 
59 years, respectively. The majority of both groups were female, living with a 
partner, and lower educated. Almost half of both groups suffered from two or more 
chronic illnesses. Using Chi-square analysis and Student’s t-test, we found no 
significant differences between survivors and references in the sociodemographic 
characteristics and the number of chronic illnesses. Among cancer survivors, the 
most important cancer sites were breast cancer (53%), colorectal cancer (22%), and 
gynaecological cancer (19%). The majority of the cancer survivors (91%) were 
diagnosed with stage I or II, indicating a relatively good prognosis. Most of the 
patients were treated with surgery (48%) or surgery and radiotherapy (22%).  
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Physical functioning 
 
Quantitative data 
At eight years after diagnosis (T3), survivors reported significantly higher levels of 
physical symptoms (p < .001) and more limitations in their household (p < .05) and 
social activities (p < .01) than references (Table 2).  
In the first year after diagnosis (T1 to T2), survivors showed a significant 
decrease in physical symptoms and limitations in their household and social  
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Table 1. Sample characteristics at eight years after diagnosis 
 
 Survivors 
(n = 206) 
References 
(n = 120) 
Gender (% female)  79  71 
Current age (mean ± SD)  61.9 ± 13.6  59.3 ± 13.2 
Marital status (% having a partner)  74  78 
Education (%)     
 Primary  31  27 
 Lower  vocational/secondary  43  37 
 Middle  vocational/secondary  15  21 
 Higher  vocational/university  11  15 
Number of chronic illnesses (%)     
 0  31  31 
 1  29  31 
  2 or more  40  38 
Cancer site (%)     
 Breast  53   
 Colorectal    22   
 Gynaecological  19   
  Lung     4   
  Other    2   
Stage (%)     
 I  49   
 II  42   
  III-IV    9   
Initial treatment (%)   
  Only surgery   48   
  Surgery and radiotherapy  22   
  Surgery and chemotherapy     9   
  Surgery, radio- and chemotherapy    9   
  Surgery and hormonal therapy    4   
  Surgery, radio- and hormonal therapy     5   
  Other    3   
Recurrence or new primary tumor (%)  20   
Still going to follow-up visits (%)  84   
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Table 2. Mean scores on quantitative measures of functioning in survivors and references at  
3 months (T1), 15 months (T2), and 8 years (T3) after diagnosis 
 
     Survivors     
   Mean (SD) 
  References 
   Mean (SD) 
 pb 
Physical functioning             
Physical symptomsc      
  T1    24.65 (5.78)   21.17 (4.45)  *** 
  T2   22.61 (5.16)   21.38 (4.72)  * 
  T3   24.79 (6.66)   22.05 (4.64)  *** 
 T1-T2     -1.96 (4.55) ***a       .21 (3.46)  *** 
  T2-T3     2.11 (4.94) ***       .75 (4.40)  * 
Limitations in household activities        
  T1   11.67 (5.44)     7.89 (2.34)  *** 
  T2     9.33 (3.98)     7.98 (3.33)  ** 
  T3   10.41 (5.72)     9.09 (4.80)  * 
  T1-T2    -2.34 (5.31) ***        .09 (3.41)  *** 
  T2-T3     1.05 (4.62) **     1.01 (4.82) *   
Limitations in social activities       
  T1   10.00 (4.89)     5.00 (2.18)  *** 
  T2     7.50 (4.09)     5.60 (2.83)  *** 
  T3     7.38 (4.41)     6.03 (3.71)  ** 
  T1-T2    -2.32 (4.95) ***       .60 (2.99)*  *** 
  T2-T3      -.09 (4.25)       .41 (3.81)   
Psychological functioning      
Depressive symptoms       
  T1    6.22 (6.38)     3.68 (4.29)  *** 
  T2    4.94 (6.36)     3.68 (4.97)  * 
  T3    5.60 (6.33)     4.37 (5.53)   
  T1-T2   -1.31 (4.91) ***      -.01 (4.00)    ** 
  T2-T3      .63 (5.09)       .74 (5.04)   
Anxiety        
  T1   34.48  (9.69)   33.94  (9.30)   
  T2   33.68 (10.89)   32.52  (9.99)   
  T3   35.23 (10.16)   34.34 (10.25)   
  T1-T2      -.95  (9.19)    -1.43  (8.61)   
  T2-T3     1.52  (9.28) *     1.23  (8.88)   
 
aPaired t-test within survivors and references: * p < .05; ** p < .01; *** p < .001. 
bIndependent t-test between survivors and references: * p < .05; ** p < .01; *** p < .001. 
cHigher scores on the RSCL, GARS, CES-D, and STAI indicate higher levels of physical and 
psychological problems. Higher scores on the SWLS, LRI, RSE, and SSL indicate higher 
levels of satisfaction, whereas higher scores on the MMQ indicate lower levels of satisfaction.   
 LONG-TERM ADJUSTMENT  89
 
     Survivors     
   Mean (SD) 
  References 
   Mean (SD) 
 pb 
Personal resources      
Overall satisfaction with life        
  T1   27.33 (7.01)   27.84 (6.16)   
  T2   27.81 (6.42)   27.88 (6.36)   
  T3   26.73 (6.99)   27.09 (6.95)   
  T1-T2       .46 (5.85)       .04 (5.80)   
  T2-T3      -.99 (6.72)      -.78 (6.02)   
Meaning in life (fulfilment)       
  T3   32.96 (5.66)   32.72 (6.04)   
Meaning in life (framework)       
  T3   26.15 (3.41)   26.40 (3.58)   
Self-esteem (positively formulated)        
  T1   15.76 (2.19)   15.58 (2.04)   
  T2   15.67 (2.15)   15.65 (2.07)   
  T3   15.57 (2.14)   15.53 (2.07)   
  T1-T2      -.10 (1.69)       .07 (1.70)   
  T2-T3      -.08 (1.98)      -.16 (1.76)   
Self-esteem (negatively formulated)        
  T1   15.35 (2.53)   15.52 (2.51)   
  T2   15.45 (2.78)   15.58 (2.39)   
  T3   15.44 (2.79)   15.53 (2.61)   
  T1-T2       .10 (1.97)       .06 (2.17)   
  T2-T3      -.01 (2.28)      -.09 (2.12)   
Social resources      
Lack of emotional support        
  T1     9.94 (3.29)   10.11 (2.93)   
  T2     9.97 (3.25)     9.89 (2.88)   
  T3   10.41 (3.35)   10.15 (2.97)   
  T1-T2       .02 (2.67)      -.22 (2.50)   
  T2-T3       .41 (3.29)       .23 (2.75)   
Marital satisfaction        
  T1   10.83 (11.38)   13.17 (12.37)   
  T2   11.92 (12.77)   13.93 (12.28)   
  T3   12.91 (11.31)   16.50 (14.15)   
  T1-T2     1.01  (8.11)       .60  (6.32)   
  T2-T3     1.59 (11.16)     2.61  (9.25) *    
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activities (p < .001). Nevertheless, compared to references, survivors reported 
elevated levels of physical symptoms (p < .05), limitations in their  
household (p < .01) and social activities (p < .001) till 15 months after diagnosis 
(T2).  
In the seven years between T2 and T3, we found a significant increase in 
limitations in household activities, both in survivors (p < .01) and in references (p < 
.05). Among survivors, we also found a significant increase  
in physical symptoms (p < .001), which was significantly stronger than in references 
(p < .05).  
 
Qualitative data 
In line with the quantitative data, 52% of the survivors reported during the interview 
that they still experienced cancer-related physical problems (especially fatigue and 
arm problems) at eight years after diagnosis. However, we found no significant 
differences between survivors and references in the limitations in their current daily 
life, with 75% of the survivors and 84% of the references reporting no or few 
limitations. Regarding changes over time, 56% of the survivors and 41% of the 
references said that, in general, they did less on a day now than eight  
years ago. Moreover, 35% of the survivors and references reported that  
they did less household activities now than eight years ago. No significant 
differences between survivors and references were found in the amount  
of these changes over time.  
 
 
Psychological functioning 
 
Quantitative data 
At eight years after diagnosis (T3), cancer survivors did not differ significantly from 
the references in their levels of depressive symptoms and feelings of anxiety (Table 
2).  
In the first year after diagnosis (T1 to T2), we found a significant decrease in 
depressive symptoms in survivors, compared to references (p < .01). Still, survivors 
reported significantly more depressive symptoms till 15 months after diagnosis (T2) 
than references (p < .05).  
In the seven years between T2 and T3, we found no significant changes  
in depressive symptoms, neither in survivors nor in references, but both groups 
showed a tendency towards an increase of anxiety over time. 
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Qualitative data 
The results of the interview supplemented these findings, showing that 94% of the 
survivors reported no or little emotional distress as a result of cancer. Moreover, 
96% of the survivors said that they had learned to live with the disease. However, 
the majority of the survivors still had recurrent thoughts about the cancer (51% once 
in a while and 25% even regularly), especially when experiencing physical 
symptoms (47%) and when talking to other cancer patients (46%). The most 
important issues they still thought about were the disease period itself (37%), a fear 
of recurrence (36%), and changes in body image (19%). Furthermore, 42% of the 
survivors had become more attentive to physical symptoms over time, compared to 
25% of the references (p < .05). 
 
Psychosocial resources 
 
Quantitative data 
No significant differences between survivors and references were found in their 
overall satisfaction with life, meaning in life, self-esteem, lack of emotional support, 
and marital satisfaction, neither in the first year after diagnosis (T1 and T2) nor at 
eight years after diagnosis (T3) (see Table 2). We also found no significant 
differences between survivors and references in the course of these resources over 
time. Both groups showed stable levels of these resources from T1 to T2 and T2 to 
T3. The only exception was found for marital satisfaction. In the seven years 
between T2 and T3, references reported a decrease in marital satisfaction (p < .05).    
 
Qualitative data 
Similar to the quantitative data, we found no significant differences between 
survivors and references in the appreciation of themselves, their life in general, and 
their social relationships during the interview at eight years after diagnosis (T3). 
Specifically, the majority of the survivors and references appreciated themselves 
(76% and 75%, respectively), their life in general (91% and 88%, respectively), and 
their relationships with the partner, family, and others (90% to 98% of the survivors 
and 92% to 94% of the references).  
However, in contrast to the quantitative data showing stable levels of resources, 
a large number of survivors as well as references reported during the interview that 
their resources had changed over time. Specifically, more than half of both survivors 
and references reported no change in the appreciation of themselves (64% and 70%, 
respectively), their life in general (45% and 55%, respectively), and their social 
relationships (66% to 73% of the survivors and 64% to 74% of the references). But a 
large number of survivors and references did report a greater appreciation of 
themselves (30% and 28%, respectively), their life in general (48% and 41%, 
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respectively), and their social relationships (26% to 30% of the survivors and 21% to 
28% of the references). We found no significant differences between survivors and 
references in these changes over time. 
We also asked survivors and references whether specific aspects of themselves 
and of their lives had changed in the past eight years. Compared to references, 
survivors more often reported that they took life less for granted (34% versus 12%, 
respectively) (p < .001). However, other positive changes were reported about 
equally frequent by survivors and references. For instance, survivors as well as 
references reported that they had become more emotional (14% and 10%), more 
self-confident (28% and 30%), and had a greater empathy and understanding of 
others (16% and 10%). In addition, survivors and references reported that they had a 
heightened awareness of mortality (11% and 19%), lived more conscious (25% and 
20%), lived more at ease (16% and 15%), and put life more into perspective (17% 
and 13%).  
Intriguingly, when we asked survivors to what extent cancer had influenced 
these changes, many survivors said that cancer had affected changes in the 
appreciation of themselves (40%), life in general (54%), relationships with the 
partner, family, and others in general (30% to 45%), and specific aspects of 
themselves (39%) and of their life (47%). In other words, although we found no 
significant differences between survivors and references in changes in their 
resources, many survivors did attribute changes to the cancer experience. 
 
The impact of a recurrence of the cancer or new primary tumour 
In order to examine the impact of a cancer recurrence or a new primary tumour on 
survivors’ long-term adjustment, cancer survivors were categorized into two groups: 
those who had remained disease-free and those who had developed a recurrence or a 
new primary tumour in the eight years following diagnosis. In all, 38 survivors had 
experienced a recurrence or a new primary tumour. 
First, we compared disease-free survivors and survivors who had developed a 
recurrence or a new primary tumour on their sociodemographic (i.e. gender, age, 
marital status, and education) and medical characteristics (site, stage, and treatment). 
We also compared the sociodemographic characteristics of these two groups of 
survivors with those in the reference group. The only significant difference that was 
found was that survivors with a recurrence or a new primary tumour were 
significantly older  
(i.e. mean age 65.8) than disease-free survivors (i.e. mean age 60.6) and than 
references (i.e. mean age 59.3) (p < .05).  
Next, we compared disease-free survivors and survivors who had developed a 
recurrence or new primary tumour with the reference group on all quantitative 
aspects of functioning at eight years after diagnosis (T3). Since the survivors who 
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had developed a recurrence were significantly older, we controlled these analyses 
for age. The results indicated that survivors who had remained disease-free reported 
significantly higher levels of physical symptoms than references (p < .01). However, 
survivors who had developed a recurrence or new primary tumour reported, besides 
higher levels of physical symptoms, also more limitations in household and social 
activities than references (p < .01). They also showed a tendency towards higher 
levels of depressive symptoms than references (p = .07). No other significant 
differences between survivors and references were found. 
The results of the interview were in line with these quantitative findings. 
Compared to references, survivors who had experience a recurrence or new primary 
tumour reported more often that they generally did less on a day now than eight 
years ago (76% versus 41%) (p < .01) and they showed a tendency towards more 
limitations in their current daily life (35% versus 16%) (p = .06). However, 
consistent with the quantitative data, they did not report lower levels of resources 
than references. 
Compared to disease-free survivors, survivors who had developed a recurrence 
or a new primary tumour reported more cancer-related physical problems (e.g. 
fatigue, short of breath, and decreased appetite) (65% versus 48%) and more 
regularly cancer-related thoughts (43% versus 20%) (p < .05) and a tendency 
towards more cancer-related emotional distress (14% versus 4%) (p = .06).  
  
The cancer experience through the eyes of long-term cancer survivors 
At the end of the interview, we asked cancer survivors a few general questions about 
their experiences with cancer. In response to the question “Overall, how would you 
describe your cancer experience?”, 36% said positive as well as negative, 20% 
negative, 16% positive, and 28% neither positive nor negative.  
When we asked survivors to what extent cancer had changed their life, 28% of 
the cancer survivors responded not at all, but the majority said that cancer had 
changed their life (36% a little and 36% a lot). Cancer survivors who reported that 
cancer had not changed their lives said that other factors had more impact on their 
well-being, such as the ability to do things for oneself (autonomy), other chronic 
illnesses and life events (such a the death of a partner or a divorce), ageing in 
general (which made them living more conscious and putting life more into 
perspective), and a positive attitude. Others mentioned that, only in the initial year 
after diagnosis, they had experienced problems in their daily functioning as a result 
of cancer. In contrast, survivors who said that cancer had changed their lives 
reported both negative effects (e.g. experiencing persistent physical problems and a 
fear of a recurrence) and positive effects (e.g. taking life less for granted, living 
more conscious, experiencing a greater appreciation of life and more joy) as a result 
of cancer. 
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In order to examine whether the presence of negative consequences affects the 
presence of positive consequences, we performed additional correlation analyses at 
eight years after diagnosis (T3). The results showed that survivors who experienced 
higher levels of physical symptoms reported higher levels of limitations in 
household (r = .48) and social activities (r = .51), depressive symptoms (r = .64) and 
feelings of anxiety (r = .49) and, during the interview, higher levels of cancer-related 
emotional distress (r = .24) and a fear of recurrence (r = .26). At the same time, they 
reported lower levels of overall satisfaction with life (r = -.38), meaning in life 
(framework, r = -.22; fulfilment, r = -.37), self-esteem (r = -.29), emotional support 
(r = .31), and satisfaction with the marital relationship (r = .32). The strength and 
direction of these correlations suggest a rather weak to moderate negative 
relationship between the positive and the negative consequences. In order words, the 
negative and positive consequences of cancer seem to be relatively independent of 
each other and cancer survivors may experience them both at the same time. 
 
 
Discussion 
 
In this study, we have investigated the long-term adjustment to cancer in a large 
group of cancer survivors who were diagnosed with a relatively early disease stage 
and had survived cancer for eight years after diagnosis. The findings indicated that, 
at eight years after diagnosis, cancer survivors experience similar levels of 
psychological functioning and psychosocial resources as similar-aged references 
with no history of cancer. However, cancer survivors did report significant higher 
levels of physical symptoms and limitations in household and social activities than 
references. Additional analyses showed that these higher levels of functional 
limitations were especially seen in survivors who had experience a recurrence or 
new primary tumour. The longitudinal analyses showed significant improvements in 
survivors’ physical and psychological functioning in the first year after diagnosis. In 
the seven years thereafter, both survivors and references showed an increase in 
limitations in household activities and survivors also showed an increase in physical 
symptoms during this period. Regarding the personal and social resources, the 
longitudinal analyses showed stable levels of these resources over time, whereas 
during the interview, survivors as well as references reported positive changes in 
their resources.   
The results of the study clearly demonstrated the persistence of physical 
symptoms and survivors’ greater attentiveness to these symptoms. Moreover, many 
survivors still had recurrent thoughts about the cancer, especially about the initial 
period after diagnosis and a fear of a recurrence. These results are in line with 
previous studies showing elevated levels of physical impairment and somatic 
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distress in cancer survivors (Ferrell et al., 1998b). In the context of persistent 
physical symptoms and a decrease in medical surveillance and contact with the 
health care providers, it can be expected that cancer survivors are focused on 
physical changes and concerned about a recurrence of the cancer. Providing 
information about the process of physical recovery and self-monitoring of physical 
symptoms may help survivors to manage their feelings of uncertainty (Ferrell et al., 
1998b; Gray et al., 1998). Although heightened somatic distress may to some degree 
be an unavoidable consequence of cancer, such information may help survivors to 
establish or maintain a balance between inattentiveness and preoccupation with 
physical symptoms (Somerfield et al., 1999).  
Besides higher levels of physical symptoms, survivors who had developed a 
recurrence or new primary tumour also reported elevated levels of limitations in 
household and social activities and more depressive symptoms, compared to 
references. But we found no significant negative impact of a recurrence or new 
primary tumour on survivors’ resources. These findings are consistent with those of 
other studies, showing the negative impact of a recurrence on survivors’ physical 
and psychological functioning (Dorval et al., 1998; Okamura et al., 2000). The 
physical symptoms and functional limitations in cancer survivors with a recurrence 
experience may increase feelings of dependency and isolation. Some studies among 
cancer survivors have found no significant effect of a recurrence on depression and 
anxiety (Frost et al., 2000). The discrepancy in the results regarding psychological 
functioning may be due to differences in the instrument used to measure distress, 
sample characteristics (e.g. age, concurrent treatment), the duration of the disease-
free interval between initial diagnosis and recurrence, and the time since recurrence. 
Further longitudinal research is needed to examine the specific needs and concerns 
of survivors with recurrent cancer and the course of adjustment to a cancer 
recurrence over time. 
Both in survivors and references, we found an increase in limitations in 
household activities in the past seven years. This finding shows that the process of 
ageing influences survivors’ long-term physical functioning. Interestingly, survivors 
also reported a sharp increase in physical symptoms in the past seven years, which 
was significantly greater than the increase in physical symptoms in references. Other 
studies among cancer survivors have also found such a recurring worsening of 
functioning in cancer survivors after initial improvement (Ganz et al., 1996; Holzner 
et al., 2001). The question is whether this stronger increase in physical symptoms in 
survivors is because of the cancer or because of other factors. A common factor that 
is related to emotional stability as well as to the tendency to be more attentive of and 
concerned about physical sensations is neuroticism (Somerfield et al., 1999). Indeed, 
additional analyses showed that especially high neurotic cancer survivors reported 
an increase in physical symptoms in the past seven years. This finding, akin to those 
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of others (Bower et al., 2000; Chaturvedi & Maguire, 1998), suggests that physical 
symptoms in cancer patients probably have both an somatic and a psychological 
component.  
Despite the elevated levels of physical problems at eight years after diagnosis, 
survivors’ psychological functioning and resources at this point in time were similar 
to those in the reference group. The finding is in line with other studies that showed 
that most cancer survivors are able to cope with the cancer experience (through 
positive thinking and the support from others and religion) and report a good overall 
quality of life (Dorval et al., 1998; Fredette, 1995; Halstead & Fernsler, 1994).  
Regarding the resources, the quantitative (longitudinal) data showed stable levels 
of personal and social resources, both in survivors and in references. In contrast, 
during the interview, many survivors and references reported (positive) changes in 
their resources over time, such as a greater appreciation of life. This finding is 
consistent with the results from Cordova et al. (2001), which showed that cancer 
patients and healthy references reported similar improvements in self-respect, 
relationships with others, and outlook on life. Why do people report these positive 
changes? According to Taylor (2000), people hold mildly distorted positive beliefs 
(“illusions”) about themselves and their life. This might explain the tendency of both 
survivors and references to evaluate their past in a positive way. Furthermore, as 
mentioned in the introduction, both survivors and references are likely to have been 
confronted with other life-events and chronic illnesses. Successful coping with such 
events may eventually increase feelings of control, self-confidence, and self-
understanding, strengthen social relationships, and change the individual’s 
perspective on problems and important values and beliefs.   
Intriguingly, many survivors said that cancer had influenced the changes in their 
resources. Thus, although survivors did not report more positive changes in their 
resources than references, they did attribute these changes to the cancer experience. 
Festinger’s theory of cognitive dissonance (Festinger, 1957) may be relevant to 
understand the underlying mechanisms of survivors’ attribution of positive changes 
to the cancer experience. According to this theory, dissonance (e.g. the disruption of 
a sense of personal invulnerability and meaning in life), being psychologically 
uncomfortable, motivates people to reduce the dissonance, for instance by denying 
or minimizing the negative consequences or by looking for positive ones. Other 
researchers have also demonstrated that, in the context of a threatening event, people 
will attempt to reduce the negative implications and search for and create positive 
meaning in the event (through causal attributions and positive reappraisal) 
(Folkman, 1997; Moos & Schaefer, 1984; Taylor, 1983; Taylor & Armor, 1996). 
The co-occurrence of negative and positive consequences, also observed by other 
studies (Folkman, 1997; Schroevers et al., 2000; Vickberg et al., 2000), seems to 
serve an important function. Finding positive meaning may provide a psychological 
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break, enhance the individuals’ coping efforts and resources, and buffer the negative 
consequences of the event (Folkman & Moskowitz, 2000; Vickberg et al., 2000). It 
remains unclear to what extent these processes are conscious or unconscious. 
Probably, people use both unintentional and intentional strategies to process 
threatening information and to reconstruct their lifes. 
It should be kept in mind that the majority of the cancer survivors in the present 
study were diagnosed with a low stage of disease and mainly treated with surgery 
and/or radiotherapy. In a longitudinal study on the long-term adjustment to cancer, it 
is inevitable to examine those patients with a relatively good prognosis and life 
expectancy. Furthermore, the examination of group data may undermine individual 
differences and minimize the difficulties experienced by some cancer survivors.  
The present study has important methodological strengths and extends prior 
research among cancer survivors in several ways. First, we examined a wide variety 
of negative as well as positive aspects of physical and psychological functioning and 
psychosocial resources, using both quantitative and qualitative data. Second, we 
examined a large group of cancer survivors and a reference group of individuals 
without cancer at three fixed points in time since diagnosis. Using such a 
longitudinal, case-control design enabled us to explore the process of adjustment in-
depth. Furthermore, the inclusion of a reference group appeared to be very useful in 
distinguishing the long-term effects of cancer from those of the other factors (e.g. 
the ageing process) and in understanding the role of cognitive processes in 
psychological adjustment.  
With respect to the clinical relevance, the findings of the present study challenge 
the idea that psychosocial functioning is permanently and globally impaired by a 
diagnosis of cancer and treatment. Thus the majority of cancer survivors probably do 
not need organized late psychosocial treatment. Nevertheless, some survivors may 
experience ongoing problems, and therefore, health care providers should be alert 
for continuing psychosocial problems during follow-up visits. When observed, these 
persons should be carefully monitored and offered some form of psychosocial 
intervention, such as education and individual/group counselling (Ferrell et al., 
1998b; Henderson, 1997). In order to facilitate the early recognition of cancer 
survivors who are at increased risk of long-term problems, longitudinal studies are 
needed to investigate risk factors of long-term maladjustment to cancer. The 
persistence of cancer-related physical problems and other chronic diseases, a lack of 
personal and social resources (e.g. optimism, mastery, social support), and 
premorbid dysfunction may place individuals at a greater risk for long-term 
maladjustment. 
 
   
 
The role of age at the onset of  
cancer in relation to long-term adjustment:  
a controlled comparison over an eight-year period 
 
 
 
Abstract 
The goal of the study was to explore the role of age in survivors’ long-term 
adjustment to cancer (n = 206), in comparison with references from the general 
population (n = 120). Both groups were assessed at three points in time: at 3 months, 
15 months, and 8 years after diagnosis. First, within both groups separately, we 
examined age differences in physical and psychological functioning, positive 
consequences of illness, meaning in life, and more specific aspects of well being, as 
measured by a qualitative interview. Secondly, in order to distinguish the effects of 
cancer from those of ageing, comparisons were made between cancer survivors and 
similar-aged references. At eight years after diagnosis, younger survivors reported 
more physical problems and more depressive symptoms than references of their age. 
No significant differences between survivors and similar-aged references were found 
in meaning in life. Interestingly though, younger survivors experienced more 
positive consequences of illness than older survivors. Overall, the findings 
demonstrate that age is more than a statistical variable. Information about the time at 
which cancer occurs may provide further insight into the physical and psychological 
problems as well as benefits likely to result from cancer. 
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Introduction 
 
Although a diagnosis of cancer is a stressful life-event for patients of all ages, the 
impact of cancer and its treatment on patients’ functioning is believed to be strongly 
associated with patients’ age at the time of diagnosis (Northouse, 1994). 
Furthermore, there is a growing concern that, in the long term, the normal process of 
ageing may strongly affect survivors’ functioning (Gotay & Muraoka, 1998). In 
order to address these issues, we conducted a longitudinal study on the long-term 
adjustment to cancer in three different age groups of cancer survivors. To distinguish 
the effects due to cancer from those due to ageing, we included an age- and gender-
matched reference group of individuals without a history of cancer from the general 
population.  
A diagnosis of cancer, like any other life-threatening disease, can have a 
profound impact on an individual’s well being. Especially in the first months after 
diagnosis, cancer patients can face severe physical impairment and feelings of 
depression (Pasacreta, 1997; Schmale, 1983; Schroevers et al., 2001a). As time 
passes, the negative impact of the cancer event will become less salient and life will 
become more and more dominated by more mundane concerns associated with daily 
living (Fromm et al., 1996; Kornblith, 1998; Schroevers et al., 2001b). Still, long-
term cancer survivors (i.e. those who have survived cancer for five years or longer) 
may continue to experience particular late effects of cancer, such as physical 
symptoms, a fear of cancer recurrence, and a preoccupation with physical symptoms 
(Ferrell et al., 1998b; Kornblith, 1998; Schroevers et al., 2001b; Tross & Holland, 
1989). At the same time, a substantial number of cancer survivors report positive 
consequences of illness, such as more assertiveness, more concern for others, 
changed priorities, and a greater appreciation of life and relationships with others 
(Fredette, 1995; Fromm et al., 1996; Kornblith, 1998; Pelusi, 1997; Wyatt & 
Friedman, 1996). In the following paragraphs, we will review the theoretical and 
empirical evidence regarding the role of age in the adjustment to cancer. Hereby, we 
make a distinction between three important aspects of adjustment: physical 
functioning, psychological functioning (distress), and the experience of positive 
consequences of illness.  
Regarding physical functioning, many cancer patients are in the age of 60 years 
or older when they receive a diagnosis of cancer. Therefore, they can suffer from 
comorbidity and general health problems (e.g. less energy, decreased activity), 
which may, in addition to cancer, impair their physical functioning (Greimel et al., 
1997; Mor, 1992). Over time, the amount of cancer-related physical problems seems 
to diminish in the first year after diagnosis (Ganz et al., 1996; Schroevers et al., 
2001b). As a consequence, the impact of the cancer is likely to become less 
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prominent and other illnesses and health problems may play a part in survivors’ 
physical functioning in the long term (Gotay & Muraoka, 1998).  
Empirical studies generally found no significant association of age with the 
amount of physical symptoms and functional limitations in cancer patients in the 
first year after diagnosis (De Haes et al., 1990; Given et al., 1994; Kurtz et al., 1994; 
Wenzel et al., 1999). However, among middle-term survivors (1 to 5 years after 
diagnosis), Ganz et al. (1998) found that physical and role functioning significantly 
declined as age increases. Similarly, among long-term survivors (6 to 18 years after 
treatment), Bush et al.  
(1995) found that an increased age was associated with more fatigue and 
concentration problems. Thus, especially in the long-term, age seems to be 
significantly related to survivors’ physical functioning.  
According to the stress-coping model of Lazarus and Folkman (1984),  
the personal meaning of a stressful event is the most important aspect of stress with 
which a person must cope. They direct the person’s coping strategies and ultimately 
his or her adjustment to the event (Lazarus, 1993). In the context of a physical 
illness, the appraisal (i.e. perceived meaning)  
of the illness is believed to be strongly associated to patients’ age and developmental 
stage (i.e. where the person is with respect to life cycle-related biological, personal 
and social goals and tasks) at the time of diagnosis (Moos & Schaefer, 1984; 
Rowland, 1989a). Given that chronic illnesses, including cancer, are more common 
among the elderly, younger cancer patients may be less anticipated and therefore, a 
diagnosis of cancer may be more threatening and distressing at a younger age. 
Furthermore, younger cancer patients, especially those younger than 45 years, may 
have a more profound sense of loss and deprivation, as they may be especially 
challenged with the disruptions of their daily routines and roles, uncertainty about 
the future and important life goals, concerns about the relationship with their partner 
and children, feelings of being different and isolated, disfigurement and sexual 
problems, and a sense of physical vulnerability experienced normally at a later stage 
(Rowland, 1989a; Siegel et al., 1999; Vinokur et al., 1990). Older patients, 
especially those older than 65 years, may also be confronted with multiple negative 
consequences of the cancer, such as increased physical and functional impairment, 
social isolation, feelings of dependency, and fears of being a burden to others. 
However, they are more likely to have accomplished many important life goals and 
to be less involved in some social roles (e.g. work and family), thus having fewer 
competing demands and responsibilities (Aldwin et al., 1996). Moreover, their 
greater maturity and more extensive coping experience with previous stressful life 
events may help them to minimize problems and appraise the diagnosis of cancer as 
less stressful (Moos & Schaefer, 1984; Mor et al., 1994).  
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Based on the aforementioned notions regarding age differences in the perceived 
meaning of the cancer, it can be expected that younger cancer patients are more 
likely to experience depressive symptoms, particularly in the initial period after 
diagnosis. In the long term, especially when treatment has been successful and when 
experiencing few late physical side-effects, it can be hypothesized that younger 
cancer survivors are able to cope with the multiple demands of the illness and thus 
do not report elevated levels of depressive symptoms. On the other hand, when 
recognizing the significance of the multiple demands that younger cancer survivors 
have to face, it can also be questioned whether younger survivors are fully able to 
restore their psychological functioning. Thus, it can also be hypothesized that 
younger cancer survivors do still experience depressive symptoms to some extent.   
Empirical studies have consistently shown that, in the first months after 
diagnosis, younger patients perceive the cancer to be more threatening and 
experience more intrusive thoughts and depressive symptoms than older cancer 
patients (Epping-Jordan et al., 1999; Schroevers et al., 2001a; Vinokur et al., 1990; 
Wenzel et al., 1999). As to the long term, Weitzner et al. (1997) found no significant 
relationship between age and depressive symptoms in cancer survivors (more than 
five years after diagnosis). However, in a study among long-term survivors (6 to 18 
years after treatment), Bush et al. (1995) found that a younger age was associated 
with more health-related worries. Similarly, Schover et al. (1995) found that 
younger survivors (0 to 10 years after diagnosis) worried more often about a cancer 
recurrence than older survivors. Thus, in contrast to the initial period after diagnosis 
when a younger age is significantly related to higher levels of psychological distress, 
the psychological functioning of younger cancer survivors does not seem to be 
globally impaired but rather specific in terms of more concerns about health and 
cancer recurrence. 
It has been suggested that, as a result of the greater psychological impact of a 
cancer diagnosis, younger cancer survivors are more likely to search for meaning in 
the cancer experience, both in terms of causal attributions (about the cause of the 
cancer and the question “Why me?”) and in terms of a search for positive 
consequences of the cancer experience (Dirksen, 1995). However, only a few studies 
among cancer survivors have examined the association of age with a search for 
meaning in the cancer experience. Among survivors (0 to 17 years after diagnosis), 
Salmon et al. (1996) found that those younger than 65 years gained more 
appreciation of life from their illness than those older than 65 years. In addition, 
Dirksen (1995) found that younger cancer survivors (5 to 20 years after diagnosis) 
were more likely to report a reappraisal of life and changed priorities as a result of 
cancer than older cancer survivors.  
In general, the most frequently mentioned positive changes as a result of the 
cancer experience are changed priorities and a greater appreciation of life (Fredette, 
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1995; Kornblith, 1998; Pelusi, 1997; Wyatt & Friedman, 1996). Little is known, 
however, to what extent such positive consequences prompted by and attributed to 
the cancer experience are related to a global sense of meaningfulness in life. As a 
consequence, the question can be raised to what extent survivors’ age is related to a 
global sense of meaning in life. Furthermore, life-span development theories suggest 
that, in general, a global sense of meaningfulness in life is related to a person’s age 
(Erikson, 1963; Levinson, 1978). For instance, individuals in the age of 40 and 50 
often have a need to question the meaning and direction of their life. This process 
may ultimately lead to a new, more fulfilling life structure. Around the age of 60, 
people start to reappraise their life and to put life into a broader perspective. This 
may lead to a sense of meaning in life or to despair. The confrontation with cancer 
may accelerate or strengthen these developmental processes (Rowland, 1989a).  
In sum, there is reason to believe that patients’ age at diagnosis is strongly 
related to their physical and psychological adjustment to cancer over time. However, 
although the findings and explanations of previous studies may have some appeal, 
the empirical evidence is elusive. Particularly, since previous studies lack an age-
matched control group, it remains unclear to what extent the physical problems in 
cancer survivors are due to cancer or to comorbidity and ageing in general. 
Secondly, most previous studies assessed cancer survivors only at one point in time, 
often with a wide variable time after diagnosis. Thirdly, many studies included only 
a limited range of outcome variables. Fourthly, many studies were correlational and 
have overlooked the importance of distinguishing distinct age groups and thus only 
show global trends. In the present study, we made an attempt to fill in these gaps, 
through the use of a longitudinal study design with fixed points in time since 
diagnosis, the inclusion of an age- and gender-matched reference group of 
individuals without a history of cancer from the general population, and the use of 
quantitative and qualitative data on the negative as well as the positive consequences 
of cancer. Based on the adult developmental model (Rowland, 1989a), we made a 
distinction between three different developmental groups: younger or mature adults 
(those younger than 45 years), older adults (those in the age of 45 to 65 years), and 
ageing adults (those of 65 years or older) at diagnosis.  
The primary goal of the present study was to explore the role of age in long-term 
adjustment to cancer. In order to obtain a more comprehensive knowledge, we 
examined this issue from two perspectives. First, in a large group of long-term 
cancer survivors, we examined age differences in physical functioning (i.e. the 
presence of physical symptoms and functional limitations) and psychological 
functioning (i.e. depressive symptoms) at 3 months (T1), 15 months (T2), and 8 
years after diagnosis (T3). The focus of the present article will be on survivors’ 
long-term adjustment (T3). At this point in time, we also examined age differences 
in the report of positive consequences of illness, a global sense of meaningfulness in 
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life, and specific aspects of well-being, as measured by a qualitative interview. 
Secondly, to distinguish the effects of cancer from those of ageing, we compared the 
levels of outcomes in cancer survivors with those in similar-aged references.  
 
 
Methods 
 
Subjects and Procedures 
The study was conducted among cancer survivors of a cohort of 475 newly 
diagnosed patients who have previously participated in a study on the social network 
of cancer patients and their adjustment to cancer in the first 15 months after 
diagnosis (De Ruiter, 1995; Van der Zee et al., 1996). This study also included a 
cohort of 255 references without a history of cancer from the general population. 
 
Initial study 
Cancer patients were recruited from 12 hospitals in the northern part of the 
Netherlands, with the assistance of the Dutch Cancer Registration of the 
Comprehensive Cancer Centre North Netherlands (CCCNN). The inclusion criteria 
for study participation were: (a) age 18 years or older, (b) newly diagnosed with 
cancer, (c) no distant metastases, (d) a life expectancy of at least one year, and (e) 
informed on the diagnosis of cancer. A letter containing information about the 
project and a participation form was attached to the patients’ medical status and their 
physician approached patients for participation in the study.  
In the period from 1990 to 1992, 516 patients returned a participation form. At 
approximately three months after diagnosis, 475 of the 516 (92%) eligible patients 
entered the study. Patients were also interviewed and filled out a questionnaire at 9 
and 15 months after diagnosis. In total, 403 patients (85% of 475) participated at 15 
months after diagnosis. The main reasons for drop out during the first year were 
serious illness and death.  
Based on the gender and age distribution of the patient group, 559 references 
were selected from the register office of five townships in the same region as 
patients and sent a participation form. Of the 559 eligible references, 255 references 
(46%) participated in the first interview. Similar to the patient group, references 
were also interviewed and filled out a questionnaire twice with time intervals of 6 
months. In total, 225 references (88% of 255) participated at 15 months after 
diagnosis. The main reasons for drop out during the first year were unwillingness to 
participate, the impossibility to locate, or incomplete questionnaire data.  
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Follow-up study 
At 15 months after diagnosis, 358 (of the 403) patients and 194 (of the 225) 
references gave informed consent to be approached for a follow-up study. Of these 
persons, 102 patients and 27 references died in the following seven years. For the 
present study, the 256 patients and 167 references who were still alive were sent a 
participation form, accompanied with a letter informing them of the follow-up study. 
A research assistant then telephoned participants when participants had not returned 
the participation form within 14 days of sending the letter.  
In total, 206 patients participated in the study at eight years after diagnosis. The 
main reasons of non-response of the 50 patients who dropped out were ill health, 
unwillingness to participate, and reluctance to talk about the cancer experience. 
Compared to cancer survivors who participated at eight years after diagnosis, cancer 
survivors who dropped out since the first interview were significantly more often 
diagnosed with colorectal cancer or lung cancer, stage III or IV, and treated with 
only radiotherapy or chemotherapy (p < .01). Patients who were older, male, and 
lower educated at T1 were also more likely to drop out (p < .01). 
In addition, 128 references participated in the follow-up study. The main reasons 
of non-response of the 39 references that dropped out were unwillingness to 
participate and ill health. For the analyses in the present study, we excluded eight 
references that were diagnosed with cancer in the past eight years, leading to a final 
sample of 120 references. Compared to the references who participated at eight 
years after diagnosis, references who dropped out of the study since the first 
interview were significantly older, lower educated, and less often had a partner at T1 
(p < .05). 
The results presented in the present study are based on the 206 cancer survivors and 
120 references that participated at 3 months (T1), 15 months (T2), and 8 years (T3) 
after diagnosis. These points in the course of the illness are considered to reflect the 
initial period of crisis (3 months), short-term adjustment (15 months), and long-term 
adjustment (8 years). Using Chi-square analysis and t-tests for independent samples, 
we found no significant differences between cancer survivors and references on the 
main demographic characteristics (i.e. gender, age, marital status, and education). 
 
Measures 
At all points in time, survivors and references filled out a self-report questionnaire 
and were interviewed at home, using a semi-structured interview. At T3, the semi-
structured interview was followed by a more qualitative interview.  
 
Physical symptoms were measured with the 17-item subscale Physical Symptom 
Distress from the Rotterdam Symptom Checklist (RSCL) (De Haes et al., 1990; De 
Haes et al., 1996). Persons were asked to indicate the degree to which they had been 
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bothered by each of the 17 symptoms (e.g. lack of appetite, fatigue, stomach-ache, 
back pain, dizziness, decreased sexual interest, and shortness of breath) during the 
last week on a 4-point scale (ranging from 1 to 4). Cronbach’s alpha was .85 in 
survivors and .80 in references.  
Limitations in household activities were measured with the Groningen Activities 
Restrictions Scale (GARS) (Kempen et al., 1996; Kempen et al., 1993). The 
subscale consists of 7 items. Examples of household activities include: doing light or 
heavy household jobs and preparing meals. Four additional items were developed to 
measure limitations in social activities. Examples of social activities include: paying 
a visit to someone, participating in outdoor activities, and doing strenuous hobbies. 
On both scales, persons were asked to indicate the degree to which they are able to 
do certain activities on their own on a 5-point scale (ranging from 1 to 5). For the 
Limitations in Household Activities scale, Cronbach’s alpha was .90 in survivors 
and .93 in references. For the Limitations in Social Activities scale, Cronbach’s 
alpha was .83 in survivors and .88 in references.  
Depressive symptoms were assessed with the Dutch version of the Center for 
Epidemiologic Studies Depression (CES-D) scale (Bouma et al., 1995; Radloff, 
1977; Weissman et al., 1977). Persons were asked to indicate how often they felt 
each of the symptoms during the last week on a 4-point scale (ranging from 0 to 3). 
In the present study, we used a sumscore based on the 16 negatively formulated 
CES-D items (e.g. depressed mood, feelings of anxiety and loneliness, difficulties to 
get going). In a previous study, we found that a sumscore based on the 16 negatively 
formulated CES-D items, excluding the four positively formulated items, was a 
more valid measure of depressive symptoms, both in cancer patients and healthy 
individuals (Schroevers et al., 2000). The 16-item version of the CES-D scale still 
includes some somatic items (e.g. lack of appetite and sleeping problems) that may 
represent symptoms of depression and/or symptoms of cancer and its treatment. 
Cronbach’s alpha was .90 in survivors and .89 in references.  
The Silverlining questionnaire (SLQ), a 38-item self-report questionnaire, was 
used to measure a wide variety of positive consequences of illness (Sodergren & 
Hyland, 2000). The items are based on the content of the interviews held with 55 
people, either currently sick or having recovered from their illness. Examples of 
items include: “My illness helped me find myself” and “My illness strengthened my 
relationships with others”. On a  
5-point scale (ranging from 1 to 5), persons are asked to indicate whether they agree 
or not (or no opinion) with each of the statements. An overall score is obtained by 
scoring each item as 1 for responses ”strongly agree” and “agree” and 0 for the 
responses “not sure”, “disagree”, and “strongly disagree”. Thus the total score 
reflects the total number of items that patients agree with.  
                                                                                                     CHAPTER 6  106
The Life Regard Index (LRI), a 23-item self-report questionnaire, was used to 
measure a global sense of meaning in life (Battista & Almond, 1973; Debats, 1990; 
Debats, 1998). The scale consists of two subscales: “Framework” (10 items) and 
“Fulfilment” (13 items). The Framework scale measures the degree to which 
individuals can envision their lives within some meaningful perspective or have 
derived a set of life goals (e.g. “I have a clear idea of what I’d like to do with my 
life”), whereas the Fulfilment scale measures the degree to which people see 
themselves as having fulfilled or being in the process of fulfilling their life goals 
(e.g. “I feel that I live fully”). On a 3-point scale (ranging from 1 to 3), persons are 
asked to indicate whether they agree or not (or had no opinion) with each of the 
statements. For the Framework scale, Cronbach’s alpha was .75 in survivors and .82 
in references and for the Fulfilment scale .87 and .90, respectively.  
 
The aim of the qualitative interview at eight years after diagnosis was to collect 
information about the more specific aspects of long-term adjustment to cancer and 
functioning in general. Both survivors and references were asked about their current 
physical and psychological functioning and the appreciation of their activities, 
relationships with others, themselves, and life in general as well as about possible 
changes herein in the past eight years since diagnosis. Cancer survivors were asked 
additional questions about their specific concerns regarding the cancer experience 
(e.g. attentiveness to physical symptoms, thoughts about a recurrence, about the 
cause of the cancer, and about the question “Why me?”). Based on pilot interviews 
and the literature on long-term adjustment to cancer, categories of response were 
developed to code these open-ended responses. During the interview, survivors and 
references were encouraged to talk freely at their own past, but carefully prompted 
to talk about the aforementioned aspects of functioning. The trained interviewer then 
scored the answer to the questions on one or more response categories. 
When cancer survivors reported a change, they were asked to indicate to what 
extent cancer had influenced this change. Thus, rather than asking cancer survivors 
directly about the consequences of cancer, we first asked them to indicate changes in 
their functioning, and subsequently, the influence of cancer upon these changes. By 
formulating the questions in such a neutral way, we wanted to avoid influencing 
patients’ response about the consequences of cancer. It also enabled us to ask the 
reference group the same questions.  
 
Information about sociodemographic characteristics (gender, age, education, and 
marital status) was collected during the semi-structured interview. Information about 
disease characteristics (cancer site, stage, treatment) was derived from the cancer 
registration from the Comprehensive Cancer Centre North Netherlands. During the 
 AGE AND LONG-TERM ADJUSTMENT                                                                                                                              107
semi-structured interview at T3, we asked patients whether they had experienced a 
recurrence of the cancer or a new primary tumour in the past eight years.  
 
Statistical analyses 
Chi-square analysis was used to examine differences between the patient and 
reference group in their sociodemographic characteristics. Pearson’s correlation 
coefficients were computed to examine the relationships among the variables of 
outcome. Analyses of variance (ANOVA) were performed to examine age 
differences in outcomes, in the patient and reference group separately. When the test 
reached significance (p < .05), post-hoc tests were inspected to detect which age 
groups significantly differed from each other. The data from the qualitative 
interview were analysed using Chi-square analysis (p < .05). T-tests for independent 
samples were used to examine differences in outcomes between survivors and 
references (p < .05). 
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Table 1. Sample characteristics of cancer survivors (n = 206) and references (n = 120) at 
eight years after diagnosis 
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Thus, within the three different age groups, we examined differences between 
survivors and references. For instance, we compared levels of physical symptoms in 
survivors younger than 45 years with those in references younger than 45 years. 
 
 
Results  
 
Sample characteristics 
The characteristics of the present sample at eight years after diagnosis (T3) are 
shown in Table 1. Using Chi-square analysis, we found that younger persons, both 
in the group of survivors and references, were more likely to be living with a partner 
and to have a higher education than older persons (p < .01). Within the group of 
survivors, we found significant age differences in site (p < .05) and treatment (p < 
.001). Consistent with the associations of age with site and treatment (Coebergh et 
al., 1995), younger survivors were more likely to be diagnosed with breast or 
gynaecological cancer and to be treated with chemotherapy.  
 
Descriptives 
The intercorrelations among the outcome variables are presented in Table 2, for 
survivors and references separately. In both groups, we found significant 
relationships between physical symptoms and limitations in household and social 
activities on the one hand and depressive symptoms and meaning in life on the other 
hand. This shows that higher levels of physical symptoms and limitations were 
associated with higher levels of depressive symptoms and lower levels of meaning 
in life. The strength of these associations was similar in survivors and references. 
The only exception was the relationship between limitations in household activities 
and meaning in life (both scales), which was stronger in survivors than in references.  
 
Physical functioning 
In the first year after diagnosis, we found no overall significant relationship between 
patients’ age and the level of physical symptoms and limitations in household and 
social activities (see Table 3). In the reference group, on the other hand, we found 
significant associations of age with measures of physical functioning, with persons 
aged 65 years or older reporting more limitations in household and social activities. 
When we compared patients’ levels of physical functioning with those in similar-
aged references, we  
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Table 2. Intercorrelations among outcome variables in cancer survivors and references   
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found, at three months after diagnosis (T1), that patients in the two age groups 
younger than 65 years reported significantly more physical symptoms and 
limitations in household and social activities than similar-aged references (p < .001). 
At this point in time, survivors aged 65 years or older differed significantly from 
similar-aged references only in their level of limitations in social activities (p < .01) 
and showed a non-significant tendency towards relatively higher levels limitations in 
household activities (p < .10). At 15 months after diagnosis (T2), patients aged 45-
65 years still reported more physical symptoms and limitations in household 
activities  
(p < .01) and social activities (p < .001) than similar-aged references. Patients 
younger than 45 years also showed higher levels of limitations in social activities 
than similar-aged references (p < .05).  
In contrast to the first year after diagnosis, we did find a significant relationship 
between survivors’ age and physical symptoms (p < .05) and limitations in 
household and social activities (p < .001) at eight years after diagnosis (T3). In 
general, survivors in the two age groups younger than 65 years at diagnosis reported 
significant fewer physical symptoms and limitations in their household and social 
activities than survivors of 65 years or older. The only exception was found in 
survivors aged 45-65 years, who showed significant higher levels of physical 
symptoms than those younger than 45 years. In fact, at eight years after diagnosis, 
the level of physical symptoms in survivors aged 45-65 years was more comparable 
with that in survivors of 65 years or older.  
In the reference group, we found similar associations of age with physical 
symptoms (p < .01) and limitations in household and social activities  
(p < .001) at eight years after the first interview (T3). Comparisons of survivors and 
similar-aged references revealed that survivors aged 45-65 years reported 
significantly more physical symptoms than similar-aged references (p < .001). Such 
a tendency was also found in survivors younger than 45 years (p < .10). Survivors in 
the two younger age groups also reported more limitations in their social activities 
than similar-aged references (p < .05). In contrast, survivors aged 65 years or older 
reported comparable levels of physical symptoms and limitations in their activities 
as similar-aged references. 
In line with these findings, the results of the qualitative interview showed that 
survivors in the two age groups younger than 65 years reported more cancer-related 
physical problems (e.g. fatigue and arm problems) at eight years after diagnosis than 
the oldest survivors group (69% and 51% versus 34%) (p < .01). 
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Table 3. Age differences in outcome variables in cancer survivors and references at 3 months 
(T1), 15 months (T2), and 8 years (T3) after diagnosis 
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Psychological functioning 
At three months after diagnosis (T1), patients’ age was significantly related to 
depressive symptoms (p < .01), with patients in the younger two age groups 
reporting significantly more depressive symptoms than patients of 65 years or older. 
In references, on the other hand, age was not significantly related to the level of 
depressive symptoms. Comparisons of patients and similar-aged references showed 
that patients younger than 45 years (p < .05) and those aged 45-65 years (p < .001) 
reported significantly more depressive symptoms at three months after diagnosis 
(T1) than similar-aged references. At 15 months after diagnosis (T2), only patients 
aged 45-65 years still reported significantly more depressive symptoms than similar-
aged references (p < .01). 
At eight years after diagnosis (T3), age was not significantly related to 
depressive symptoms, neither in cancer survivors nor in references. However, 
comparisons between survivors and similar-aged references revealed that survivors 
aged 45-65 years still reported more depressive symptoms than similar-aged 
references (p = .05). The same tendency was found in survivors younger than 45 
years (p < .10). In contrast, older cancer survivors reported comparable levels of 
depressive symptoms as similar-aged references.   
The results of the qualitative interview showed that younger cancer survivors 
were more preoccupied with the cancer experience than older cancer survivors at 
eight years after diagnosis. Specifically, compared to older survivors, the two 
youngest groups of survivors reported more general cancer-related thoughts (36% 
and 23% versus 15%) (p < .001), more thoughts about a possible cause of the cancer 
(42% and 35% versus 13%)  
(p < .05), and more thoughts about the question “Why me?” (24% and 22% versus 
4%) (p < .01). Furthermore, compared to older survivors, the two youngest groups 
of survivors (especially those younger than 45 years) reported to a greater extent that 
they had become more attentive to physical symptoms over time (60% and 38% 
versus 28%) (p < .05). We found no significant association between age and a fear 
of recurrence (42%, 34%, and 31%, respectively in the three age groups). 
 
Meaningfulness in life 
At eight years after diagnosis (T3), we found a significant relationship between 
survivors’ age and both scales (i.e. framework and fulfilment) of a global sense of 
meaningfulness in life (p < .05). Survivors in the two age groups younger than 65 
years at diagnosis reported significantly more framework and fulfilment than 
survivors of 65 years and older. Thus, compared to older survivors, younger 
survivors reported to a greater extent that they had a meaningful perspective and 
important goals in life and that they gained a sense of fulfilment out of their life.  
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A similar tendency was found in the reference group, with those younger than 65 
years at the time of the first interview reporting a greater sense of meaningfulness in 
life. Comparisons between survivors and similar-aged references showed no 
significant differences in a sense of meaningfulness in life. In other words, the levels 
of framework and fulfilment in younger survivors were comparable to those in 
younger references. Similarly, older survivors and older references reported 
comparable levels of framework and fulfilment. 
 
Positive consequences of illness 
At eight years after diagnosis (T3), we asked cancer survivors about the positive 
consequences of illness. The results showed that survivors younger than 65 years at 
diagnosis reported more positive consequences of illness than those aged 65 years or 
older, but this was not significant. However, a closer look at the individual items 
showed that certain items were endorsed significantly more often by younger than 
by older cancer survivors (p < .01). Specifically, compared to survivors of 65 years 
and older, survivors in the two younger age groups reported more often that they had 
become more mature (46% and 31% versus 12%), had a greater awareness of their 
own strengths (51% and 35% versus 22%), were less concerned about the approval 
of others (67% and 59% versus 35%), had a greater appreciation for life (87% and 
77% versus 53%), and lived more intense (62% and 63% versus 37%) as a result of 
illness. Other items, however, were endorsed about equally frequent by the three 
age-groups, such as the illness made me: more tolerant, doing things for myself, 
stand up for one self, more determined, facing problems in life, having stronger 
relationships, others more open towards me, reflecting about myself, and about a 
goal in life. 
The results of the qualitative interview at eight years (T3) also showed that 
survivors in the two youngest age groups reported more often than older survivors 
that they had a greater appreciation of their relationships with their family (42% and 
26% versus 8%) and with their partner (47% and 26% versus 11%) than eight years 
ago (p < .01). Survivors in the two youngest groups also reported more often that 
they had a greater appreciation of themselves (48% and 33% versus 4%) and of their 
life in general (65% and 52% versus 21%) than eight years ago (p < .01). It is 
important to note that a substantial number of the younger survivors  
(about 30 to 60%) attributed these changes to the cancer experience.  
In response to the general question “Overall, to what extent has cancer changed your 
life?”, the two younger groups of survivors were more likely to say that cancer had 
changed their life than those of 65 years or older  
(56% and 34% versus 13%) (p < .001). 
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Discussion 
 
The aim of the present study was to examine how three different age groups of 
cancer survivors function in the eight years following diagnosis, in comparison with 
an age- and gender-matched reference group of individuals without a history of 
cancer from the general population. Overall, our findings suggest that, when taken 
into account the levels of functioning in the reference group, the impact of cancer 
and its treatment is greatest in patients younger than 65 years at the time of 
diagnosis. Specifically, compared to similar-aged references, younger cancer 
patients (especially those aged 45-65 years) reported a significantly poorer physical 
functioning (i.e. more physical symptoms and limitations in household and social 
activities) and poorer psychological functioning (i.e. more depressive symptoms) in 
the first year after diagnosis. At eight years after diagnosis, younger cancer survivors 
still reported more physical symptoms, limitations in social activities, and somewhat 
more depressive symptoms than similar-aged references. No significant differences 
between survivors and similar-aged references were found in a global sense of 
meaningfulness in life. Interestingly though, compared to older cancer survivors, 
younger cancer survivors sought more meaning in the cancer experience. That is, 
they reported more often that they had thought about a possible cause of the cancer 
and about the question “Why me?”. Besides such causal attributions, they also 
reported more positive consequences of the cancer experience. 
First, the results demonstrated a strong association of age with survivors’ 
physical functioning at eight years after diagnosis, with survivors of 65 years or 
older at diagnosis reporting more physical symptoms and limitations in activities 
than those younger than 65 years. However, a similar association of age with 
physical functioning was found in the reference group. Comparisons of survivors 
and similar-aged references revealed no significant differences between the levels of 
physical impairment in cancer survivors in the age of 65 years or older and those in 
similar-aged references. Thus, older cancer survivors seem to experience levels of 
physical functioning, that are natural at an advanced age, with the increased 
incidence of chronic illnesses and general health problems. This finding does not 
preclude, that, at an individual level, older cancer survivors may still experience late 
physical problems as a result of cancer. The data from the qualitative interview 
showed that older cancer survivors reported fewer cancer-related physical problems 
than younger cancer survivors. Overall, the findings suggest that cancer has only a 
marginal impact on the physical functioning of older cancer survivors. 
In younger cancer survivors, on the other hand, cancer does seem to have a 
strong impact on long-term physical functioning. That is, compared to similar-aged 
references, cancer survivors younger than 65 years at diagnosis (especially those 
aged 45-65 years) showed elevated levels of physical symptoms at eight years after 
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diagnosis than similar-aged references. Younger cancer survivors also reported more 
limitations in their social activities than similar-aged references. In addition, the data 
from the qualitative interview showed that, compared to older cancer survivors, 
younger cancer survivors had become more attentive to physical symptoms over 
time. On the whole, these findings provide support for the belief that, in younger 
cancer survivors, cancer and its treatment may accelerate the ageing process and 
accentuate a sense of physical vulnerability experienced normally with ageing 
(Rowland, 1989a). Since physical symptoms in cancer patients probably have both a 
somatic and a psychological component, it remains unclear to what extent this 
“speeding up” of the ageing process is real or imagined (Chaturvedi & Maguire, 
1998). Providing information about the process of physical recovery and the late 
effects of cancer and its treatment during follow-up medical check-ups may help 
younger cancer survivors to deal with the physical symptoms and limitations and to 
maintain a balance between inattentiveness to and preoccupation with physical 
symptoms (Gray et al., 1998; Jenkins et al., 2001; Somerfield et al., 1999).  
Consistent with the findings of the study of Weitzner et al. (1997), we found no 
significant association of survivors’ age with depressive symptoms at eight years 
after diagnosis. However, comparisons of survivors with similar-aged references 
revealed a different picture. These analyses showed that cancer survivors younger 
than 65 years at the time of diagnosis reported higher levels of depressive symptoms 
than similar-aged references. In the Introduction, we already mentioned several 
reasons for why younger cancer patients are more likely to report depressive 
symptoms. They may be less anticipated, have fewer prior coping experience with 
illness and adversity, more competing demands and responsibilities, and a greater 
sense of loss and deprivation. The process of social comparison may also play an 
important role herein. It can be imagined that in the aftermath of cancer and its 
treatment, younger cancer survivors compare themselves with family members and 
friends of their age. Since serious chronic illnesses are less common at this age, such 
comparisons may lead to feelings of being different and isolated and a sense of 
deprivation, seeing for example that others have a better physical health and fewer 
restrictions in their daily life (Van der Zee, 1996).  
Regarding the search for meaning, we found that younger cancer survivors 
reported a greater search for meaning in the cancer experience than older survivors, 
in terms of more thoughts about the cause of the cancer and about the question 
“Why me?”. Younger cancer survivors were also more likely than older survivors to 
experience benefits of the cancer experience, such as a greater maturity, greater 
awareness of own strengths, less concern about the approval of others, living more 
intense, and a greater appreciation of the self, life in general, and relationships with 
others. Besides a greater search for meaning in the illness experience, younger 
cancer survivors reported a greater global sense of meaningfulness in life at eight 
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years after diagnosis than older cancer survivors. However, such an association was 
also found in references and comparisons between survivors and similar-aged 
references revealed no significant differences in a global sense of meaningfulness in 
life. Thus, in the long term, a diagnosis of cancer does not seem to affect a global 
sense of meaningfulness in life. 
Why do cancer survivors, especially those being younger at the time of 
diagnosis, search for meaning in the cancer experience? The confrontation with a 
life-threatening event may challenge patients’ basic beliefs about their personal 
invulnerability, their self-worth, and the meaningfulness of life (Janoff-Bulman & 
Frieze, 1983). In such periods of uncertainty and confusion, people often actively 
search for meaning, in an attempt to understand why the unexpected and stressful 
event happened and its personal significance (Taylor, 1983). The greater sense of 
threat and emotional response to a diagnosis of cancer may have motivated younger 
cancer patients to search for and create positive meaning (Folkman, 1997). These 
cognitive efforts may have enabled them to cope with the negative consequences of 
the illness and to restore their psychological well-being (Folkman, 1997; Taylor, 
1983). 
When interpreting the results of the present study, several methodological 
considerations should be considered. First, we examined a heterogeneous sample of 
cancer survivors, diagnosed initially with breast, colorectal, gynaecological, or lung 
cancer. These types of cancer represent the most common types of cancer. Thus the 
results of the present study are likely to be relevant for a large group of cancer 
patients (Visser et al., 1998). Still, cancer patients diagnosed with other types of 
cancer may show a different course of long-term adjustment. Secondly, in the 
present study, no information was available about the level of a global sense of 
meaningfulness in life and positive consequences of illness in the initial period after 
diagnosis. Consequently, no conclusions could be drawn about the short-term effect 
of cancer upon these outcomes. Finally, regarding the analyses, we have focused on 
age differences in the presence of functioning rather than in changes in functioning 
(e.g. difference scores), since the primary goal of the study was to elaborate on the 
role of age in survivors’ long-term functioning at eight years after diagnosis. A 
problem with analysing changes is the lack of a true baseline assessment, that is, of a 
premorbid assessment of cancer patients. Given that patients were included after the 
diagnosis, their functioning was impaired by the cancer and its treatment. Therefore, 
comparisons between patients and references in difference-scores of functioning will 
misrepresent the process of adjustment to cancer.  
Overall, the results of the present study demonstrate that age is more than a 
statistical control variable. The findings provide an intriguing description of the 
complex and interwoven processes of long-term adjustment to cancer and ageing 
and extend previous studies in several ways. First, the higher levels of physical 
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impairment in older cancer survivors are comparable with those in older individuals 
from the general population. Secondly, in comparison with similar-aged individuals 
from the general population, the short- and long-term impact of cancer and its 
treatment is greatest among younger cancer survivors. Future research is needed to 
examine more closely why a younger age is so strongly related to long-term 
adjustment to cancer. Furthermore, there is a need for multivariate studies that will 
identify those younger cancer survivors who are at greatest risk of poor long-term 
adjustment to cancer. 
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General discussion 
 
 
 
 
 
 
 
 
 
 
 
 
The thesis started off with the statement that, both from a scientific and common-
sense point of view, there are many ideas about how patients adjust to cancer, yet 
that the empirical evidence on this topic is still elusive. Having carried out the 
present study, where do we stand now? In this final chapter, the main findings of the 
study are reviewed and conclusions are drawn about the two main research 
questions. In addition, some overall methodological considerations regarding the 
design of the present study are addressed in order to evaluate the conclusions drawn. 
This chapter will end with some theoretical reflections and the implications for 
future research and clinical practice will be outlined.  
 
 
Main findings 
 
The Introduction described the multiple physical and psychosocial consequences 
that cancer patients may experience as a result of the disease and its treatment. In the 
period following the diagnosis of cancer, patients must come to terms with the 
diagnosis of a life-threatening and still stigmatised disease and the often painful, 
disfiguring, and disabling treatment and side-effects. Patients may also experience 
emotional problems as a result of cancer and its treatment and changes in their self-
image, sense of autonomy and competence, social activities and relationships with 
others. In the long term, most cancer patients adapt remarkably well to the cancer 
experience and are able to continue their lives. Some survivors even feel that cancer 
has improved their life in a certain way.  GENERAL DISCUSSION                                                                                                                               121
Figure 1. Stress-coping model of Moos and Schaefer  
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In order to organize the main variables of interest and to reach a clearer 
understanding of the adjustment to cancer and the individual differences herein, the 
stress-coping model of Moos and Schaefer was introduced (see Figure 1). The model 
proposes that three sets of factors influence patients’ health and psychological well-
being: (a) characteristics of the life crisis (e.g. disease characteristics such as cancer 
site, stage, and treatment), (b) more or less stable personal factors (i.e. 
sociodemographic characteristics and personal resources), and (c) the environmental 
system (i.e. social resources and other life events and chronic illnesses). The bi-
directional paths in the model indicate that reciprocal feedback can occur. For 
instance, patients’ social resources (e.g. social support) can enhance their personal 
resources (e.g. self-esteem) and vice versa. Furthermore, the process of adjustment 
to cancer may lead to personal growth, in terms of enhanced personal and social 
resources and more effective coping skills. Based on the model, two main research 
questions can be formulated:  
 
(a)  what is the impact of a diagnosis of cancer and its treatment on patients’ 
physical and psychological functioning and on their personal and social 
resources during the course of the illness?  
(b)  what is the role of patients’ sociodemographic and disease characteristics 
and their personal and social resources in the process of adjustment?  
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First part 
The first part of the book (Chapter 2, 3, and 4) focused on depressive symptoms in 
the year following diagnosis. Specifically, we explored the extent to which cancer 
patients develop such symptoms shortly after diagnosis and whether these symptoms 
persist in the year following diagnosis. In addition, the associations of patients’ 
sociodemographic and medical characteristics and personal and social resources 
with depressive symptoms in the year following diagnosis were investigated. First, 
however, we examined the psychometric properties of the self-report questionnaire 
that was used in the present study to measure depressive symptoms, the Center for 
Epidemiologic Studies Depression (CES-D) scale.  
 
The main interest of Chapter 2 was to examine the content and function of the four 
positively formulated items in the CES-D scale, a mainly negatively formulated 
measure of depressive symptoms. The results clearly demonstrated that, both in 
cancer patients and in references without cancer from the general population, the 
negatively and the positively formulated items measure two distinct and relatively 
independent concepts, subsequently called Depressed Affect and Positive Affect. 
Therefore, subsequent analyses focused on the reliability and validity of these two 
scales. Both scales were found to have good internal consistency (i.e. Cronbach’s 
alpha > .70). The study also provided strong evidence for the validity of the 
Depressed Affect scale. First, the content of the items reflected the definition of 
depression. Secondly, the scale appeared to be strongly correlated with other 
measures of psychological distress, physical symptoms, and neuroticism and 
discriminated cancer patients from references.  
The validity of the Positive Affect scale, on the other hand, could not be 
demonstrated. First, the correspondence between the content of the four positively 
formulated items and the definition of depression was less clear. For example, when 
someone reports that he or she has rarely or little of the time “felt as good as others”, 
“felt hopeful about the future”, “was happy”, and “enjoyed life”, does this 
necessarily mean that this person is depressed? Probably not. The scale was also 
weakly related to other measures of psychological distress and was not able to 
discriminate cancer patients from references in the initial period after diagnosis. 
Furthermore, since positive affect has in general been related to extraversion, the 
weak correlations between the Positive Affect scale and extraversion raised further 
doubt about the validity of the scale. Finally, Depressed Affect and Positive Affect 
were about equally strong related to positive outcomes, such as quality of life, life 
satisfaction, and self-esteem.  
All together, the findings indicated that the CES-D measures two distinct 
concepts questions. This questions the validity of the use of the original total 
sumscore. The Depressed Affect scale proved to be a reliable and valid measure of 
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depressive symptoms, both in cancer patients and in the general population, but the 
validity of the Positive Affect scale could not be determined. Therefore, 16-item 
version of the CES-D was used throughout the thesis as a more valid measure of 
depressive symptoms. 
 
Chapter 3 examined the presence and course of depressive symptoms in cancer 
patients at 3 and 15 months after diagnosis, compared to a reference group of 
individuals without cancer from the general population. We also examined to what 
extent sociodemographic and disease characteristics were associated with the 
presence and course of depressive symptoms. Hereby, two important issues were 
taken into account. First, sociodemographic factors have also been related to 
depressive symptoms in the general population. Second, patients’ sociodemographic 
characteristics are likely to be related to their disease characteristics.  
Importantly, the results showed that, at three months after diagnosis, cancer 
patients experienced significantly more depressive symptoms than references, with 
about a quarter of all cancer patients being possible cases of depression. Despite a 
small improvement in these symptoms over time, patients continued to report 
elevated levels of depressive symptoms up till 15 months after diagnosis. Clearly, 
the findings show that depressive symptoms in cancer patients are associated with 
the disease and its treatment, rather than merely a reflection of general psychological 
morbidity. These results provide evidence for the belief that a diagnosis of cancer 
may be regarded as a life crisis. Adaptation to such a crisis is believed to involve a 
process in which phases of emotional distress and coming to terms with the disease 
alternate with phases of denial and repression of intrusive thoughts (Horowitz, 
1986). Thus to some extent, depressive symptoms may be viewed as a normal 
response to the diagnosis of cancer. However, if depressive symptoms become more 
severe and persistent and impair patients’ daily functioning and adherence to cancer 
treatment, they are not adaptive and frequently require psychological treatment. In 
this context, it is important to note that the level of depressive symptoms in patients 
at 15 months after diagnosis was strongly related to the amount of depressive 
symptoms shortly after diagnosis. This finding demonstrates that early recognition 
and treatment of patients with heightened levels of depressive symptoms may be 
fruitful to prevent that these symptoms become long lasting.   
The examination of the risk factors showed that especially patients younger than 
65 years at the time of diagnosis experienced depressive symptoms in the first year 
after diagnosis. Of the disease characteristics, only cancer site was associated with 
higher levels of depressive symptoms. However, this effect of site disappeared when 
controlling for sociodemographic characteristics such as patients’ age and gender. 
Thus, although it seems to be counter-intuitive, specific disease characteristics seem 
to be less important than the overall impact of cancer itself. Regarding the course of 
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depressive symptoms in the period between 3 to 15 months after diagnosis, it was 
found that cancer patients with a lower stage and those with a higher education 
showed relatively more improvement over time than those with a higher stage and 
lower education, respectively.     
To conclude, a diagnosis of cancer and its treatment may induce depressive 
symptoms in a significant minority of the patients in the period following diagnosis, 
especially in those being relatively younger at the time of diagnosis.  
  
Chapter 4 explored the associations of personal and social resources (i.e. self-esteem 
and social support), measured at three months after diagnosis, with depressive 
symptoms at 3 and 15 months after diagnosis. First, however, we examined to what 
extent feelings of positive self-esteem are related to social support (i.e. perceived 
availability of emotional support, lack of problem-focused emotional support, and 
negative social interactions). Surprisingly, in contrast to theoretical notions, self-
esteem appeared to be rather weakly related to all three types of social support, both 
in cancer patients and in references. Only the perceived availability of emotional 
support was moderately related to positive self-esteem.  
Next, we examined to what extent self-esteem and social support are 
independently related to the presence and course of depressive symptoms. We also 
made comparisons between patients and references in these associations of social 
support and self-esteem with depressive symptoms. Both resources were 
independently related to depressive symptoms at three months after diagnosis, 
indicating that those who lack social support and those who have low feelings of 
positive self-esteem experience higher levels of depressive symptoms. In general, 
the associations of social support and self-esteem with depressive symptoms were 
similar in patients and references. The only exception was problem-focused 
emotional support, which was more strongly related to depressive symptoms in 
cancer patients than in references. The longitudinal analyses revealed that only 
social support but not positive self-esteem was related to the future level of 
depressive symptoms at 15 months after diagnosis, when controlling for the initial 
level of depressive symptoms at three months after diagnosis.  
Overall, the findings demonstrate that both self-esteem and social support mainly 
fulfil basic human needs, namely the need to like oneself and to see oneself as 
competent and the need to belong and to feel attached to others (Maslow, 1970). 
Only problem-focused emotional support, characterized by reassuring, comforting, 
problem-solving, and advice, seems to be especially important for cancer patients in 
the initial period after diagnosis. This shows that the availability of someone which 
whom patients can talk about the disease and his or her worries and concerns is of 
great importance for patients’ psychological adjustment to cancer.   
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Second part 
In the second part of the book (Chapter 5 and 6), we shifted our attention from 
patients’ short-term adjustment to cancer to their long-term adjustment at eight years 
after diagnosis. In order to obtain a comprehensive description of their adjustment to 
the illness, a wide variety of aspects of physical and psychological functioning and 
personal and social resources were investigated.  
 
The first results were presented in Chapter 5. The focus of the study was to examine 
differences between cancer survivors and references without cancer on a wide 
variety of outcome measures at three points in time: 3 months, 15 months, and 8 
years after diagnosis. We also examined differences between the two groups in the 
level of changes in these outcomes measures over time. Additional analyses were 
performed to examine the impact of a recurrence or new primary tumour on 
survivors’ long-term functioning. A key finding of the study was that survivors’ 
levels of psychological functioning and resources at eight years after diagnosis were 
comparable to those in references from the general population. Thus, cancer and its 
treatment do not seem to have a long-term effect on psychological functioning, nor 
does the cancer experience seem to affect the presence of personal and social 
resources. However, cancer survivors did still experience higher levels of physical 
symptoms at eight years after diagnosis than references. Survivors who had 
developed a recurrence or new primary tumour reported also more limitations in 
their daily and social activities and to some extent more depressive symptoms than 
references. The data from the qualitative interview showed that many cancer 
survivors had become more attentive to physical symptoms over time and were still 
concerned about a recurrence of the cancer. 
Longitudinal analyses showed significant improvements in physical and 
psychological functioning in cancer patients in the first year following diagnosis. In 
the years thereafter, both survivors and references showed a worsening of physical 
functioning. The longitudinal data further showed that, at group level, the amount of 
personal and social resources in survivors and references was stable over time. In 
contrast, during the interview at eight years after diagnosis, both survivors and 
references reported positive changes, such as a greater appreciation of themselves 
and life in general. Furthermore, although the amount of these positive changes in 
survivors was similar to that in references, many cancer survivors attributed these 
positive changes to the cancer experience.  
Taken together, the findings suggest that long-term cancer survivors still 
experience elevated levels of physical problems as well as a greater attentiveness to 
physical symptoms and a fear of recurrence. At the same time, they report good 
psychological well-being and no loss of their personal and social resources. 
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In Chapter 6, we pursued into greater depth survivors’ long-term adjustment to 
cancer, by examining the role of patients’ age at the time of diagnosis in the process 
of their long-term adjustment. First, we examined, within the group of cancer 
survivors, age differences in physical and psychological functioning, in a global 
sense of meaningfulness in life, and in positive consequences of illness. Secondly, 
we compared the levels of outcomes in cancer survivors with those in similar-aged 
references.  
The findings clearly demonstrated the existence of certain age patterns. Cancer 
survivors in the age of 65 years or older at the time of diagnosis reported 
significantly more physical impairment at eight years after diagnosis than younger 
survivors. However, a similar association of age with physical functioning was 
found in references. Comparisons of survivors with similar-aged references revealed 
that the higher levels of physical impairment in older survivors were comparable 
with those in similar-aged references. Thus, it seems that older cancer survivors 
experience a level of physical functioning that is normal at their age. Survivors 
younger than 65 years, on the other hand, did report significantly more physical 
impairment than similar-aged references. Furthermore, although survivors’ age was 
not significantly related to the level of depressive symptoms at eight years after 
diagnosis, comparisons with similar-aged references revealed that younger survivors 
reported more depressive symptoms than references of their age.  
A diagnosis of cancer does not seem to affect survivors’ global sense of 
meaningfulness in life, as indicated by similar levels of a sense of meaning in life in 
cancer survivors and similar-aged references. Interestingly though, younger 
survivors did report a greater search for meaning in the cancer experience than older 
survivors, in terms of causal attributions (about the cause of the cancer and the 
question “Why me?”) and finding benefits in the cancer experience. For instance, 
younger cancer survivors reported that they felt more mature, more aware of own 
strengths, were less concerned about the approval of others, lived more intense, and 
had a greater appreciation of the self, life in general, and relationships with others.  
On the whole, it can be concluded that the long-term impact of cancer and its 
treatment on physical and psychological functioning is most apparent in younger 
cancer patients. Among older cancer survivors, the impact of cancer and its 
treatment seems to be marginal. Their functioning is more affected by ageing 
processes in general.  
 
 
Conclusions 
 
In the following two paragraphs, we will return back to the two main research 
questions and draw some overall conclusions about the short- and long-term 
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consequences of cancer and its treatment and the significance of certain factors as 
predictors of (mal) adjustment. 
 
The impact of cancer on patients’ physical and psychological 
functioning and on their personal and social resources 
The vast evidence from the present study is that the majority of the cancer patients 
adapt remarkably well, after the initial adjustment in the first year after diagnosis. 
Thus even under conditions of extreme stress and uncertainty, people seem to have a 
great capacity to adapt to life crises and transitions. Still, certain problems, such as 
physical symptoms and a greater attentiveness to physical symptoms and fear of 
cancer recurrence, may endure till years after cancer and its treatment. In the context 
of less medical surveillance and persistent physical problems, it is not surprising that 
cancer survivors feel uncertain about their body. Despite these long-term physical 
and psychological sequelae, cancer survivors also report positive outcomes as a 
result of their cancer experience. They feel more self-confident and have a greater 
appreciation of their relationships with others and life in general. In their “struggle 
for existence”, cancer patients attempt to adapt to the new situation as good as they 
can, by reducing or managing the negative consequences and striving for growth and 
fulfilment. It has to be emphasized, however, that these overall encouraging concern 
only patients who have survived cancer for eight years. It should not be overlooked 
that a substantial number of the patients who were originally included in the study 
have died.  
The impact of cancer and its treatment on patients’ physical and psychological 
functioning is most apparent in the first year following diagnosis. Especially in the 
first months after diagnosis, patients report physical symptoms and limitations in 
their activities and experience elevated levels of depressive symptoms. During the 
year following diagnosis, these problems diminish, but at 15 months after diagnosis, 
patients still report more physical and psychological problems than references 
without a history of cancer.  
In the years following the first year after diagnosis, a worsening of patients’ 
physical functioning was observed. These changes in physical functioning may 
partly be the result of ageing in general. In addition, the association of neuroticism 
(i.e. emotional instability) and a fear of recurrence with physical symptoms suggest 
that physical symptoms in cancer patients may have both a somatic and 
psychological component.  
 
The role of patients’ sociodemographic and disease characteristics 
and resources in the process of adjustment 
The present study explored a range of disease and sociodemographic characteristics 
and psychosocial resources as correlates of patients’ short- and long-term adjustment 
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to cancer. These analyses revealed three important factors that were associated with 
elevated levels of physical and/or psychological problems: (a) a younger age at the 
time of diagnosis, (b) a lack of social support, and (c) low feelings of positive self-
esteem.  
Both in the patient and in the reference group, being female was associated with 
higher levels of depressive symptoms in the first year after diagnosis. This finding 
suggests that the greater likelihood of depressive symptoms in female cancer 
patients primarily reflects general vulnerability, rather than an increased risk of 
depressive symptoms as a result of cancer. A younger age, on the other hand, was 
only in cancer patients significantly related to higher levels of depressive symptoms. 
Thus a younger age at the time of diagnosis can be regarded as a predictor of 
depressive symptoms as a result of cancer. In the long-term, younger patients still 
reported elevated levels of depressive symptoms, compared to similar-aged 
references. They also experience relatively elevated levels of physical problems, 
compared to references of their age.  
Besides a younger age, low feelings of social support and self-esteem were 
related to higher levels of depressive symptoms in the first year after diagnosis, both 
in patients and in references. Thus as with gender, a lack of these resources seems to 
primarily reflect general vulnerability. The only exception was problem-focused 
support, which was clearly more important for patients’ psychological functioning in 
the initial months after diagnosis.   
Overall, two different types of risk factors can be distinguished:  
(a) factors that are associated with adjustment problems as a result of cancer and its 
treatment, and (b) factors that primarily reflect an increased vulnerability in the 
general population. This finding has clinical implications. Whereas some cancer 
patients may need an intervention that focuses on particular cancer-related issues 
and concerns, other cancer patients may benefit from general psychological care as 
well.   
 
 
Methodological considerations 
 
In the present longitudinal study, a large group of cancer patients and references 
without a history of cancer from the general population were assessed at four points 
in time in the eight years following diagnosis. Furthermore, both quantitative and 
qualitative measures were used to capture the process of long-term adjustment to 
cancer. This elegant methodological design had important advantages over previous 
research. First, the use of the age- and gender-matched reference group enabled us to 
draw more firm conclusions about the true effect of cancer upon outcomes and the 
factors associated with these outcomes in patients. Secondly, through the use of a 
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longitudinal design with fixed assessment points in time, we were able to examine 
the process of adjustment to cancer, thus recognizing that the physical and 
psychosocial sequelae that patients face may vary over the course of the illness. The 
multiple points of assessment also enabled us to examine predictors of future (mal) 
adjustment. Finally, the qualitative data at eight years after diagnosis supplemented 
the quantitative data in a valuable way and provided more insight in the specific 
concerns of long-term cancer survivors.  
The carrying out of the current study gave rise to some methodological thoughts 
about the study design and methods being used. In the section below, we will 
discuss these issues, including the sample characteristics, the use of a reference 
group, the longitudinal design, and the combination of quantitative and qualitative 
data. In some cases, the discussion will centre on the present study, whereas in other, 
more general methodological concerns will be discussed. 
 
Sample characteristics 
One of the inclusion criteria of the present study was that patients had to have a life 
expectancy of at least 12 months. As a result, the majority of the patients were 
diagnosed with an early stage of disease. An important advantage of including 
mainly patients with a relatively good prognosis is that a large group of cancer 
patients could be followed up from diagnosis till eight years thereafter. Obviously, 
long-term adjustment can only be studied in cancer patients who have a good 
prognosis. Nevertheless, it can be reasoned that the results of the present study 
regarding patients’ short-term adjustment concern only patients with a good 
prognosis and not patients with a worse prognosis and those being terminally ill.  
During the study, there was a decline in response in cancer patients diagnosed 
with colorectal or lung cancer, a stage III or IV, a more advanced age, being male, 
and a lower education. Many of these cancer patients had died. In the reference 
group, we also found a declining response in those with an advanced age, a lower 
education, and those without a partner. Some of these references had died, whereas 
others were too sick or unwilling to participate. These processes of selective drop 
out may have affected the results presented in the present thesis. That is, it seems 
that patients with a poorer functioning were more likely to drop out and therefore, 
one must not exclude the possibility that some of the findings are an underestimation 
of the effects of cancer upon patients’ physical and psychological functioning. The 
drop out of people is often regarded as a problem in longitudinal studies. However, 
the position can also be taken that longitudinal studies reveal some of these 
processes of selection that are often masked in cross-sectional studies or in studies 
using convenient samples. The availability of the information in longitudinal studies 
about the sample under study and the characteristics of those who dropped out may 
thus be more valuable than is often recognized.   
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The use of a reference group 
In the present study, the reference group was matched on age, gender, and region 
(i.e. city or countryside) with the patient group. At all points in time, we found no 
significant differences between both groups in their sociodemographic 
characteristics. This enabled us to make valid comparisons between patients and 
references regarding outcomes and factors associated with these outcomes. When 
making such comparisons, we assume that the functioning of these references 
reflects a level of functioning that is “normal” in the general population. However, 
this does not necessarily have to be the case. Therefore, we compared the levels of 
physical symptoms and depressive symptoms in references with those in other 
samples from the general population (Bouma et al., 1995; De Haes et al., 1996; 
Hann et al., 1999). Both the amount of physical symptoms and the level of 
depressive symptoms were in line with the levels in other samples from the general 
population. This finding underpins the representation of the reference group in the 
present study.  
 
Longitudinal design 
In longitudinal studies, it is important to decide at which points in time patients are 
being assessed. There are various ways of doing this. In this paragraph, we will 
describe two different approaches that can be distinguished. The first approach 
argues that assessment points should be meaningful and capture the different phases 
of adaptation or the different stages in the course of the illness. This approach is 
probably most relevant when the aim of the study is descriptive. The second 
approach concentrates on the relationship between predictors and outcomes. 
Assessment points need to be chosen in such a way that valid and meaningful 
conclusions can be drawn about the role of a particular factor as a predictor of a 
certain outcome. The latter approach is probably most useful when the aim of the 
study is explanatory.  
 
Meaningful assessment points 
The specific physical and psychosocial demands that cancer patients can face at a 
particular time and that ultimately determine their adjustment to cancer are likely to 
change over the course of the illness. In order to capture these changes, the present 
study examined cancer patients at four fixed points in time since diagnosis: at 3 
months, 9 months, 15 months, and 8 years after diagnosis. These points in time are 
believed to capture different phases of adaptation: the period of crisis, intermediate 
adjustment, relatively short-term adjustment, and long-term adjustment, 
respectively. However, such assumptions about the meaning of the assessment 
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points may be invalid and thus this approach may lead to a misrepresentation of the 
adaptational process. 
Recently, it has been suggested that, rather than using fixed points in time since 
diagnosis, it might be more fruitful to examine patients’ adjustment in relation to 
their stage of illness (Heim et al., 1997). Such an approach studies adjustment to 
cancer in terms of different phases in the course of the illness. For instance, in the 
case of breast cancer, the following stages of illness can be distinguished: (a) initial 
detection of a problem,  
(b) hospitalisation, confirmation of diagnosis, and surgery, (c) post-discharge with 
no additional therapy, (d) post-discharge with adjuvant chemo- and/or radiotherapy, 
(e) rehabilitation and adaptation, (f) metastatic disease and cancer recurrence, and 
(g) terminal illness and dying (Heim et al., 1997; Jacobsen & Holland, 1991). Thus, 
the stage of illness model proposes a more individual approach of assessing patients 
over time. Relating assessment to meaningful changes in the course of the illness 
and its treatment may provide more in-depth knowledge about the process of 
adjustment. However, it obviously requires complex procedures of data collection, 
in which the assistance from the medical team is essential. It should also be noted 
that the model above was developed to characterize the course of breast cancer and 
its treatment. Other types of cancer may have a different sequence of stages, 
especially in the short term. This means that for every type of cancer, the different 
stages of illness have to be determined. Clearly, such an approach is very complex in 
studies using a heterogeneous sample of cancer patients.  
The stage of illness approach is most relevant for patients’ short-term adjustment 
to cancer. In the long term, the impact of the illness and its treatment will be less 
prominent and other factors such as comorbidity and ageing may play a part in 
survivors’ functioning as well. Therefore, the stage of illness approach will be less 
useful for the examination of survivors’ long-term adjustment. At this point in time, 
it seems to be most important to distinguish survivors in the phase of rehabilitation 
and adaptation and those in the phase of metastatic or terminal illness.  
Returning back to the design of our study, it can be concluded that the 
assessment points were meaningful but also arbitrary to some extent. In any case, the 
design did not use the different phases in the course of the illness as a starting point. 
Since most changes in the illness stages occur in the first months following 
diagnosis, it can be argued that our first assessment at three months after diagnosis is 
too global. Over time, the impact of the illness will diminish. Therefore, the 
assessments at 15 months and eight years can be taken as a valid representation of 
the phase of short- and long-term adjustment, respectively.  
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Predictors and causality 
Besides describing the course of functioning over time, longitudinal studies aim to 
disentangle relationships and to draw conclusions about the causal direction between 
two or more factors. The problem of examining causality renews the discussion on 
the time and frequency of assessment. In general, relatively little attention is paid to 
the question whether the number of assessments and the time between assessments 
is to such an extent that an effect of a certain predictor on a future measure of 
outcome can be expected. Issues that need to be considered in this context are for 
example whether a certain predictor has an immediate effect on an outcome or 
whether its effect is only visible after some time. Furthermore, certain predictors 
may have a short-term effect, whereas others may have a long-lasting effect on a 
particular outcome. It can also be imagined that the direction of the relationship 
between a predictor and outcome changes over time. For instance, the perceived 
availability of social support may have a positive effect on patients’ coping 
responses in the early phases of the illness, but continued high levels of social 
support have a negative impact, through undermining independent coping and 
restricting the patients’ repertoire of coping strategies. Finally, in the examination of 
the effect of a predictor on future outcomes, the (in)stability of predictors and 
outcomes over time has to be taken into account. For instance, if we want to 
examine the effect of social support on future levels of well-being and social support 
is not stable over time, we might not find a significant effect, since well-being may 
be more strongly related to current levels of social support. This holds particularly 
for predictors with a short-term effect. The aforementioned issues are important to 
consider in a longitudinal study. All too often, points of assessments are chosen 
routinely or too global. If the focus of a study is to examine the role of a particular 
predictor (e.g. social support), it seems to be most important to properly choose the 
points of assessments, keeping in mind the issues mentioned in this paragraph. If the 
focus of the study is  
to explore which factors are able to predict a particular outcome (e.g. depressive 
symptoms), it may be less feasible to take these issues into account. But when 
performing such analyses, we need to be careful in drawing firm conclusions about 
the role of the predictors under study, since they were examined in a global way.  
In the case of long-term adjustment to cancer, it can be questioned whether it is 
useful to examine the role of certain factors as measured in the initial period after 
diagnosis as predictors of survivors’ long-term functioning. Long-term survivorship 
is defined as the period starting five years after diagnosis and onwards (Gotay & 
Muraoka, 1998; Schag et al., 1994). Consequently, there is a long period of time 
between the time of diagnosis and follow-up assessment. In this period of time, 
patients may have encountered other stressful life-events and chronic illnesses, and, 
of course, they have grown older. These factors may have a strong effect upon 
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survivors’ functioning, perhaps even stronger than the factors in the initial period 
after diagnosis.    
So far, we have addressed the importance of the timing and frequency of the 
assessment points for the examination of the causal direction between a particular 
predictor and outcome. However, we have not mentioned yet that, in reality, 
processes are often complex and the concepts under study are likely to influence 
each other mutually (see the model of Moos and Schaefer). For instance, physical 
symptoms may induce anxiety and depression and these feelings may subsequently 
lead to a heightened experience of physical symptoms. Another example is the 
relationship between resources and outcome. A lack of social support may induce 
depressive symptoms, which may subsequently influence the amount, perception, 
and satisfaction with social support. A third example of bilateral relationships is the 
association between different resources. Persons who lack self-esteem may receive 
little social support and this lack of support may further deteriorate feelings of 
personal strength. When conducting a longitudinal study, we need to be aware that, 
regardless the way in which assessment points were chosen, such a study can only 
portrait patients’ functioning at a given moment in time in the on-going feedback 
loop. In  
other words, the results can only provide information about the causal relationship 
between different factors, given the choice of assessment points in time and the 
assumptions made by the researcher. This again emphasizes the importance of 
choosing meaningful assessment points.  
 
Combined approach of quantitative and qualitative measures 
In the present study, a self-report questionnaire, a semi-structured interview, and a 
more qualitative interview were used to collect the data.  
In general, quantitative research methods (e.g. self-report questionnaires) provide 
systematic measures of specified variables for all persons and has the advantage that 
within-and between-subjects comparisons can be made. An important limitation of 
this approach is that one cannot discover new or unexpected variables, that is, 
factors beyond those that were defined by the researcher in advance. Qualitative 
research methods (e.g. an open unstructured interview) may elicit more in-depth 
information about a relatively new topic and may lead to a better understanding of 
the experience from the person’s perspective. Important limitations of the latter 
approach are that sample sizes are often small and that one cannot obtain 
comparable data for all persons under study, thus persons cannot be compared.     
For the present thesis, we developed an interview that can be regarded  
as a combination of a quantitative and qualitative approach. The interview 
encompassed a set of topics and interviewers were free to decide in which order to 
discuss these topics and to (re) formulate the questions. Respondents were 
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encouraged to talk openly at their own pace. Both cancer survivors and references 
were interviewed, with the exclusion of particular cancer-related topics in the latter 
group. The interviews lasted on average for about one hour in the reference group up 
till two hours in the survivor group. After the interview, the interviewer coded the 
stories of the respondents on one or more response categories. The advantage of 
such a type of interview is that, in a large sample of cancer survivors and references, 
information could be collected that could not have been measured with existing 
questionnaires (e.g. changes in the appreciation of life and the role of the cancer 
experience herein). Furthermore, as a result of the coding system, the data could be 
analysed using statistical tests. As can be read in Chapter 5 and 6, the data appeared 
to be very fruitful in pointing out the issues at stake and the extent to which they 
occurred. For instance, the interviews clearly demonstrated the perception of 
positive changes, both in cancer survivors and in references, and the extent to which 
survivors attributed these changes to the cancer experience. The interviews also 
showed that particular illness-related issues, such as a search for positive meaning, 
attentiveness to physical symptoms, and a fear of recurrence were more noticeable in 
younger than in older cancer survivors.  
When interpreting the interview data, one has to be aware that bias may have 
occurred, among others, as a result of cognitive processes. Festinger’s theory of 
cognitive dissonance (Festinger, 1957) may be relevant to understand these 
processes. The theory holds that dissonance, being psychologically uncomfortable, 
motivates people to reduce this dissonance, by denying or minimizing the negative 
consequences or by looking for positive consequences. This theory may explain why 
cancer survivors search for and create positive meaning in the cancer experience. 
The search for meaning is believed to help patients to cope with the stressful aspects 
of the situation and to restore their emotional balance and resources (Taylor, 1983; 
Folkman & Moskowitz, 2000). Taylor’s theory of positive illusions (Taylor & 
Armor, 1996) may also be useful to understand cognitive processes. The theory 
states that normal human perception is marked by mild positive biases (e.g. self-
aggrandizement, unrealistic optimism, and exaggerated perceptions of control). This 
may explain why a substantial number of both survivors and references in the 
present study reported positive changes in their functioning.   
To conclude, the quantitative longitudinal data and the more qualitative data 
were both important sources of information and supplemented each other in a 
valuable way. The quantitative data enabled us to describe the process of long-term 
adjustment and the late impact of cancer upon survivors’ general functioning. The 
qualitative data shed more light on cancer-specific aspects of long-term adjustment.  
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Theoretical reflections and future research 
 
Negative and positive outcomes 
An important finding of the present study is that survivors may experience positive 
consequences of the cancer experience, relatively independent of whether they 
experience negative consequences as a result of cancer. Traditionally, stress-coping 
models have focused predominantly on negative affect and other adverse outcomes 
such as feelings of loneliness, uncertainty, pessimism, and hopelessness. Positive 
affect and positive outcomes such as hope, optimism, happiness, and meaning in life 
have received much less attention.  
Recently, there is a greater interest in the adaptational function of positive 
outcomes in the face of adversity (such as a diagnosis of cancer). The model of 
Moos and Schaefer is a good example of a conceptual framework that takes into 
account that, in the aftermath of a crisis, people may emerge from a life crisis with 
enhanced personal and social resources and new coping skills (Schaefer & Moos, 
1998). In her theory of cognitive adaptation, Taylor (1983) maintains that when 
individuals have experienced a threatening event and the negative consequences are 
difficult to deny, they search for positive meaning in the experience (e.g. by 
reappraisal of life) and try to regain mastery and self-esteem. Such positive 
perceptions are believed to enhance the person’s coping and adjustment to the event 
(Taylor & Armor, 1996). Similarly, Folkman (1997) suggests that, in the context of 
significant and enduring stress, distress may motivate people to search for and create 
positive meaning (e.g. by positive reappraisal and goal-directed coping). Attributing 
(positive) meaning to certain areas in one’s life may help people to cope with the 
negative consequences of an event and enhance their well-being (Folkman, 1997; 
Folkman & Moskowitz, 2000). It remains unclear to what extent these processes are 
conscious or unconscious (Vaillant, 2000). Probably, people use both unintentional 
and intentional strategies to process threatening information and to reconstruct their 
lifes.  
When looking more closely at these theoretical notions, it becomes clear that 
there exists a lack of clarity regarding the time frame (i.e. process) and the status 
(i.e. coping or outcome) of positive consequences. Since it is not clear when coping 
characterized by positive reappraisal and goal-directedness is most likely to occur 
(i.e. during the early, middle, or later stages of the crisis or once the crisis is 
resolved), it may be difficult to distinguish between coping characterized by positive 
reinterpretation and positive outcomes in general. Nevertheless, these models 
recognize the strength of human intrinsic motivation and possibilities to cope with 
life crises. Therefore, they describe the complex processes of adjustment to adversity 
in a more accurate and complete way. They are the starting point from which the 
process of positive consequences of illness and its determinants can be studied.  
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More research is needed to sophisticate the definition and assessment of positive 
consequences of illness (Cohen et al., 1998). First, regarding the definition, it is 
possible and necessary to distinguish perceived positive changes or benefits of the 
illness as an outcome from those of coping strategy or style? In addition, to what 
extent is perceiving benefits a meaningful outcome in itself, apart from adjustment 
outcomes? Secondly, what type of changes should be considered as personal 
growth? Perceived benefits of illness may to some extent be an individual process, 
that encompasses shifts in values or beliefs that a particular person subjectively 
experiences as favourable. Thirdly, is the perception of positive consequences a one-
dimensional concept (and thus can we add all positive consequences into one overall 
sumscore) or do we need to distinguish multiple dimensions? Finally, what is the 
time frame for the assessment of perceiving benefits of illness and which factors are 
associated with the report of positive consequences of illness?  
The notion that positive consequences may occur in the course of the illness and 
are presumed to be related to better adjustment has implications for designing 
psychosocial interventions. Rather than focusing solely on alleviating negative 
sequelae, psychosocial interventions need to incorporate explicitly elements 
intended to reinforce patient’s own positive and adaptive strengths. For instance, by 
fostering feelings of hopefulness, encouraging a more positive (re) appraisal of the 
stressful situation and otherwise ordinary event, and helping patients to find new 
goals and remain engaged with life, such interventions may help patients to cope 
with the cancer experience.  
 
Risk factors and screening 
To the extent that a substantial number of cancer patients suffers from psychological 
distress as a result of the diagnosis of cancer, early identification and treatment is 
essential to help these patients to adapt more effectively to the diagnosis of cancer. 
Treatment of psychological distress may improve medical outcomes, reduce health 
care costs, and increase patients’ overall quality of life. However, the majority of the 
cancer patients do not experience severe psychological distress and thus probably do 
not need an intervention. Therefore, it is essential to select cancer patients who are 
most likely to benefit from some form of intervention. Clinically strong and cost-
effective outcomes are most likely to result from interventions targeted at those 
patients suffering from or at high risk of significant psychological distress. The 
question is: how?  
One possibility is to offer a psychological intervention to cancer patients who 
request psychological treatment themselves. However, many cancer patients are 
unable or unwilling to share their problems with their clinician and thus do not ask 
for help. Another possibility is that members of the health care team detect and refer 
cancer patients with adjustment problems to a mental health practioner. In practice, 
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clinicians and nurses may not see it as their task to probe into the psychological 
problems of patients and in the constraints of a busy clinical schedule, they may 
have little time available to explore the psychological concerns of every patient. 
Thus, it is probably not sufficient to direct psychological interventions only at those 
patients who request such support or those who are referred by the health care team.  
From a research perspective, it seems logical to target interventions at risk 
groups. It has been found that certain factors are associated with an increased risk of 
psychological morbidity: patients’ medical (e.g. advanced disease and physical 
burden) and sociodemographic (e.g. younger age) characteristics, a lack of personal 
and social resources (e.g. low self-esteem, lack of control, insufficient social 
support, and poor coping styles), a psychiatric history, and the presence of 
concurrent life stressors and chronic illnesses. Targeting interventions at risk groups 
means that, ideally, cancer patients can be offered an intervention before they 
develop severe psychological distress. However, this approach has several 
drawbacks. First, there is obviously not one predominant factor, but rather a series of 
factors that may contribute to elevated levels of psychological distress. This makes it 
difficult to identify particular risk groups. Furthermore, the presence of a certain risk 
factor in a cancer patient indicates at the most an increased risk of problems, often 
not even a huge risk but a somewhat elevated risk at group level. No firm 
judgements can be made at an individual level. Furthermore, people that do not 
belong to any of the risk groups may also experience severe problems that require 
professional help. Thirdly, offering an intervention to every patient that meets one or 
more risk factors may be patronizing. For instance, when having a lower education 
turns out to be a risk factor, does this mean that all lower educated cancer patients 
should be offered a psychological intervention? Obviously, the answer to this 
question seems no.  
A more effective use of the theoretical knowledge about risk factors in clinicial 
practice may be to incorporate the information in individual screening. If clinicians 
and nurses are aware of the prevalence of psychological distress and the type of 
cancer patient likely to experience distress, they may detect problems earlier and 
treat or refer more appropriately. Information about the risk factors may also be 
incorporated in screening instruments. Most screening instruments focus on existing 
psychological distress or poor quality of life (Hall et al., 1999; Hopwood et al., 
1991). However, careful screening on the presence of multiple risk factors 
associated with developing psychological problems may increase the effectiveness 
of these instruments. For instance, an item such as “Do you have someone to talk 
about your experience with cancer?” may give an indication about the availability of 
someone with whom the patient can talk about his or her concerns, fears, worries 
regarding the illness and its consequences. Again, it should not be the case that all 
patients who meet one or more risk factors are routinely offered an intervention. A 
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clinical judgement from a clinician or specialized nurse is still needed to decide, in 
consultation with the patient, whether referral for psychosocial care is desirable. 
Nonetheless, in a busy clinical setting, screening may proved to be a rapid method to 
gain an impression of patient’s strengths and burden and to help health care 
providers to identify patients who may experience difficulties in their adjustment to 
the cancer and its treatment. The information from the screening instrument may 
subsequently be used to tailor the amount and type of psychosocial care at the needs 
and concerns of the patient. The majority of the cancer patients will not report 
excessive psychological morbidity and will thus benefit mostly from the interactions 
with the medical team and good information about the cancer, its treatment, the 
process of physical recovery, the chance and symptoms of recurrence, and life style 
issues (Ferrell et al., 1998b; Gray et al., 1998; Helgeson et al., 2001; Henderson, 
1997). Some cancer patients, however, may need and benefit from specialized 
psychosocial treatment, with one or more sessions in an individual or group setting.   
Information about the risk factors can also identify issues that merit further 
attention during psychological interventions. For instance, the findings of Chapter 4 
concerning the association of social support and self-esteem with depressive 
symptoms suggest that it may be useful to stimulate patients to focus on the positive 
aspects of themselves and opportunities in their lives and to teach them 
communication skills and encourage them to actively seek support. At first sight, the 
fact that fixed sociodemographic factors such as a younger age are associated with 
maladjustment seems to be of little practical relevance. However, since age is 
believed to strongly affect well-being through its effect on patients’ appraisal of the 
cancer, it might be fruitful to discuss the meaning of the cancer for the patient (e.g. 
sense of deprivation, loss, and threat) during interventions.  
In sum, psychological treatment should be available for all cancer patients, but as 
the costs of medical services are under increased scrutiny, psychological 
interventions need to demonstrate their necessity and feasibility. Early screening 
may provide a method of efficiently evaluating a large number of patients and 
identifying those patients at high risk of or those currently experience severe 
psychological burden. Future research is needed to identify brief, simple, and 
accurate screening tools and to investigate the feasibility of these methods to detect 
patients at risk of or suffering from adjustment problems to cancer. Which factors 
should be assessed during screening? Do we need to screen all cancer patients? 
When should screening take place? Should patients be screening only once or 
multiple times in the course of illness? The ultimate criterion is that interventions are 
effective. Therefore, more research is needed to examine the effectiveness of 
interventions targeted at those at risk of or suffering significant distress and to 
identify which form (e.g. group or individual) and components (e.g. psycho-
education, relaxation, emotional support, training in coping skills and cognitive 
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restructuring) of treatment are most effective for whom and when. All together, this 
research may lead to more effective screening tools and eventually to standard 
guidelines for screening and psychosocial intervention and a better integration of 
medical health care and psychosocial services. 
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Samenvatting 
 
Jaarlijks wordt in Nederland bij meer dan 57.000 personen kanker vastgesteld en 
sterven 37.000 personen aan deze ziekte. Dit maakt kanker,  
na hart- en vaatziekten, de belangrijkste doodsoorzaak in Nederland. Als gevolg van 
de bevolkingsgroei, een toenemende vergrijzing, veranderingen in de risicofactoren 
en verbeterde screeningsmethoden is de incidentie  
(het aantal nieuwe ziektegevallen) van kanker in de afgelopen decennia toegenomen. 
Tegelijkertijd zijn door een eerdere diagnose en verbeteringen in de behandeling de 
overlevingskansen voor de meeste vormen van kanker sterk verbeterd. Dat betekent 
dat een groot aantal patiënten met kanker in leven blijft. Dit proefschrift richt zich 
op de vraag hoe kankerpatiënten zich, in lichamelijk, psychisch en sociaal opzicht, 
aanpassen aan de ziekte. Om meer inzicht te krijgen in het aanpassingsproces 
hebben we vanaf het moment kort na diagnose tot acht jaar later een groep 
kankerpatiënten gevolgd. Daarnaast hebben we ook een groep personen zonder 
kanker over een periode van acht jaar gevolgd. Door patiënten met deze zogenaamde 
‘referentiegroep’ te vergelijken, hopen we meer duidelijkheid te krijgen over de 
wijze waarop patiënten zich aanpassen aan de ziekte en de factoren die op het 
aanpassingsproces van invloed zijn.  
 
 
Inleiding en theoretische achtergrond van de studie 
 
In Hoofdstuk 1 wordt beschreven dat een diagnose kanker een ingrijpende 
gebeurtenis is, die grote gevolgen kan hebben voor het lichamelijk, psychisch en 
sociaal welbevinden van de patiënt. Patiënten moeten vaak een zeer belastende en 
soms langdurige behandeling ondergaan. Als gevolg hiervan kunnen ze in meer of 
mindere mate te maken krijgen met ernstige lichamelijke klachten (zoals pijn en 
vermoeidheid), aantasting van het lichaamsbeeld en beperkingen in het dagelijks 
functioneren. Daarnaast kan de ziekte het psychisch evenwicht van de patiënt ernstig 
verstoren. Patiënten voelen zich vaak kwetsbaar en onzeker over hun eigen lichaam 
en de toekomst. Verder kunnen ze gevoelens van angst, depressie en boosheid 
ervaren. Ook kunnen ze een verminderd gevoel van eigenwaarde en competentie en 
veranderingen in de relatie met partner, kinderen, familie, vrienden en collega’s 
ondervinden. Het eerste jaar na diagnose is bijzonder belastend en stressvol voor 
patiënten. In de daaropvolgende jaren weten de meeste patiënten die de ziekte 
overleven, zich aan te passen aan de situatie en het vroegere niveau van functioneren 
te herwinnen. Toch kunnen kankerpatiënten ook op de langere termijn nog gevolgen 
van de ziekte ervaren, zoals bepaalde blijvende lichamelijke klachten en de angst 
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Om meer inzicht te krijgen in het aanpassingsproces en een ordening aan te 
brengen in de factoren die hierin, als uitkomstmaat of als voorspeller, een rol spelen, 
introduceren we het model van Moos en Schaefer (1993).  
Het model veronderstelt dat drie factoren de aanpassing aan ziekte bepalen:  
(a) medische factoren (zoals het type kanker, het ziektestadium en de behandeling), 
(b) persoonsfactoren (sociaal-demografische kenmerken zoals geslacht en leeftijd, 
en persoonlijke hulpbronnen zoals gevoel van eigenwaarde), en (c) 
omgevingsfactoren (de aanwezigheid van andere stressvolle gebeurtenissen en 
chronische ziekten, en sociale hulpbronnen zoals sociale steun). Volgens het model 
kunnen patiënten uiteindelijk ook positieve gevolgen van de ziekte ervaren, zoals 
een toename van hun persoonlijke en sociale hulpbronnen.  
Op basis van het model zijn twee algemene onderzoeksvragen geformuleerd die 
in dit proefschrift centraal staan. Ten eerste: wat is de invloed van de ziekte op het 
lichamelijk en psychisch functioneren en op de persoonlijke en sociale hulpbronnen 
van de patiënt? Ten tweede: in hoeverre spelen medische en sociaal-demografische 
kenmerken en de persoonlijke en sociale hulpbronnen hierin een rol? Het 
onderzoeken van deze vragen stelt hoge eisen aan de opzet van de studie. Om het 
complexe karakter van het aanpassingsproces goed te kunnen beschrijven, zijn er 
meerdere momenten nodig waarop een breed scala aan relevante factoren zorgvuldig 
wordt gemeten. Om de invloed van de ziekte te kunnen onderscheiden van andere 
factoren die het functioneren van de patiënt beïnvloeden, zoals het natuurlijke 
verouderingsproces, is het noodzakelijk dat het functioneren van patiënten wordt 
vergeleken met het functioneren van personen die geen kanker hebben.  
De gegevens van het huidige onderzoek komen uit een acht jaar durend 
onderzoek naar de aanpassing van patiënten aan de ziekte kanker. Dezelfde 
patiënten hebben op vier momenten aan het onderzoek deelgenomen, namelijk 3 
maanden, 9 maanden, 15 maanden en 8 jaar na diagnose. Drie maanden na diagnose 
(‘crisisperiode’) hebben 475 patiënten aan het onderzoek meegedaan. Hiervan 
hebben 403 patiënten ook 15 maanden na diagnose aan het onderzoek meegewerkt 
(‘korte-termijn aanpassing’) en hebben 206 patiënten acht jaar na diagnose aan het 
onderzoek deelgenomen (‘lange-termijn aanpassing’). Daarnaast is uit de 
bevolkingsregisters van vijf gemeenten in het noorden van Nederland een steekproef 
getrokken. Via deze weg zijn 559 personen voor de referentiegroep benaderd. Deze 
groep kwam wat betreft leeftijd, geslacht en woongebied overeen met de 
patiëntengroep. Evenals de patiënten hebben de personen uit de referentiegroep ook 
in acht jaar tijd vier keer aan het onderzoek deelgenomen. Op het eerste 
meetmoment deden 255 personen aan het onderzoek mee. Hiervan hebben 225 
personen ook op het derde meetmoment meegedaan en hebben 120 personen op alle 
vier meetmomenten aan het onderzoek deelgenomen.  
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Op alle vier meetmomenten hebben we door middel van een schriftelijke 
vragenlijst en een mondeling interview gegevens verzameld over het lichamelijk 
functioneren (de aanwezigheid van lichamelijke symptomen en beperkingen), over 
het psychisch functioneren (de aanwezigheid van depressieve symptomen en 
gevoelens van angst), over de persoonlijke hulpbronnen (gevoel van eigenwaarde, 
tevredenheid met het leven, gevoel van doel en voldoening in het leven), over de 
sociale hulpbronnen (sociale steun en tevredenheid met de partnerrelatie), over de 
aanwezigheid van een andere chronische ziekte en andere stressvolle gebeurtenissen, 
en over de sociaal-demografische kenmerken van de respondenten. Tevens is op het 
vierde meetmoment een speciaal voor dit onderzoek ontwikkeld kwalitatief 
interview afgenomen, waarin de patiënt in eigen bewoordingen de specifieke 
langetermijngevolgen van de ziekte benoemt. Met hulp van het Integraal 
Kankercentrum Noord-Nederland hebben we medische gegevens over het type 
kanker, het ziektestadium en de behandeling verkregen. 
  
 
Het meten van depressieve symptomen  
 
Het hebben van depressieve gevoelens is een normale reactie op het horen van de 
diagnose kanker. Om de mate van depressieve symptomen te meten, wordt in deze 
studie gebruikgemaakt van een schriftelijke vragenlijst, de Center for Epidemiologic 
Studies Depression (CES-D) scale. Deze vragenlijst bestaat uit 20 items 
(symptomen), waarvan 16 negatief (bijv. ‘ik voelde me gedeprimeerd’) en 4 positief 
zijn geformuleerd (bijv. ‘ik voelde me even veel waard als ieder ander’). Bij elk item 
moet men aangeven in hoeverre men het desbetreffende symptoom in de afgelopen 
week heeft ervaren. Na het hercoderen van de positief geformuleerde items worden 
alle 20 items bij elkaar opgeteld. Deze somscore toont de mate waarin iemand last 
heeft van depressieve symptomen.   
In Hoofdstuk 2 wordt de hypothese getoetst of de negatief en positief 
geformuleerde items niet één begrip (depressie), maar twee verschillende begrippen 
meten. De negatief geformuleerde items komen sterk overeen met de definitie van 
depressie die stelt dat depressie gekenmerkt wordt door een neerslachtige stemming 
(verdriet, leegte, somberheid) en/of een duidelijke vermindering van interesse of 
plezier in activiteiten. Andere kenmerken van depressie zijn sterke gevoelens van 
waardeloosheid en schuld alsmede lichamelijke klachten zoals slaapproblemen, 
veranderingen in eetlust en vermoeidheid. Gezien deze definitie van depressie kan 
men zich afvragen of de positief geformuleerde items depressie meten.   
De belangrijkste conclusie van hoofdstuk 2 is dat de negatief en positief 
geformuleerde items twee relatief onafhankelijke factoren meten. Het feit dat deze 
factoren relatief onafhankelijk zijn, betekent dat mensen die de negatief 
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geformuleerde items ervaren, tegelijkertijd ook de positief geformuleerde items 
kunnen ervaren. Dit pleit tegen het gebruik van de totale somscore, gebaseerd op alle 
20 items. Verder onderzoek laat zien dat alleen de negatief geformuleerde factor 
sterk samenhangt met andere maten van depressie en angst. Op het oog kan men 
veronderstellen dat de positief geformuleerde factor positieve gevoelens meet. Beide 
factoren blijken echter maar in geringe mate samen te hangen met verschillende 
maten van positieve gevoelens, zoals tevredenheid met het leven in het algemeen, 
een subjectief gevoel van kwaliteit van leven en een gevoel van eigenwaarde. Het 
blijft dus onduidelijk wat de positief geformuleerde factor meet, maar het is in ieder 
geval geen goede maat voor depressie en positieve gevoelens. Samenvattend kunnen 
we concluderen dat de somscore van de 16 negatief geformuleerde items een meer 
valide maat van depressieve symptomen is. Dat is de reden waarom we deze in dit 
proefschrift gebruiken.  
 
 
Sociaal-demografische kenmerken, medische factoren  
en depressieve symptomen 
 
In Hoofdstuk 3 komt de vraag aan de orde in hoeverre kankerpatiënten in het eerste 
jaar na diagnose depressieve symptomen ervaren. Om te bepalen in hoeverre deze 
symptomen het gevolg van de ziekte zijn, vergelijken we het niveau van depressieve 
symptomen bij patiënten met het niveau daarvan bij personen in de referentiegroep. 
Dit hoofdstuk gaat ook in op de invloed van sociaal-demografische kenmerken 
(geslacht, leeftijd, burgerlijke staat en opleiding) en medische factoren (type kanker, 
ziektestadium en behandeling) op de mate waarin sprake is van depressieve 
symptomen.  
Een belangrijke bevinding is dat patiënten in vergelijking met referentiepersonen 
meer depressieve symptomen ervaren, zowel 3 als 15 maanden na diagnose. Tijdens 
de periode van crisis, drie maanden na diagnose, ervaart een kwart van de patiënten 
een verhoogde mate van depressieve symptomen. In de periode tussen 3 and 15 
maanden na diagnose rapporteert een deel van de patiënten hierin een verbetering. 
Andere patiënten blijven echter tot 15 maanden na diagnose een verhoogde mate van 
depressieve symptomen ervaren. Daarnaast is er een kleine groep patiënten die vlak 
na diagnose geen depressieve symptomen ervaart, maar in het jaar daaropvolgend 
wel een toename daarvan laat zien.      
Onderzoek naar de invloed van sociaal-demografische factoren op depressieve 
symptomen toont aan dat vrouwelijke patiënten meer depressieve symptomen 
rapporteren dan mannelijke patiënten. Eenzelfde verband tussen geslacht en 
depressieve symptomen is bij de personen uit de referentiegroep gevonden. Dit 
suggereert dat vrouwen over het algemeen een groter risico lopen om depressieve 
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symptomen te ervaren dan mannen. Met andere woorden, geslacht lijkt een 
weerspiegeling van een algemene kwetsbaarheid voor depressieve symptomen, los 
van de aanwezigheid van een ernstige ziekte als kanker.  
Leeftijd is de enige factor die bij patiënten op een andere manier met depressieve 
symptomen samenhangt dan bij referentiepersonen. Alleen bij patiënten is er sprake 
van een duidelijk verband tussen een relatief jongere leeftijd (jonger dan 65 jaar) en 
meer depressieve symptomen, met name drie maanden na diagnose. Het feit dat dit 
verband niet bij personen in de referentiegroep voorkomt, betekent dat leeftijd geen 
algemene kwetsbaarheid weerspiegelt, maar specifiek een rol speelt wanneer een 
ernstige ziekte als kanker zich voordoet. Aangezien chronische ziekten over het 
algemeen vaker bij oudere personen voorkomen, is een mogelijke verklaring voor 
het voorgaande, dat jongere personen minder zijn voorbereid op de diagnose kanker. 
De ziekte en de lichamelijke gevolgen kunnen gevoelens van lichamelijke 
kwetsbaarheid en afhankelijkheid oproepen die gewoonlijk pas in een latere 
levensfase optreden. Dit kan bij jongere patiënten leiden tot gevoelens van 
anderszijn en eenzaamheid. Verder zullen jongere patiënten meer gevolgen van de 
ziekte ervaren in hun dagelijks functioneren, in de relatie met hun partner en 
kinderen en in hun toekomstperspectief en levensdoelen. Tegelijkertijd zullen 
jongere patiënten over het algemeen minder ervaring hebben met het omgaan met 
ziekte en ingrijpende levensgebeurtenissen. Kortom, er zijn verschillende goede 
verklaringen mogelijk voor het voorkomen van meer depressieve symptomen bij 
relatief jongere kankerpatiënten.  
Men zou verwachten dat de reactie van patiënten op de diagnose kanker ook 
samenhangt met medische factoren, zoals het type kanker, de behandeling en het 
ziektestadium. Alleen het type kanker blijkt samen te hangen met de mate waarin 
patiënten depressieve symptomen ervaren.  
Dit verband verdwijnt echter wanneer we de invloed van de sociaal-demografische 
kenmerken op depressieve symptomen meenemen.  
Kortom, medische factoren lijken weinig invloed te hebben op de mate waarin 
patiënten depressieve symptomen ervaren.  
 
 
Sociale steun, gevoel van eigenwaarde en  
depressieve symptomen  
 
Verschillende theorieën en studies benadrukken de belangrijke rol van persoonlijke 
en sociale hulpbronnen voor het psychisch welbevinden. Volgens sommige 
onderzoekers hangen deze hulpbronnen sterk samen met het psychisch welbevinden, 
ongeacht of personen blootstaan aan stressvolle omstandigheden of niet. Andere 
onderzoekers beweren daarentegen dat hulpbronnen vooral bij personen die 
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geconfronteerd worden met stressvolle omstandigheden zoals een ernstige ziekte, 
een gunstig effect hebben op het psychisch welbevinden. Volgens deze onderzoekers 
kunnen hulpbronnen de nadelige gevolgen van de situatie op het welbevinden 
verminderen. 
In Hoofdstuk 4 komt de vraag aan de orde of een gevoel van eigenwaarde 
(persoonlijke hulpbron) en sociale steun (sociale hulpbron) onafhankelijk van elkaar 
samenhangen met depressieve symptomen. Vervolgens bekijken we of dit 
verschillend is voor patiënten en referentiepersonen. Er zijn drie belangrijke vormen 
van sociale steun te onderscheiden: (a) subjectieve ervaring van beschikbare steun 
(bijv. ‘het gevoel dat anderen je waarderen en tijd voor je hebben’), (b) een tekort 
aan feitelijk ontvangen emotionele steun (bijv. ‘hoe vaak gebeurt het dat anderen je 
geruststellen, troosten, goede raad geven en helpen problemen te verhelderen, en in 
hoeverre komt dat overeen met je eigen behoefte aan steun’), en (c) hoeveelheid 
negatieve sociale interacties (bijv. ‘hoe vaak gebeurt het dat anderen je kritiek 
geven, verwijten maken, zich met je bemoeien’). 
De belangrijkste conclusie van dit hoofdstuk is dat zowel een gebrek aan gevoel 
van eigenwaarde als weinig sociale steun samenhangen met meer depressieve 
symptomen drie maanden na diagnose. Over het algemeen vinden we hierin geen 
verschillen tussen patiënten en referentiepersonen. Dit suggereert dat hulpbronnen 
bepaalde menselijke basisbehoeften vervullen. Ze blijken, of er nu sprake is van een 
acute ernstige ziekte of niet, een grote invloed te hebben op het psychisch 
functioneren. Alleen een tekort aan feitelijk ontvangen emotionele steun blijkt bij 
kankerpatiënten een veel sterkere invloed te hebben op de mate waarin sprake is van 
depressieve symptomen, dan bij referentiepersonen. Dit toont aan dat het voor de 
aanpassing aan de ziekte voor patiënten van essentieel belang is dat er iemand is bij 
wie ze terechtkunnen voor steun, troost, en goede raad. 
 
 
Het functioneren van patiënten op de lange termijn 
 
In Hoofdstuk 5 verschuift de aandacht naar het langetermijnfunctioneren van 
diezelfde patiënten. Centraal staat de vraag in hoeverre de ziekte acht jaar na 
diagnose nog steeds invloed heeft op het functioneren van de patiënten. Daartoe 
vergelijken we hun functioneren met het functioneren van op leeftijd en geslacht 
gematchte personen uit dezelfde referentiegroep van acht jaar geleden. Zij zijn 
namelijk ook over een periode van acht jaar gevolgd.   
  Een belangrijke bevinding is dat patiënten zich, in psychisch opzicht, op de lange 
termijn goed weten aan te passen aan de ziekte. Acht jaar na diagnose rapporteren zij 
niet meer depressieve symptomen of gevoelens van angst dan personen uit de 
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referentiegroep. Wel geeft 76% van de patiënten aan dat ze nog regelmatig aan de 
periode van ziek zijn denken en dat ze bang zijn voor een recidief.  
Lichamelijk blijven patiënten acht jaar na diagnose echter nog wel klachten 
ondervinden. In vergelijking met de referentiepersonen ervaren patiënten meer 
lichamelijke symptomen en meer beperkingen in hun huishoudelijke en sociale 
activiteiten. Behalve deze lichamelijke klachten geeft 42% van de patiënten ook aan 
dat ze sinds de ziekte alerter zijn op lichamelijke symptomen. 
  Er worden geen verschillen tussen patiënten en referentiepersonen gevonden in 
het niveau van persoonlijke en sociale hulpbronnen. Acht jaar na diagnose ervaren 
patiënten dezelfde mate van doel en voldoening in het leven, tevredenheid met het 
leven, gevoel van eigenwaarde en tevredenheid met emotionele steun en de 
partnerrelatie als referentiepersonen.  
Wanneer we tijdens het kwalitatief interview vragen naar veranderingen in 
gevoelens van zelfwaardering en waardering voor het leven in het algemeen in de 
afgelopen acht jaar, antwoordt 30% van de patiënten en 28% van de 
referentiepersonen dat ze in de loop der jaren meer zelfwaardering hebben gekregen. 
Tevens zegt 48% van de patiënten en 41% van de referentiepersonen een grotere 
waardering voor het leven in het algemeen te hebben. De bevinding dat beide 
groepen in ongeveer dezelfde mate deze positieve veranderingen rapporteren, 
suggereert dat de ziekte kanker hierbij vrijwel geen rol speelt. Wanneer we patiënten 
echter zelf vragen naar de invloed van de ziekte, zegt 40% dat de ziekte invloed 
heeft gehad op veranderingen in zelfwaardering en geeft 54% aan dat de ziekte 
invloed heeft gehad op veranderingen in de waardering voor het leven in het 
algemeen.  
Het is opmerkelijk dat een groot deel van de patiënten de veranderingen aan de 
ziekte toeschrijft, aangezien de referentiepersonen in dezelfde mate deze 
veranderingen rapporteren. Het zoeken en toeschrijven van positieve veranderingen 
aan de ziekte kan een manier zijn waarop patiënten omgaan met de ziekte en de 
negatieve gevolgen ervan. Een deel van de referentiepersonen zal in de afgelopen 
acht jaar waarschijnlijk ook een stressvolle gebeurtenis hebben meegemaakt. De 
aanpassing aan de nieuwe omstandigheden en het natuurlijke verouderingsproces 
kunnen in deze groep tot positieve veranderingen hebben geleid. 
   
 
De rol van leeftijd in het functioneren op de lange termijn 
 
In hoofdstuk 3 is reeds beschreven dat patiënten jonger dan 65 jaar in de eerste 
maanden na diagnose meer depressieve symptomen ervaren dan patiënten van 65 
jaar of ouder. In Hoofdstuk 6 gaan we na in hoeverre leeftijd acht jaar na diagnose 
een rol speelt in het functioneren van de patiënt. Om de invloed van de ziekte te 
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kunnen onderscheiden van de invloed van andere factoren, zoals het natuurlijke 
verouderingsproces, vergelijken we het functioneren van patiënten met dat van de 
referentiepersonen.  
De resultaten laten zien dat patiënten van 65 jaar en ouder acht jaar na diagnose 
meer lichamelijke symptomen en meer beperkingen in hun huishoudelijke en sociale 
bezigheden rapporteren dan patiënten jonger dan 65 jaar. Een soortgelijk verband 
tussen leeftijd en gezondheidsklachten treffen we bij de referentiepersonen. 
Wanneer we het lichamelijk functioneren van patiënten vergelijken met dat van de 
referentiepersonen, blijkt het niveau van lichamelijke symptomen en beperkingen bij 
patiënten van 65 jaar en ouder overeen te komen met het niveau daarvan bij 
referentiepersonen van 65 jaar en ouder. Dit suggereert dat de lichamelijke 
problemen die oudere patiënten ervaren veelal te maken hebben met het natuurlijke 
verouderingsproces en in minder uitgesproken mate met de ziekte kanker.  
Bij patiënten jonger dan 65 jaar blijkt de ziekte acht jaar na diagnose echter nog 
steeds een grote impact te hebben op het lichamelijk functioneren. Met name 
patiënten tussen de 45 en 65 jaar ervaren nog steeds meer lichamelijke symptomen 
en beperkingen in hun sociale bezigheden dan hun leeftijdgenoten in de 
referentiegroep. Behalve deze lichamelijke problemen rapporteren jongere patiënten 
ook dat ze door de ziekte alerter op lichamelijke symptomen zijn geworden.    
Een tweede opvallende bevinding binnen de patiëntengroep is dat de ziekte 
vooral bij patiënten jonger dan 65 jaar existentiële vragen oproept, zoals ‘Waarom 
moet mij dit overkomen?’, ‘Wat is de oorzaak?’,  ‘Wat is de zin ervan?’. Tevens 
ervaren deze relatief jongere patiënten meer positieve gevolgen van de ziekte dan 
patiënten van 65 jaar en ouder. Door de ziekte leven ze intenser en voelen ze zich 
ook volwassenener. Ze zijn zich bewuster van hun eigen kracht en maken zich 
minder druk om de goedkeuring van anderen. Verder zegt bijna de helft van de 
jongere patiënten dat ze, in vergelijking met acht jaar geleden, meer waardering 
hebben voor zichzelf, voor de relatie met hun partner en kinderen, en voor het leven 
in het algemeen. Kortom, er zijn allerlei aanwijzingen die de gedachte ondersteunen 
dat met name jongere kankerpatiënten op zoek gaan naar een betekenis van de 
ziekte. Het zoeken en vinden van positieve gevolgen van de ziekte kan jongere 
patiënten helpen te begrijpen waarom ze op relatief jonge leeftijd kanker hebben 
gekregen. Ook kan het hen helpen bij het omgaan met de blijvende negatieve 
gevolgen van de ziekte.   
 
 
Algemene discussie en conclusies  
 
In het laatste hoofdstuk hebben we de belangrijkste bevindingen van het onderzoek 
samengevat en enkele kritische kanttekeningen geplaatst. Ter afsluiting bespreken 
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we de theoretische en praktische relevantie van de bevindingen. Een belangrijke 
bevinding van onze studie is dat de meeste kankerpatiënten in staat zijn zich aan te 
passen aan de ziekte en de gevolgen ervan. Een groep patiënten blijft echter ernstige 
psychische gevolgen van de ziekte ervaren. Toekomstig onderzoek moet zich richten 
op de vraag wat de meest effectieve manieren zijn om deze kankerpatiënten met (een 
verhoogd risico op) aanpassingsproblemen vroegtijdig te identificeren en een 
bepaalde psychologische interventie aan te bieden. Een andere belangrijke bevinding 
van dit onderzoek is dat kankerpatiënten niet alleen negatieve maar ook positieve 
gevolgen van de ziekte ervaren. Daarom is het van belang dat toekomstige studies en 
psychologische interventies bij kankerpatiënten, naast de negatieve gevolgen van de 
ziekte, impliciet aandacht besteden aan de mogelijkheden van persoonlijke groei als 
gevolg van de ziekte. Dit kan leiden tot meer inzicht in de functie van de positieve 
ervaringen die kankerpatiënten beschrijven.   
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and previous dissertations 
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Medical Decision Making and Evaluation of Healthcare. The first programme was 
reformulated in 1996 and was continued as Disorder, Disability and Quality of Life (DDQ). 
Hence, previous dissertations in this area are listed as part of the present DDQ-programme. 
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and Public Health Services Research and Rational Drug Use. 
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Drug Use group initiated a new research programme, i.e. Implementation of Evidence Based 
Medicine in the Medical Practice.  
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internet site: http://www.med.rug.nl/nch 
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 Stellingen behorende bij het proefschrift 
 
Short- and long-term adaptation to cancer: a  
comparison of patients with the general population 
 
1  Positief geformuleerde items horen niet thuis in een depressievragenlijst. 
 
2  Wetenschappers gaan vaak voorbij aan het vermogen van mensen om zich te 
schikken naar veranderde omstandigheden, waardoor een eenzijdig negatief 
beeld van aanpassing aan ziekte ontstaat. 
 
3  Het construeren van een eigen verhaal waarin de patiënt betekenis geeft aan 
de ziekte, kan voor de adaptatie van grotere waarde zijn dan rationele, op 
algemene feiten gebaseerde verklaringen.      
 
4  Leeftijd is meer dan een achtergrondvariabele waarvoor statistisch 
gecontroleerd moet worden. 
 
5  De verbanden tussen risicofactoren en depressieve symptomen in een 
patiëntenpopulatie zijn in de meeste gevallen een weerspiegeling van een 
algemene, niet aan ziekte gerelateerde kwetsbaarheid. 
 
6  Het gemak waarmee onderzoekers aanbevelingen doen om kennis over 
risicofactoren te implementeren in de klinische praktijk, geeft blijk van een 
zekere naïviteit. 
 
7  De visie van de onderzoeker op de werkelijkheid drukt een stevig stempel op 
de onderzoeksresultaten. 
 
8  Flexibele werktijden afgestemd op het bioritme van de individuele werknemer 
leiden tot een hogere productiviteit. 
   
9     Wie het niet veel te druk heeft, telt tegenwoordig niet meer mee.  
 
10   Dromend leven is niet hetzelfde als leven in een droom.  
 
 
Maya Schroevers, 29 mei 2002 
 
 
 
 